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Angiotensin II, the main effector peptide of the renin-angiotensin system, is
an important hormonal regulator of blood pressure and electrolyte balance.
It acts through receptors in its many target organs to exert a wide range of
effects. Foremost amongst these are stimulation of the zona glomerulosa (zg)
of the adrenal gland to secrete the mineralocorticoid aldosterone, and
contraction of vascular smooth muscle, particularly resistance arterioles. The
physiological significance of All receptors in the zonae fasciculata/reticularis
(zfr) of the adrenal cortex is less well characterised, despite the fact that All
can directly stimulate glucocorticoid secretion in a number of species. The
recent use of non-peptide All antagonists and molecular cloning have
established that All receptors can be divided into two classes : ATi, which
mediate the cardiovascular actions of All, and AT2, for which no clear
physiological function has been found.
It has been argued that the bovine zg and zfr are the most appropriate
cellular models for human adrenocortical cells. This thesis presents
modifications to improve the established methods for isolation and culture of
zg cells, and characterises responses to steroidogenic agonists during short-
term primary culture. The modified zg culture was used as a tool to
pharmacologically characterise the type 1 All receptor using Schild analysis
in order to obtain pA2 values for a selective ATi receptor antagonist, losartan
(DuP753). The pA2 value is a measure of antagonist affinity which should be
constant for the antagonist at a particular receptor subtype. The pA2 values
obtained were compared to both pA2 values previously reported for bovine
zfr cell ATi receptors, and pA2 values calculated from cultured rat mesenteric
artery smooth muscle cells. No significant difference was found in the pA2
values (zg : 7.02 +/- 0.20; vsmc ; 7.28 +/- 0.23), indicating that
pharmacologically the receptors are indistinguishable.
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The bovine ATi receptor was then cloned, from bovine spleen, using
the published bovine adrenal ATi receptor sequence, by PCR. The resulting
clones were sequenced and confirmed as ATi receptors. The DNA was then
used to probe for ATi receptor mRNA expression in primary cultures of
bovine zfr cells using Northern blot analysis. Specific agonists for the adrenal
cortex, and second messenger analogues, were employed in these
experiments.
All caused homologous downregulation (86%) of its receptor mRNA,
an action found to be mimicked by stimulation of protein kinase C and
calcium influx (91%). A cyclic AMP analogue (8-bromo-cyclic AMP) also
caused downregulation of ATi receptor mRNA. In contrast, ATi receptor
mRNA was upregulated by incubation of the cells with insulin-like growth
factor-1 (IGF-1) and potassium. Finally, the possibility that adrenal
corticosteroids could exert a short-loop feedback effect on ATi receptor
mRNA was analysed. Cortisol, but not aldosterone, significantly
downregulated (41%) the level of ATi receptor mRNA, which indicated a
possible zone-specific effect on the regulation of ATi receptors in the adrenal
cortex.
This thesis therefore presents data on the nature and regulation of
type 1 angiotensin II receptors in bovine adrenocortical cells. These studies
suggest that the physiological regulation of All receptors within the adrenal
cortex is more complex than has been previously considered.
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1.1.1 Discovery and history
The octapeptide now known as angiotensin II was originally
discovered in 1939, by Braun-Menendez and by Page and Helmer (Peach,
1977), who gave it the names hypertensin and angiotonin to indicate that this
humorally-active substance acted to increase blood pressure by constricting
arteries. By 1958, it had been given the compromise nomenclature of
angiotensin, later angiotensin II as the manner of its formation in a cascade
was elucidated. Between 1954 and 1957, its peptide structure was reported :
N-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-C
and synthesised by Skeggs, Peart and Bumpus (Peach, 1977); the C-terminal
phenylalanine was found to be crucial for biological activity. Since then,
much has become known about its formation, regulation, functions and
mechanism of action; these topics form the basis of parts 1.1 to 1.4 of this
introduction.
1.1.2 Formation and regulation : the renin-angiotensin system
The formation of angiotensin II is controlled and regulated by the
renin-angiotensin system (RAS). This humoral system is involved in the
control of vascular tone, volume homeostasis and electrolyte balance (Peach,
1977; Vallotton, 1987; Ferrario, 1990; Lifton, 1996). The RAS was originally
thought to be purely systemic, but evidence has now been demonstrated of
local RAS in other organs including the adrenal gland, heart, kidney, brain
and gonads (Vinson et al. 1995b; Griendling et al. 1993b).
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The biochemistry of the renin-angiotensin system, showing the
enzymes involved and the peptides they generate.
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direct effect of All raised BP
indirect effect of All
negtive feedback
Figure 1.1b
The physiology of the renin-angiotensin system : its main effects with
regard to the cardiovascular system, (jq celts -jujctocjtoMer'oiar cells of-
tBre fciclney)
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1.1.2.1 The systemic RAS
The components of the RAS are shown in figure 1.1. Renin, an
aspartyl protease (MW 38kDa), is secreted by the juxtaglomerular cells of the
kidney (Peach, 1977), and cleaves angiotensinogen to produce angiotensin I
(AI) by hydrolysing the Leu10-Valu bond. Renin is stored in granules and
secreted into the plasma either as active renin or inactive prorenin, which is
converted to active renin, possibly by kallikrein.
Renin release is stimulated by a baroreceptor reflex, low [Na+] via the
macula densa, the sympathetic nervous system, high plasma potassium or
lowered arterial pressure in the kidney. A negative feedback loop also
operates in the RAS : raised All levels inhibit further renin release, as well as
a positive loop, possibly mediated by the activation of the angiotensinogen
gene by raised AH levels (Li & Brasier, 1996).
Angiotensinogen is the only substrate for renin and is a glycoprotein
of the a2-globulin class, belonging to the serine protease inhibitor family
(serpins) (Griendling et al. 1993b). In humans, it is mainly found in the liver
and has a MW of 55-65kDa depending on the degree of glycosylation. Its
plasma concentration is close to the Michaelis-Menten constant for renin, and
its concentration therefore critically determines the amount of AI generated
(Peters, 1995).
The final part of the cascade produces the biologically active
octapeptide, angiotensin II, through the action of angiotensin converting
enzyme (ACE) on AI. ACE is a zinc metallopeptidase (MW60kDa) which
cleaves the N-terminal dipeptide fragment from AI. It is found
predominantly in lung endothelial cells, and requires chloride ions for
efficient catalysis. ACE is identical to kininase II, which inactivates
bradykinin (Griendling et al. 1993b). All can also be formed directly from
angiotensinogen, by the action of the enzyme tonin.(ferrar'.o, 1190)
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All, the main effector peptide of the RAS, exerts multiple potent
effects, mainly on the cardiovascular system. It has a short half-life in plasma
(2-3 min) and is quickly degraded by a combination of endopeptidases and
aminopeptidases to shorter fragments. Aminopeptidase A acts upon AH to
yield A1H (des-Asp^AII), which is also physiologically active (4-5 times less
potent in vasoconstriction, equipotent to AH in facilitation of sympathetic
transmission but more potent than All in stimulation of aldosterone release :
(Peach, 1977)). A1H has a shorter half-life than its parent AD and is degraded
to AIV (Angiotensin 3-8) by non-selective aminopeptidase N. AIV has also
been reported to have some central effects (Harding et al. 1992; Harding et al.
1994). Angiotensin (1-7), produced by the action of endopeptidase 24.11 on
AH, has cardiovascular effects, in part antagonistic to those of AIT (Benter et
al. 1993). Further degradation of these fragments does not yield any other
active components of the system.
All exerts its effects by interacting with specific receptors on the cell
membrane of its target tissues. These receptors stimulate the
calcium/inositol triphosphate second messenger system to generate the
multitude of effects elicited by An, including vasoconstriction and
aldosterone secretion, and are therefore the final components of the RAS.
ADI, which is also physiologically active, binds to the same receptors as AH,
but with different affinity.
1.1.2.2 Local RAS
Local, or tissue, RAS function essentially similarly to the systemic
RAS described above. The local generation of AH by tissue RAS could allow
individual functions of AH to be performed without exerting inappropriate
systemic responses in other tissues (Vinson et al. 1995b). These tissue RAS
could also serve as a means of 'fine tuning' the actions of AH to a specific
organ or physiological event (Griendling et al. 1993b), contributing
significantly to para-and autocrine mechanisms in the regulation of the
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cardiovascular and steroidogenic systems (Paul, 1994; Chiou et al. 1995). The
evidence for the existence of these local RAS is strong in that all the
components of the system have been shown to be present, and, in some
cases, synthesised, in the tissues in question. However, renal renin is avidly
taken up by many tissues, especially the vasculature (Griendling et al. 1993b)
and therefore, although there may be a functional local RAS in the
vasculature, it may not be a true RAS (in the sense that all the components
have been synthesised in the tissue), unlike that demonstrated in the brain
(Vinson et al. 1995b).
In some tissue RAS, for example the cardiac and vascular RAS, local
effects would be difficult to separate from systemic effects. Where the two
are compartmentalised (for example in the brain) it is easier to see how the
local system could regulate effects (in this example, drinking behaviour)
over a longer period of time in comparison with the systemic system. Thus,
these local RAS could be of significance in responding to physiological
demand independently of the systemic RAS.
1.1.3 Functions ofAll
The principal functions of All are vasoconstriction and stimulation of
aldosterone secretion. It has many additional effects, primarily on the
cardiovascular system although independent of vasoconstriction and
aldosterone. These actions have been demonstrated in vivo and represent a
profound effect of All on blood pressure and volume regulation. Other more
recently discovered actions, e.g. effects on sperm motility, bear no relation to
these cardiovascular effects.
1.1.3.1 Vasoconstriction
Angiotensin II induces an increase in both systolic and diastolic blood
pressure by constricting vascular smooth muscle, particularly in resistance
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vessels and small arterioles. The precapillary arterioles of the skin,
splanchnic region and kidney are preferentially constricted, with a resultant
increase in peripheral resistance (Peters, 1995). The conduit arteries,
however, also possess receptors for AD and will constrict in response to AH
in vitro (Dzau & Safar, 1988). All is 40 times more potent as a vasoconstrictor
than noradrenaline and before the discovery of endothelin was the most
potent pressor substance known. All also raises blood pressure and
constricts arteries indirectly, through a centrally-mediated mechanism by
which it facilitates noradrenergic neurotransmission, involving the area
postrema (Scroop et al. 1971).
1.1.3.2 Steroid secretion
All stimulates secretion of the mineralocorticoid aldosterone from the
zona glomerulosa of the adrenal gland (Laragh et al. 1960), and further
stimulates the synthesis of aldosterone by increasing the conversion of
cholesterol to pregnenolone (Aguilera & Marusic, 1971), as well as later
stages in the pathway, for example the 18-hydroxylation of corticosterone
(Capponi et al. 1994; Lebrethon et al. 1994). The aldosterone produced
stimulates the kidney to retain sodium, acting in the distal convoluted
tubule, where it induces loss of potassium in exchange for sodium. In
addition to its well characterised effect on mineralocorticoid secretion and
synthesis, AH is also capable of stimulating glucocorticoid secretion in some
species, both in vivo and in vitro (McKenna et al. 1978; Mason et al. 1979;
Williams et al. 1989; Bird et al. 1992; Naville et al. 1993; Lebrethon et al. 1994),
acting on specific AH receptors in the zona fasciculata/reticularis of the
adrenal cortex.
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1.1.3.3 Independent cardiovascular effects
All exerts a positive inotropic effect on the heart (originally described
by Fowler & Holmes, 1964) by opening voltage-sensitive calcium channels. It
further acts to raise blood volume by stimulating drinking behaviour, acting
on the subfornical organ of the brain (Peach, 1977), and stimulates the
posterior pituitary to secrete vasopressin (Malvin, 1971). A direct effect of
All on the kidney has also been demonstrated, showing an increase in
sodium reabsorption and stimulation of Na+/H+ exchange at proximal
tubules (Peters, 1995). An has a differential effect on blood flow in different
vascular regions : it decreases mesenteric and cerebral blood flow while
having a variable effect on blood flow in the renal cortex (Peach, 1977;
Vallotton, 1987; Ferrario, 1990). It also stimulates catecholamine release from
the adrenal medulla (Peach, 1977).
1.1.3.4 Growth effects
Angiotensin II has long been known to have hypertrophic and
hyperplastic effects. It has been shown to mediate vascular smooth muscle
growth (Bunkenburg et al. 1992), leading to speculation that All plays a
significant role in cardiovascular hypertrophy and remodelling. Evidence
that All is also involved in fibroblast proliferation has lent further weight to
this (Brilla et al. 1994; Schorb et al. 1993; Hsueh & Do, 1994), as has the
demonstration that All induces cardiac myocyte necrosis (Tan et al. 1991).
The hypertrophic and, in some cases, mitogenic influence of All is not
restricted to the cardiovascular system. Similar effects have also been
reported in bovine adrenocortical cells (Linas et al. 1990; Clyne et al. 1993),
rat kidney tubular and mesangial cells (Hsueh & Do, 1994; Wolf, 1994). All
also mediates stretch-induced cardiac hypertrophy (Peters, 1995), in addition
to stimulating immediate-early genes such as c-fos and c-jun (Peters, 1995;
Lyall et al. 1992) and growth factor transcription and production (Wolf,
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1994). However, All has also recently been shown to play a part in apoptosis
(Yamada et al. 1996).
1.1.3.5 Non-cardiovascular effects
These actions, seemingly unrelated to the main role of All, may be
more connected with the local RAS described in section 1.1.2. Angiotensin II
has been shown to impair retention of shock-avoidance responses and to
inhibit hippocampal long-term potentiation (Lee et al. 1995; Wayner et al.
1995). It will also stimulate production of progesterone in ovarian granulosa
cells (Hsueh & Do, 1994) and has been postulated to play a part in fertility
after the observation that AD antagonists inhibit ovulation (Peterson et al.
1993). The recent discovery of All receptors in human sperm that display
increased motility after stimulation by All also leads to the conclusion that
All has an important role in this process ^Vinson etai. 1995b). Angiotensin II
also contracts non-vascular smooth muscle, and there is a high concentration
of AIT receptors in the uterine musculature (Aguilera et al. 1980); it is also
known to increase gluconeogenesis (Vallotton, 1987) in addition to
facilitating sympathetic neurotransmission (Vallotton, 1987).
1.2 The pathophysiology of the renin-angiotensin system
1.2.1 Hypertension
As the renin-angiotensin system is intimately involved in the control
of blood pressure and volume, it is not surprising that defects have been
sought as contributing to the development of essential hypertension in
humans. The efficacy of both ACE inhibitors and All antagonists as
antihypertensive therapy would seem to indicate a role for All. Alterations
in the renin-angiotensin-aldosterone system could partially explain the
pathogenesis of malignant hypertension and many of the renin-dependent
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forms of renovascular disease (Okamura et al. 1986; Dzau & Safar, 1988;
Lifton, 1996). It has also been suggested that aberrant expression ofAll in the
blood vessels, the heart and the brain may contribute to the pathogenesis of
essential hypertension (Ferrario, 1990). In hypertensive subjects, the vascular
RAS is thought to be activated and there is evidence that reduced arterial
compliance may also be a result of this (Dzau & Safar, 1988). This reduced
compliance in conduit arteries is a predisposing factor for arteriosclerosis
and could particularly affect essential hypertensives, even though the
hypertension does not derive from an obvious defect in the RAS (Dzau &
Safar, 1988).
Genetic polymorphisms in RAS components have been postulated as
causes for essential hypertension (Peters, 1995); however, only one has been
found. A single nucleotide mutation in the type 1 angiotensin II receptor
(A1166—>C) has been found at a higher frequency in hypertensive subjects
(Bonnardeaux et al. 1994), implying that this common variant of the ATX
receptor may impart a small effect on blood pressure. Linkages have been
found for polymorphisms in RAS components and primary hypertension,
pre-eclampsia, cardiac hypertrophy and myocardial infarction. A GT repeat
3' of the transcription start site in the angiotensinogen gene has been linked
to some forms of primary hypertension (Caulfield et al. 1994); the same gene
has a second polymorphism involving a single amino acid substitution
which associates with a greater tendency to pre-eclampsia (Ward et al. 1993).
No defects linked to cardiovascular diseases have been found in the human
renin gene. An insertion/deletion polymorphism in the ACE gene has been
linked to both increased risk of myocardial infarction (DD genotype;
(Cambien et al. 1992)) and left ventricular hypertrophy (Schunkert et al.
1994).
There is also a class of essential hypertensives called 'non-modulators'
who display abnormal interactions of AH with the adrenal and sodium
sensitivity of blood pressure (Williams & Hollenberg, 1991) in whom an
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enhanced local RAS is suspected; correction of this defect with ACE
inhibitors is very efficacious.
Finally, hypertension induced by glucocorticoids could be mediated
by alterations in the renin-angiotensin-system. Increased levels of
glucocorticoids have been shown to upregulate All receptors in the
vasculature in vivo and in vitro (Sato et al. 1994; Guo et al. 1995); more All
receptors leads to the possibility of increased AH action, causing
vasoconstriction and increased blood pressure. Elevated plasma
concentrations of glucocorticoids can also increase hepatic production of
angiotensinogen and thus increase plasma AH levels, compounding the
effect (Guo et al. 1995); glucocorticoids have also been shown to increase
ACE activity (Mendelsohn et al. 1982).
1.2.2 Heart failure
Abnormal functioning of the renin-angiotensin system has also been
implicated in other cardiovascular diseases. Again, this has been suspected
by the better-than-expected recovery observed in ACE inhibitor therapy, and
it is the growth factor properties of All that are implicated. Abnormal
activation of AH, and particularly the cardiac RAS, appears to be involved in
cardiac and ventricular remodelling after infarction, cardiac hypertrophy
and restenosis after angioplasty (Griendling et al. 1993b), as well as initiation
of neointimal lesions due to disturbances of the cell growth/cell death
equilibrium (Gibbons & Dzau, 1996). Treatment with ACE inhibitors slows
progression of these conditions or even prevents them where other equally
antihypertensive agents do not. These drugs therefore have a
cardioprotective effect (Lindpaintner & Ganten, 1991), although part of this
effect is thought to be due to inhibition of bradykinin metabolism. ACE has
been shown to be activated in human heart failure, and this activation is
thought to play a large role in cardiovascular pathophysiology (Paul et al.
1995).
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Congestive heart failure is another disease in which overactivity of the
renin-angiotensin system is implicated (Lindpaintner & Ganten, 1991).
Increases in All can lead to increases in heart overload (Dzau & Safar, 1988),
which increases heart wall stress, and aggravation of heart failure. The
cardiac RAS is also reported to be upregulated in number in congestive heart
failure (Eiskjaer et al. 1992).
1.2.3 Vascular under-reactivity; renal disease
In both diabetes and cirrhosis of the liver, there is a peripheral
vascular under-reactivity to angiotensin II. In the former case, this is thought
to be due to the fact that glucose induces a downregulation of AH receptors
in the vasculature (Williams et al. 1992); the explanation for the effect seen in
cirrhosis is not so clear, but may be due to a decrease in affinity of the
receptors or a lack of expression (Ryan et al. 1993). The mitogenic activation
of All in certain renal cell types, including glomerular endothelial cells,
could also be important in the pathogenesis of glomerulonephritis (Wolf et
al. 1996).
It is therefore clear that abnormalities in the renin-angiotensin system,
whether in the genes or their expression, functioning or regulation, or at the
local or systemic level, may have a major effect on many pathological states,
and that further exploration of the system and its modulation could lead to
more specific and beneficial therapies being found for some of the conditions
described above.
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1.3 Target tissues forAngiotensin II
1.3.1 The adrenal gland : structure, function and importance ofAll
The healthy human adult has two adrenal glands, situated just above
the kidneys and weighing 4-5g each. Both glands are similar in size, with
slight variations in shape. The gland consists of a connective tissue capsule
surrounding a dark cortex and a lighter inner medulla. The cortex is derived
from mesodermal cells while the medulla is derived from immigrant
neuroectodermal cells. The medulla comprises about 10% of the gland and
its function is to synthesise, store and secrete catecholamines. The function of
the cortex is to synthesise and secrete adrenal steroid hormones. It is the
cortex that is preferentially acted upon by All, and therefore this section will
focus upon cortical structure and function.
1.3.1.1 Adrenocortical zonation
The adrenal cortex is further subdivided into three zones, shown by
the diagram in figure 1.2. The name of each zone relates to the
morphological appearance of its constituent cells. Thus the outer zona
glomerulosa cells give the appearance of bundles, being succeeded by the
column-like structures of the zona fasciculata and then by the zona
reticularis, where the cells form a net-like structure.
The three zones differ functionally as well as morphologically, each
containing the correct enzymes to synthesise a particular class of steroids.
The zg, which synthesises mineralocorticoids, is the only zone containing
aldosterone synthase, which catalyses the terminal step in aldosterone
synthesis (see Figure 1.3). llp-hydroxylase, required for glucocorticoid
biosynthesis, is only present in the zf and zr.
The origin and control of zonation can be explained by two main
hypotheses. The zonal hypothesis (Swann, 1940) proposes that each zone has
a separate set of progenitor cells. The width of each zone can be controlled
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by trophic hormones: increased All levels increase zg width while high
ACTH increases zf width at the expense of the zg.
Another hypothesis relies upon the observation that most cell division
in the adrenal cortex occurs in the zg, and most cell death (by apoptosis
(Wyllie et al. 1973)) in the zr. This cell migration hypothesis proposes that a
common layer of stem cells, located either just beneath the capsule or
between the zg and zf, divides continually, producing inward migration of
cells through the cortex. How the cells adopt different phenotypes is
unknown; either age or the steroid gradient theory of Hornsby (in (Neville &
O'Hare, 1982), in which, by exposure to high steroid levels and
pseudosubstrates, adrenocortical cells may change phenotype) may be
responsible. Radial striped patterns of transgene expression have been
observed (Morley et al. 1996), consistent with this hypothesis. Again, zone
width would most probably be under the control of the trophic hormones,
All and ACTH.
1.3.1.2 Structural features of the adrenal gland
An important feature of the adrenal gland, which also contributes to
its function, is its vasculature. It is involved in corticomedullary interactions
and possibly functional zonation and growth of the gland. The right adrenal
is supplied directly from the aorta, while the left adrenal artery is a tributary
of the renal artery. These both enter the capsule to give an extensive arterial
plexus, from which some arterioles pass directly to the medulla. The cortical
blood supply differs : the zonae fasciculata and reticularis are supplied by
only a capillary network; blood drains down to the medulla first via the zona
glomerulosa, then the two inner zones, before being collected in the large
central vein.
Until recently, it was not thought that the adrenal cortex was directly
innervated. However, it is now apparent that not only is there innervation of
















The morphological zonation of the adrenal cortex, showing the three
types of cells and their particular structural arrangement.
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regulated by the splanchnic nerve, there is also neural supply from the
medulla to the cortex (Vinson et al. 1994). The neurotransmitters used in
adrenocortical innervation include noradrenaline, vasoactive intestinal
peptide, neuropeptide Y and acetylcholine (Clyne et al. 1994; Vinson et al.
1994), all of which can affect steroidogenesis in the adrenal cortex. The
adrenal medulla is innervated by preganglionic fibres of the sympathetic
nervous system. Each fibre innervates a group of cells to form a functional
unit; separate units have separate synapses.
1.3.1.3 Functions of the adrenal cortex
The adrenal cortex secretes over 20 steroid hormones, divided into
three classes : mineralocorticoids, glucocorticoids and adrenal androgens
(Brooks, 1979). Table 1.1 shows the most common of these and their relative
abundances, while figure 1.3 shows the steroid synthetic pathway operative
in the human adrenal cortex, including the intracellular location of the
enzymes. The precursor molecule for all steroid hormones is cholesterol, and
the transport of cholesterol to the inner mitochondrial membrane, facilitated
by StAR protein (Stocco & Clark, 1996) is the main site of control of
steroidogenesis by pituitary hormones e.g. ACTH. Later steps in the
pathway are controlled by other mechanisms, e.g. All upregulates
aldosterone synthase, allowing more aldosterone to be produced.
Most of the steroidogenic enzymes are members of the cytochrome
P450 family of oxidases. Four distinct enzymes are involved in
adrenocortical steroidogenesis :
• P450scc (side chain cleavage) mediates the conversion of cholesterol to
pregnenolone
• P450cll mediates ll(3-hydroxylation (e.g. 11-deoxycortisol to Cortisol)
• P450c17 mediates both 17a-hydroxylation and 17,20-lyase activity
• aldosterone synthase mediates the terminal steps in aldosterone
biosynthesis
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P450cii catalyses the final step in glucocorticoid synthesis, while
aldosterone synthase catalyses the terminal step in mineralocorticoid
synthesis; the two enzymes are therefore complementary. Pregnenolone is
converted to progesterone by 3(3-hydroxvsteroid dehydrogenase. The sites of
and chemical reactions catalysed by these enzymes are shown in Figure 1.3.
For the enzymes capable of catalysing more than one reaction, e.g. P450cl7,
the direction of the reaction depends upon the relative levels of substrate
and product in the adrenocortical cell, and on the nature of the steroidogenic
stimulus.
1.3.1.3.1 Steroid hormones
Mineralocorticoids affect the bod)/s electrolyte composition by
increasing sodium retention and increasing potassium excretion in the
kidney. The principal hormone of this class in humans is aldosterone,
although deoxycorticosterone also displays some mineralocorticoid activity.
Aldosterone is synthesised uniquely in the zona glomerulosa; its secretion is
under the control of the RAS as previously described (section 1.1.2), but
increases in potassium concentration also stimulate its production, as do
ACTH and serotonin. Potassium in fact interacts with AH in aldosterone
production, an equilibrium which can become disturbed by drugs used to
treat hypertension and heart failure (Vallotton et al. 1995).
Deoxycorticosterone, however, is mainly produced in the zona fasciculata,
thus mineralocorticoid secretion is not the sole province of the zona
glomerulosa.
The zona fasciculata secretes most of the body's glucocorticoids. These
have major effects on the metabolism of carbohydrates, fats and proteins,
raising the concentration of glucose in the blood, and have an important anti¬
inflammatory action. The main hormone of this class in humans and cattle is
Cortisol; in rats the steroid pathway differs and the major product of
glucocorticoid biosynthesis is corticosterone due to the absence of P450cl7
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(see Fig. 1.3). Secretion of Cortisol and corticosterone is under the principal
control of ACTH from the anterior pituitary and therefore follows its basal
circadian variation. This control functions as part of the hypothalamo-
pituitary-adrenal axis, in which increased Cortisol levels decrease CRF levels,
leading to decreased ACTH secretion from the pituitary. All Cortisol is
produced in the zona fasciculata, as is half the corticosterone, the remaining
half being synthesised in the zona glomerulosa and draining to the zona
fasciculata to be 17-hydroxylated (Neville & O'Hare, 1982).
The adrenal androgens, synthesised predominantly in the zona
reticularis of most mammals (with the exception of murine species), are the
precursors to the sex steroids (androgens and oestrogens). The main
compounds secreted are dehydroepiandrosterone (DHEA) and its sulphate,
androstenedione and llp-hydroxyandrostenedione. These are only weakly
androgenic but are secreted in large amounts (DHEA : 20pg/day) so their
effect may be significant. They pass through the circulation to the sex organs
where they are activated to the sex hormones oestrogen and testosterone
(although some activation may occur peripherally). Secretion of the adrenal
androgens is again principally under the control of ACTH although other
non-ACTH factors (McKenna et al. 1996), for example the putative pituitary
hormone CASH, may also play a part. (cflsH = corbca/ cndfcxp,^ sh/iobibr^
hon-cne)
1.3.1.4 Importance ofAll in the adrenal gland
The primary role of angiotensin II in the adrenal gland is the control
of aldosterone synthesis and secretion (via the RAS). However, it has been
demonstrated (see section 1.1.3) that AH can also stimulate Cortisol secretion
in the human (McKenna et al. 1978), bovine (Clyne et al. 1993) and porcine
(Breidert et al. 1996) adrenal cortex, suggesting that this stimulus also plays a
part in the inner zone. It is also known that All can facilitate sympathetic
neurotransmission, and secretion of steroids can be affected by
neurotransmitters.
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The existence of a local adrenal RAS also presents the possibility of
both auto- and endocrine effects of All. Angiotensin II is therefore an
important influence in the control of steroidogenesis in the adrenal cortex.
As AH can also stimulate the release of catecholamines from the adrenal
medulla, raised or lowered levels of RAS activity could have profound
effects on the correct functioning of the gland.
1.3.2 The resistance arteries : structure, function and importance ofAll
All arteries, except the pulmonary artery, transport oxygenated blood
away from the heart to capillary beds in the various organs and tissues of the
body. Large conduit arteries (aorta, carotid, pulmonary, femoral etc) lead
into medium sized muscular arteries (mesenteric, splenic, tibial etc : most of
the body's arteries are of this group). These then feed into arterioles which
have a lumen diameter of 30pm, decreasing to 8pm in precapillary arteries.
The arterioles then connect with veins via capillary beds or, in some cases,
anastomoses (Amenta, 1991).
Arterial walls consist of the following layers, which vary slightly in
composition according to the calibre of the artery :
tunica interna (intima)
This is the internal coat of the artery facing the lumen and
consists of an inner simple squamous endothelium, a stratum
subendotheliale (a layer of loose connective tissue) and an internal
elastic membrane (a network of elastic connective tissue fibres).
tunica media
A middle layer of circularly oriented smooth myocytes, with
some elastic fibres, separated from the tunica externa by an external
elastic membrane.
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Relative activity in assay
Steroid MR Na + GLY GR Al
Aldosterone 1 1 0.15 1
DOC 0.8 0.03 0.02 1 —
Corticosterone 0.2 0.004 0.36 2 0.3
Cortisol 0.1 0.001 1 1 1
18-OH-DOC 0.015 0.004 — 0.02 —
Dexamethasone * 0.05 0.001 17-250 10 25-169
9a-fluorocortisol ♦ 1* 0.15 6-13 10* 8-15
MR = mineralocorticoid receptor assay based on competition to 3H-a!dosterone binding sites in
rat kidney
Na* = bioassay, normally based on change of urinary NaVK* in the adrenalectomized rat
GLY = bioassay. based on glycogen deposition in the adrenalectomized rat liver
GR = glucocorticoid receptor assay, based on competition with 3H-dexamethasone binding sites
in rat or sheepC) kidney
Al = bioassay based on anti-inflammatory activity
Table 1.1
Activities of corticosteroids. The biological activities of four
endogenous and two artificial (*) steroids in various assays are given in the
table above (reprinted from Vinson, 1993)-
X6
Figure 1.3
The steroid biosynthetic pathway. All adrenocortical steroids are
synthesised from the common precursor pregnenolone. The three classes of
steroids are secreted by the three zones of the cortex as detailed in the text
All enzymes except P450scc/ P450cn and aldosterone synthase are found in
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tunica externa (adventitia)
The outermost coat of connective tissue.
Figure 1.4 shows the generalised structure of an artery (described in
detail in Amenta, 1991).
In the arterioles, the intima consists of endothelial cells resting on a
basement membrane, with a pronounced internal elastic membrane. The
tunica media contains 1-3 layers of spiralling smooth myocytes, while
fibroblasts and collagen fibres comprise the tunica externa.
The muscular arteries are thicker as they have to conduct blood at
higher pressure than the arterioles, whose main role is to provide and
modulate peripheral resistance. Thus the intima is thicker, with the
endothelial cells sending processes into the media, and a more prominent
stratum subendotheliale. This layer thickens where the arteries bifurcate,
providing a better control of blood flow. The media is also thicker, and the
outer tunica externa consists of loose connective tissue.
The large arteries are more elastic, to enable them to withstand the
very high pressures of blood flowing from the heart, and therefore elastic
fibres predominate over myocytes in the media, which is again thicker than
in the muscular arteries. The intima is similar to that of the muscular arteries,
but the externa is tightly encircled with collagen fibres.
Some arteries are of mixed type, intermediate between the elastic and
muscular arteries (e.g. the renal and coeliac arteries) or specialised to adapt
to specific situations or locations (e.g. the umbilical and coronary arteries).
The function of the vasculature relevant to this study is the provision
and modulation of resistance to blood flow. Resistance increases with
decreasing luminal diameter. Therefore, in the systemic circulation (i.e.
excluding the pulmonary circulation), the majority of the resistance lies in




Generalised structure of the arterial wall, showing the different layers
and their constituents (taken from Amenta, 1991).
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The peripheral resistance can be changed by a constriction or
dilatation of the blood vessels, most commonly in the arterioles but
sometimes in the muscular arteries. The smooth muscle in the arterial wall is
in a state of partial contraction due to continuous sympathetic nerve activity.
This state is known as vasoconstrictor tone and originates in the vasomotor
centre in the medulla oblongata. Vasomotor centre activity can be modulated
by baroreceptor reflexes (from the aortic arch and carotid sinus), which,
when stimulated, inhibit the activity of the centre. The action of the
vasomotor centre, however, is limited compared with that of systemic or
local vasoconstrictors, such as angiotensin II, or vasodilators.
Angiotensin II is an important agent in arterial smooth muscle
function, acting preferentially in the precapillary arterioles to increase
peripheral resistance and raise blood pressure. Inadequate blood flow to the
kidney stimulates renin release. This initiates the RAS cascade as described
previously (section 1.1.2), ending in the formation of AH, which interacts
with its type 1 receptors to induce widespread vasoconstriction. This may be
due to the phosphorylation of the smooth muscle myosin light chain,
enabling contraction to occur (Mendelsohn, 1985). When the myocytes
contract, the vessel lumen narrows and tension is established in the elastic
membranes, which become wavy. This narrowing of lumen diameter results
in an increase of blood pressure in the vessel. Contraction is more prevalent
in the resistance arterioles for two reasons : firstly, there are more ATa
receptors in these vessels, and secondly, the large arteries have less capacity
to contract in vivo due to the greater pressure to which they are subjected.
1.4 Angiotensin II receptors
1.4.1 Discovery and historical perspective
The presence and location of specific binding sites for angiotensin 13
3 _
in the adrenal gland was first shown in 1964 by H-AII ligand binding
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(Bumpus et al. 1964). Goodfriend and Lin (1970) showed, using 125I-AII/ that
these binding sites in rat adrenal cortex exhibited the characteristics of
receptors : the binding was specific, reversible, saturable and of high affinity.
Specific All binding sites were later demonstrated in rabbit and guinea pig
aorta (Baudouin et al. 1972; le Morvan & Palaic, 1975), rat uterus (Devynck et
al. 1976), and rat, rabbit and bovine adrenal cortex (Glossmann et al. 1973;
Gurchinoff et al. 1975; Forget & Heisler, 1976). AH receptors have since been
demonstrated in renal glomeruli (Bennett & Snyder, 1976) and whole brain
(Sraer et al. 1974). These studies showed that the receptor was located in the
plasma membrane of the target organ cells. Other investigators, however,
reported binding sites in isolated mitochondria (cited in Devynck & Meyer,
1978) and nuclear membranes (Robertson & Khairallah, 1971).
It is now known that All receptors are integral membrane proteins
which are internalised and recycled (Hunyady et al. 1994b), although it was
shown recently, using tadk^icso'-id binding / that there are AH receptors in
the nucleus (Jimenez et al. 1994). The binding affinity of AH for its receptors
in most target tissues was found to be in the range of 1010 - 10%Un &
Goodfriend, 1970); this would imply half-saturation of the receptors at
concentrations of AH of 0.1-lnM, whereas basal blood levels of AH are much
lower (0.025nM). Such discrepancies are common for peptide hormones,
however, and reflect the ability of many target organs to be activated by only
fractional occupancy of receptors (Catt & Aguilera, 1980).
Later studies were able to locate All receptors more precisely, for
example Douglas et al (cited in Devynck & Meyer, 1978) showed that in the
rat adrenal, All receptors were more concentrated in the zona glomerulosa,
with fewer in the zona fasciculata. In the bovine species, though, the
difference in distribution is not so great, as there are more receptors in the
zona fasciculata than observed in the rat (Catt & Aguilera, 1980). The
majority of sites corresponded to known areas of AH action, including the
pituitary gland, subfornical organ and area postrema, whereas some
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investigators reported All binding sites in less expected locations, for
example in platelets (Mendelsohn, 1985).
The low numbers of All receptors in target tissue cell membranes and
their relative instability made isolation extremely difficult, although
characterisation of AH receptors in dog adrenal cortex and uterus by
photoaffinity labelling (Capponi & Catt, 1980) yielded receptors of MW 65
and 68kDa respectively. It was not until after the receptor was cloned in the
early 1990s that the structure was clearly elucidated.
1.4.2 Heterogeneity ofAll receptors
The studies described above, conducted in the 1970s and early 1980s,
suggested the possibility of heterogeneity of angiotensin II binding sites or
receptors. The main arguments for this were as follows :
• Altering the salt or potassium status of rats had reciprocal effects on
receptor number and/or affinity in the adrenal gland and vascular
smooth muscle (Douglas, 1979; Aguilera et al. 1980; Aguilera & Catt,
1981). For example, sodium depletion led to an increase in receptor
number in the adrenal cortex, but a decrease in vascular smooth muscle
(Aguilera et al. 1980).
• Studies by some groups in a variety of target organs, including adrenal,
liver and smooth muscle, indicated only a single population of receptors
when ligand binding data was fitted to a Scatchard plot (reviewed in
Devynck & Meyer, 1978). However, other groups suggested a
heterogeneous population (Wright et al. 1983; Gunther, 1984; Hausdorff et
al. 1987). Indeed, Gunther's group published the existence of two classes
of ATT binding sites in rat hepatocytes : one high and one low affinity.
• In Gunther's study, only the low affinity site was susceptible to
dithiothreitol, which inhibited 12T-All-binding (Gunther, 1984).
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• In the early 1980s, it became apparent that AH could work through two
different signal transduction pathways (IP3/Ca and adenylate
cyclase/cAMP : see section 1.4.3.1). This was used as further evidence that
AD receptors could belong to more than one class (Balla et al. 1991).
• At this time, the only AH antagonists available to researchers were
peptide analogues of AH, including the most widely used, saralasin ([sar1-
5 8 2 3 i tval -ala ]-AH) and sarile ([sar -ile ]-AII). These were not able to
distinguish between any potential subclasses of AH receptors. However,
the potency order of these analogues and antagonists differed between
tissues. (TiNMe/fstns eL aS>. iqq3)
• The heptapeptide breakdown product of AH, Affi, was also shown to bind
with differing affinities to the two potential classes of receptor (Griendling
et al. 1993a). AID bound with equal affinity to the 'low-affinity' site, and
less potently to the 'high-affinity' site.
Discrimination between two classes of angiotensin H receptors
became possible following the development of non-peptide antagonists. In
1989, Whitebread et al. (1989) and Chiu et al. (1989) published reports of two
classes of non-peptide antagonists, the biphenylimidazoles, exemplified by
DuP753 (losartan), and the tetrahydroimidazopyridjnes, exemplified by
PD123319 and PD123177, which could discriminate between two subtypes of
AH receptor. Whitebread's group divided the An receptors into type A,
found in uterus and blocked by CGP42112A (a compound related to
PD123177), and type B, found in vascular smooth muscle, blocked by Ex89
(precursor compound to DuP753), binding to which sites was abolished by
dithiothreitol. Chiu's group, who studied the rat adrenal gland, also
identified two subtypes. They named them An-1, found mainly in the cortex
and blocked by DuP753, and AH-2, found almost exclusively in the medulla
and blocked by EXP655 (a PD-like compound). A combination of the two
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1.25
non-peptide antagonists abolished all I-AII binding in the rat adrenal
gland.
Chang & Loth (1989) further demonstrated that it was the type B or
A13-1 (now named ATx) receptor which mediated the known physiological
actions of AIL The presence of two subtypes of All receptors-has since been
demonstrated in many target tissues of AH (reviewed in Timmermans et al.
1993).
There is a wide species variation in the tissue distribution of
angiotensin 13 receptors. In the rat adrenal, 20% of binding in the cortex is to
the AT2 subtype, whereas in the bovine adrenal cortex the proportion of ATT-
2 receptors is negligible. In vascular smooth muscle, some species (rat) have
almost entirely ATi receptors, while others (rabbit, dog) have a mixed
population. The ATX subtype is mainly found in the adrenal cortex, vascular
smooth muscle, liver, kidney, heart, pituitary and uterus while the AT2
receptor predominates in the adrenal medulla and brain. AT2 receptors are
also expressed at a high level throughout foetal development, with levels
declining towards birth (Timmermans et al. 1993).
Another AD receptor subtype has also been reported. Sandberg et al.
(1992) showed by molecular methods the presence in rat adrenals and
pituitary gland of a type 1-like receptor which was not identical to that
found by previous investigators and was thus termed the AT3 receptor.
Receptors have also been discovered for a smaller homologue of All:
AII(3-8), also known as AIV. Harding et al first proposed such binding sites
(Swanson et al. 1992) in guinea pig hippocampus; distinct from All receptors,
neither AH or AIII could displace AI¥~from these binding sites. The same
(Hard ire/ eta/, (994-3
group later published a report of AIV binding sites in other tissues : aorta,
brain, heart, kidney, liver lung and adrenal cortex of a number of species,
including bovine and guinea pig. Since AIV is reported to have effects
antagonistic to AH, the finding of these receptors is likely to have profound
implications for understanding the renin-angiotensin system (Harding et al.
1994).
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The presence of multiple AH receptors, and the possibility that All
may have additional physiological effects to those previously categorised,
suggests that the true physiological significance of All receptor subtypes is
not yet fully understood.
1.4.3 Cloning of angiotensin II receptors
The molecular cloning of All receptors described in this section, as
well as yielding important structural information about both AT} and AT2
receptors, has led to subdivision of the AT} subclass. In rodents, the ATX
(<3ci-2c>)
receptor has two forms, ATla and ATlb; a third subtype, ATlc, has also been
^proposeA/ J^s "yet, additional ATi subtypes have yet to be described for
bovine and human species.
1.4.3.1 Cloning of the ATa receptor
The type 1 angiotensin II receptor was first cloned in 1991 by two
groups simultaneously from bovine adrenocortical cells (Sasaki et al. 1991)
and rat vascular tissues (Murphy et al. 1991), using expression cloning
techniques. Both receptor clones contained an open reading frame of
l,077bp, encoding a protein of 359 amino acids, yielding a predicted 41kDa
(ScCQto e+ol, J9CI/. Hotpvyj eJr a$. <9^0
protein. The entire coding region, a portion of the 5' untranslated region and
the 3' untranslated region are all contained within a single exon (Bernstein &
Alexander, 1992). Hydropathy analysis revealed that the receptor belonged
to the seven-transmembrane region class of G-protein coupled receptors, and
the presence of one cysteine residue in each of the four extracellular loops
indicated that these could form disulphide bridges, providing a site for
(qrie/tM ircteXai. W3b)
ligandoinding. There are 3 potential sites for N-glycosylation (one in the N-
terminal extracellular region and two in the third extracellular loop), which
would account for the higher MW of 65kDa reported for the ATi receptor
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(Griendling et al. 1993a). The second and C-terminal cytoplasmic domains
contain serine and threonine residues which may be important in regulation
(cyiendlirTq iqftSrj}
of receptor activity by phosphorylation. There was only a 20-30% sequence
identity with other known G-protein-coupled receptors, and also with the
mas oncogene, which had previously been postulated to encode an AD
receptor (Jackson et al. 1988). A pictorial representation of the rat vascular
ATx receptor is shown in Figure 1.5.
(Sasqki et at.
The bovine adrenal receptor gene^encoded an mRNA of 3.3kb, which
was expressed in kidney as well as both adrenal cortex and medulla. When
expressed in cos-7 cells, the protein displayed the pharmacological
CSaecjtj et o!
characteristics of an ATi receptor. The vascular receptor, isolated from a rat
aortic cDNA library, contained the same size open reading frame as in the
bovine adrenal clone, but two transcripts of different size were found in
(Norphy et oJ. 1991)
various rat tissues. A transcript of 3.5kb was observed in liver, kidney,
adrenal, lung and very strongly in vsmc. A smaller, 2.3kb transcript was
present at a much higher abundance in all the above tissues than the larger
transcript, and was additionally detected in aorta, uterus, ovary, heart and
(ftofpHu et oJ (Hi)
spleen. These two transcripts may represent either alternative splicing of the
gene, alternative processing of a common RNA precursor, or two highly
similar products from the same gene. Later analysis of the cloned human
ATx receptor (Curnow et al. 1995) indicates that the first possibility is the
correct one. The greatest number of differences between the rat and bovine
receptors was in the carboxyl terminus (Bernstein & Alexander, 1992).
Shortly after this, other investigators reported the cloning of the ATx
receptor from other species, and also the further discovery of a second ATx
receptor subtype in the rat and, later, in mouse (Iwai et al. 1991; Iwai &
Inagami, 1992a; Yoshida et al. 1992).
Iwai et al. (1991) cloned an ATi receptor identical to that cloned by
(fflO
Murphy et al, from a rat kidney cDNA library. Soon afterwards, a second
'■•V
ATx-tvpe receptor was cloned, from rat adrenal (Iwai & Inagami, 1992a) and
pituitary (Kakar et al. 1992). The vascular and kidney subtype was classified
37
as ATla/ and the adrenal and pituitary subtype ATib. The two subtypes
showed 96% homology at the amino acid level, and both encoded a 359
amino acid, seven-transmembrane region type of receptor, with virtually
identical N-glycosylation sites and cysteine residues. Pharmacologically
(when transiently expressed in cos-7 cells) both displayed the characteristics
of ATi receptors and were indistinguishable using a wide range of ATj-
specific antagonists (Balmforth et al. 1994), although they were the products
of distinct genes. The 5' and 3' untranslated regions of the mRNAs for the
two ATi receptors displayed very little homology, raising the possibility that
the two genes could be regulated differently (Bernstein & Alexander, 1992),
(see 1.4.5). Differences in the coding regions of the two types were
concentrated in the carboxy termini of the receptors, which could be
important in differential regulation, as this is this region where regulatory
fat
phosphorylation occurs (Griendling et al. 1993a). The mRNA for the ATla
subtype was found preferentially in the vasculature, lung and ovary, while
that for the ATlb was found in the adrenal, anterior pituitary and the uterus,
(fcQUSQr ef- at ;z)
and both were present to the same extent in spleen, liver and kidney. A later
A.
study by Gasc et al. (1994) used in situ hybridisation to localise the two rat
subtypes by cell type. This showed some differences in the pattern of
expression, for example in the pituitary, the mRNA for ATla was expressed
in the intermediate and posterior lobes, and that for ATlb in the anterior
lobe.
The ATlb receptor was found to be identical to the AT3 subtype cloned
by Sandberg et al. (1992). A third AT} receptor subtype has also been
reported in rats, the ATic receptor cloned by Hahn et al. (1993). This receptor
was detected in brain, kidney, liver, lung, spleen and abundantly in vsmc
and mesangial cells, and has 90% homology at the nucleic acid level with the
ATla and 82% with the ATlb subtype. The significance of this third ATx
subtype is not yet clear.
The human ATi receptor gene has also been cloned (Takayanagi et al.
1992; Furuta et al. 1992) but, like the bovine receptor, no ATi subtypes have
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Figure 1.5
Representation of the structure of the rat vascular ATj receptor
(Griendling et al. 1993a). It is a seven-transmembrane region G-protein
coupled receptor. The branched regions indicate N-glycosylation sites, and
the dark cysteine residues in all probability form two disulphide bonds
important for ligand recognition.
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been demonstrated to date. It also encodes a 359-amino acid protein with an
open reading frame of 1,077 bp, and exhibits 95% homology with the bovine
receptor and 94% with the rat ATla receptor. A 2.3kb ATi receptor transcript
can be detected in the human liver, lung and adrenal. Work done by
Curnow et al. (1995) indicates, however, that although there is only one
subtype, alternative splicing of the mRNA occurs yielding two transcript
sizes, a situation comparable with the rat ATia mRNA.
Analysis of the ATi receptor gene by Yoshida et al. (1992) has
suggested that there are at least two genes for ATa receptors in the rat and
mouse (which they cloned in this paper), but only one in bovine and human,
and so far, this has proved to be the case.
1.4.3.2 Important functional elements of the ATi receptor
The amino acid sequences of ATi receptors from bovine, rat and
human tissues are highly conserved (Inagami et al. 1992). Site-directed
mutagenesis has been used to elucidate which sequences of amino acids are
important for receptor activation and internalisation.
Four cysteine residues are present in the four extracellular loops of the
receptor, one cysteine in each loop (Griendling et al. 1993a). These probably
form two disulphide bridges, which would provide a ligand-binding
domain. The presence of such disulphide bridges would explain the
sensitivity of the ATj receptor to dithiothreitol.
Like other peptide hormone receptors, the ATi receptor is internalised
after complexing with its ligand. Certain residues in the ATi receptor have
been found to be vital for this process (Balmforth et al. 1995) : deletion of 41
amino acids from the carboxy terminus of the receptor sequence led to an
impairment of receptor internalisation after binding to AH, but the signal
transduction coupling was normal.
The critical nature of tyrosine residue 215 in G-protein coupling was
elucidated by its substitution with phenylalanine, which resulted in a
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mutant receptor with reduced affinity for AD analogues and no JP3
responses after stimulation with AH (Hunyady et al. 1995) This residue was
also found to be important for internalisation of the receptor, as this process
was impaired in the mutant receptor. Recently, another tyrosine residue,
tyrosine 302, was shown to be involved in mediating signal transduction but
its mutation did not affect internalisation (Laporte et al. 1996).
Further site-directed mutagenesis experiments (Hunyady et al. 1994b)
showed that the aspartate residue 74 is also extremely important for receptor
activation, since its substitution with asparagine results in severely impaired
G-protein coupling and IP3 signalling, but normal ligand binding and
internalisation kinetics. Mutation of this same residue to tyrosine (Hunyady
et al. 1994a) resulted in greatly impaired internalisation, but signal
transduction similar to the wild type receptor, while deletion of residues
215-220 severely impaired internalisation, and deletion of 221-226 resulted in
no G-protein coupling. There are therefore different requirements for
receptor internalisation and second messenger signalling, leading to the
conclusion that activation of G-proteins and signal transduction is unlikely
to be required for receptor internalisation, and the the two processes are
distinct. This was confirmed by Kapas et al. (1994), and Vinson et al. (1995a),
who used a monoclonal antibody to the ATi receptor to anchor the receptor
in the cell membrane of rat zg cells, thus preventing internalisation, but
permitting activation of PLC after stimulation with AH. PKC, however, was
not activated under these circumstances, suggesting that internalisation is
necessary for PKC activation to occur.
1.4.3.3 Cloning of the AT2 receptor
Historically, study of the AT2 receptor was hampered by the inability
to assign a known physiological response or signal transduction system to
this subtype. The AT2 receptor cDNA was cloned simultaneously from a rat
PC12W cell cDNA library (Kambayashi et al. 1993b) and a rat foetus
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expression library (Mukoyama et al. 1993), both of which tissues are known
to express high levels of AT2 receptors. In each case the cDNA encoded a 363
amino acid protein with 34% homology to the rat ATla receptor. Hydropathy
analysis showed that it belonged to the seven-transmembrane region G-
protein coupled receptor family. It was most similar to the dopamine D3 and
somatostatin receptors, a class of receptors in which G-protein coupling
exists but where there is no sensitivity to GTP analogues. The AT2 receptor
was shown to be coupled to a pertussis toxin sensitive protein (Mukoyama et
al. 1993). Initial evidence (Kambayashi et al. 1993b) showed that the AT2
receptor was coupled to a protein tyrosine phosphatase, and that stimulation
of the receptor modulated the phosphatase activity. Further studies have
confirmed this (Kambayashi et al. 1994; Yamada et al. 1996), as well as
assigning a putative function for AT2 receptors in mediating apoptosis. Both
groups found N-glycosylation sites and also serine and threonine residues
for possible regulatory phosphorylation. The mRNA transcript is 3.5kb in
length, and is highly expressed in foetal tissues and in adult adrenal, brain
and uterus.
The human AT2 receptor, 92% identical to the rat sequence, has also
been cloned (Martin et al. 1994), as has the mouse subtype (Nakajima et al.
1993). The human gene transcript is of a similar size to that of the rat gene,
and is present in adult lung, heart, aorta and adrenal medulla, and highly
expressed in foetal kidney and lung.
At the time of its cloning, little was known about the function of this
receptor and its signal transduction, and therefore no work similar to that for
the AT} receptor has been carried out in terms of site-directed mutagenesis.
It is likely, though, that similar regions of importance will be uncovered in
the near future.
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1.4.4 Mechanism ofAll receptor function
1.4.4.1 receptors
The ATi receptor subtype, until very recently, was thought to
mediate all the physiological actions of angiotensin II. In 1984, de Lean et al
published evidence that the AH receptor in bovine adrenal zona glomerulosa
interacted with a G-protein to stimulate the secretion of aldosterone (de Lean
et al. 1984a). Most of the physiological responses to All are now known to be
2+
mediated via the IP3/Ca signal transduction system (Vallotton, 1987). Some
groups have also indicated that All inhibited basal and ACTH-stimulated
cAMP generation (Hausdorff et al. 1987), and that AH increased cAMP
generation (Rainey et al. 1991). All also stimulates 12-HETE, a lipoxygenase
intermediate, through the ATi receptor (Natajaran et al. 1988; Stern et al.
1993). A recent report by Marrero et al. (1995) shows that the Jak-STAT
tyrosine kinase pathway, commonly used by cytokines and thought to be
purely an intracellular pathway, is also stimulated by All through the ATi
receptor in rat aortic smooth muscle cells. Phospholipase A2 can also be
stimulated by All through the AT! receptor, although this may be secondary
to PKC stimulation (Griendling et al. 1993a). Figure 1.6 shows a
representation of the signal transduction pathways known to be activated by
All through the ATi receptor.
The steroidogenic response to All is mediated through a pertussis
toxin-insensitive G-protein (Gq) at low All concentrations, but supramaximal
concentrations of AD involve a pertussis toxin-sensitive G-protein, which
mediates attenuation of the steroidogenic response (Griendling et al. 1993a).
The sequence of events triggered by activation of the AT! receptor is
identical in vascular smooth muscle and the adrenal cortex and consists of
two successive phases (Griendling et al. 1993a). The first starts within
seconds of exposure to All and lasts for ~1 minute. There is a rapid
activation of PLC, with concomitant generation of IP3 and a rapid rise in
intracellular calcium and activation of PKC. The second phase starts within 1
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minute of exposure and lasts for up to half an hour. PLD is activated, leading
to an accumulation of phosphatidic acid, which results in increasing DAG
levels and maintains PKC activation. This is accompanied by a sustained
influx of extracellular calcium, which may participate in intracellular
calcium oscillations. This second phase, unlike the first, is dependent on
external calcium, unaffected by PKC and requires internalisation of the AII-
receptor complex (Griendling et al. 1993a).
All then induces the phosphorylation of numerous cellular proteins
by calcium-dependent protein kinases, PKC and tyrosine kinases. For
instance, ACs action on smooth muscle is thought to be brought about by
phosphorylation of the light chain of myosin (Mendelsohn, 1985), while AH
exerts a mitogenic effect via stimulation of the lipoxygenase pathway to
produce 12-HETE, which stimulates cell proliferation; PKC is also involved
in this response (Natajaran et al. 1992).
It has long been known that calcium plays an important part in All-
stimulated steroidogenesis, and it was thought that this effect was mediated
by PKC. Recently, it has been suggested that PKC is less important in the
steroidogenic response to All in bovine adrenocortical cells than was
originally thought. Experiments using specific inhibitors to PKC,
calmodulin and calcium-calmodulin kinase-13 (CAM-kinase II) have shown
2+
that Ca -calmodulin plays the more important role in stimulation of steroid
secretion, and in particular, CAM-kinase II (Ganguly et al. 1995). Another
recent report demonstrated that All-mediated steroidogenesis, through the
ATi receptor, can occur through a different signalling pathway involving
inhibition of a novel potassium channel which stimulates calcium entry
through depolarisation-dependent channels (Mlinar et al. 1995).
1.4.4.2 The AT2 receptor






Simplified diagram (taken from Griendling et al. 1993a) showing
signal transduction through the ATa receptor, indicating the different
systems involved. R = receptor; PLC = phospholipase C; PLA2 =
phospholipase A2; PKC = protein kinase C; AC = adenylate cyclase; IP3 =
inositol triphosphate; cAMP = cyclic adenosine monophosphate; PLD =
phospholipase D; other abbreviations as in index. Activation of the AT!
2+ 2+
receptor can lead to signalling through IP3/Ca , cAMP, Ca influx through
T- and L-type channels, leukotrienes and also Jak/STAT (not illustrated; see
text).
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coupled to any known signal transduction system, nor to mediate any clear
physiological response. Early theories postulated that it was a 'silenf
receptor or, because it was expressed at a high level in the foetus and
neonate, a developmental role was proposed for it (Johnson & Aguilera,
1991; Shanmugam et al. 1995). Other reports, after the development of
specific antagonists to block any potential functions, suggested a growth-
inhibitory role (Nakajima et al. 1995; Stoll et al. 1995), and a role in
modulating cerebral blood flow (Stromberg et al. 1992; Naveri et al. 1994).
There is now evidence that the AT2 receptor is involved in the regulation of
apoptosis (Yamada et al. 1996), and indeed its tissue distribution would seem
to fit this function well as it is particularly prevalent in tissues in which
apoptosis occurs to a large extent (i.e. the zona reticularis of the adrenal
cortex).
Following the cloning of the AT2 receptor subtype (see section 1.3.4) it
was proposed that it functions as an inhibitor of protein tyrosine
phosphatase (Kambayashi et al. 1993b; Kambayashi et al. 1994) through a
pertussis toxin-sensitive G-protein. Earlier studies, which demonstrated that
GTP analogues had no effect on binding of All or AH analogues to AT2
receptors, had concluded that this subclass was not coupled to G-proteins
(Dudley et al. 1990; Aguilera, 1992); the AT2 receptor in fact belongs to a
unique class of G-protein receptors which are not sensitive to GTP
fNoUcauai-te*. et e»( l99"5)
analogues, including the dopamine D3 receptor. Dzau et al (Yamada et al.
1996) have suggested that the AT2 receptor induces dephosphorylation of
MAP kinase via activation of a protein tyrosine phosphatase. The
relationship of this observation to the demonstration by Kambayashi
(Kambayashi et al. 1993b) that the AT2 receptor inhibits protein tyrosine
phosphatase is presently unclear. It could be that All produces a different
modulation of protein tyrosine phosphatases in different cell types.
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1.4.5 Regulation ofAll receptors
Studies on the regulation of AD receptors were initially carried out by
examining changes in the number and affinity of AD binding sites in rats
after dietary variation (e.g. Aguilera et al. 1980) or infusions of All (Gunther
et al. 1980). The information gained from these studies was complicated and,
in some cases, contradictory, and was only resolved when the distinction
between the various AH receptors was understood. The regulation of ATT
receptors is now appearing increasingly complex, with many local and
systemic factors interacting to control the level of expression of the receptors.
In this section, the regulation of the two subtypes of All receptors will be
considered separately, discussing what is known about the regulation of the
subtype by a particular class of stimulus. Tables 1.2 and 1.3 summarise the
regulation of the AT} and AT2 receptors respectively.
1.4.5.1 Regulation of AT} receptors
1.4.5.1.1 Variations in ionic balance regulate ATi receptor number and affinity
Since sodium levels are important in the control of RAS activity,
alterations in sodium status were also thought to be important in the
regulation of All receptors. Aguilera et al investigated such regulation in the
rat adrenal zona glomerulosa; 36h sodium restriction doubled AD receptor
numbers and increased their affinity; longer restriction increased this effect.
However, reciprocal effects were observed when sodium-loaded diets were
employed. Parallel changes were also seen in All-stimulated aldosterone
secretion (Aguilera et al. 1978).
However, when vascular smooth muscle, the other principal target
tissue for All was examined, opposite effects to those observed in the
adrenal zona glomerulosa were observed. Following sodium restriction, All
receptors in mesenteric artery smooth muscle, and non-vascular smooth
muscle decreased in number and affinity. The converse was again observed
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Stimulus Human ATi Bovine ATi Rat ATi Rat AT1a Rat ATih
Na+ depletion + (2, 9) T (10) ^ (10)
Na+ loading *(2)
K+ depletion *(1)
K+ loading *(12) •t (1, 9)
All * (7,11) *(4) *(2) * (5)
IP3/Ca"+ *(H) *(4)
cAMP *(H) * (3, 4)
IGF-1, bFGF *(8)




Regulation of the AT} receptor in the adrenal gland. This table
summarises the information given in the text; where no information is
available for a given species, the column is left blank. Only the direction of
regulation is shown, as the degree varies with concentration and duration of
stimulus The references in parentheses are as follows : 1: Douglas, 1979; 2:
Aguilera et al, 1980; 3: Andoka et al, 1984; 4: Penhoat et al, 1988; 5: Inagami et
al, 1992; 6: Takayanagi et al, 1992; 7: Naville et al, 1993; 8: Langlois et al, 1994;
9: LeHoux et al, 1994; 10: Llorens-Cortes et al, 1994; 11: Bird et al, 1994; 12:
Bird et al, 1995a; 13: Bird et al, 1995c.
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following sodium loading (Aguilera et al. 1978; Gunther et al. 1980; Aguilera
& Catt, 1981).
These contradictory results could not be explained by the subdivision
of All receptors into types 1 and 2, as the physiological responses mediated
by All in both adrenal cortex and vascular smooth muscle were due to ATi
receptor stimulation (Chang & Lotti, 1989). An explanation was given by the
cloning of two subtypes of AT} receptor (Murphy et al. 1991; Iwai et al. 1991)
in rats, with a reciprocal expression pattern in these two target tissues. The
ATla receptor was preferentially expressed in vascular smooth muscle, while
the ATxb predominated in the adrenal cortex. Later studies examining the
regulation of these two subtypes confirmed that they were indeed regulated
reciprocally by sodium imbalance (Lehoux et al. 1994; Sandberg et al. 1994;
Du et al. 1995). Altered sodium status also regulates ATx receptor expression
in the brain (Ray et al. 1990; Sandberg et al. 1994).
Imbalanced potassium status is also capable of producing similar
reciprocal changes in ATi receptors (Douglas, 1979). Potassium loading of
rats increases adrenocortical All receptor number, while decreasing vascular
smooth muscle All receptor number. Again, the converse effect is seen in
potassium depletion. Studies have since shown that this is due to reciprocal
changes in the two ATi receptors (Lehoux et al. 1994). In vitro experiments
on cultured vsmc have shown similar results (Alexander, 1980; Linas et al.
1990).
1.4.5.1.2 All concentration regulates ATi receptors
Variations in sodium levels, as discussed above, can clearly regulate
AD receptors. This is due to the alteration produced in the AH levels (Catt &
Aguilera, 1980). Experiments where an ACE inhibitor was fed to rats in
conjunction with a low sodium diet (Aguilera et al. 1980; Gunther et al. 1980)
prevented the low-sodium-induced changes described above (1.4.5.1.1) from
appearing. This indicated that these sodium-induced changes were due to
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changes in plasma AD concentration affecting All receptor number. Infusion
of ATT into rats (Aguilera et al. 1980) mimicked the effects of a low sodium
diet in that it produced an increase in All receptor number in both adrenal
zona glomerulosa and renal glomeruli. The reciprocal regulation described
above following variations in dietary sodium has also been demonstrated for
rat adrenal ATlb and vascular ATla receptor mRNA (Iwai et al. 1991; Iwai &
Inagami, 1992b) following All infusion.
However, such reciprocal regulation of ATi receptor numbers in
different tissues appears to be restricted to the rat. Treatment of cultured
bovine and human adrenocortical cells produces a significant decrease in
both ATi receptor protein and mRNA (Penhoat et al. 1988; Naville et al. 1993;
Bird et al. 1994; Bird et al. 1995a). AH also downregulates its receptor protein
in many other tissues, including liver (Sernia et al. 1985) and human platelets
(Moore et al. 1984). This would seem to indicate that the upregulation
observed in rat ATlb receptor mRNA in adrenocortical and renal tissue in
response to AH is an exception.
1.4.5.1.3 ATi receptor regulation can be mediated by more than one signal
transduction system
The action of All in regulating its own receptors has been mimicked
by the use of phorbol esters and calcium ionophores to stimulate the
IP3/Ca2+ signal transduction system. These effects have been demonstrated
at both the receptor protein and mRNA levels for rat (Chen et al. 1994; Lu et
al. 1994; Cheng et al. 1995), bovine (Penhoat et al. 1988) and human (Naville et
al. 1993; Bird et al. 1995a) tissues. Both mRNA and protein levels are
regulated in the same direction in response to AH, with the changes in
protein levels lagging approximately 6 hours behind those in mRNA levels
(Bird et al. 1995a).
Activation of the cyclic AMP signal transduction system is also able to
regulate All receptor levels in a number of tissues. In bovine and human
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adrenocortical cells in culture, the physiological ligand ACTH produces a
significant downregulation of AH receptors (Penhoat et al. 1988) and AT}
mRNA (Andoka et al. 1984; Naville et al. 1993). This can be duplicated by
cAMP analogues and agonists, such as 8-bromo-cyclic AMP and forskolin
(Penhoat et al. 1988; Bird et al. 1995a). Downregulation of ATi mRNA by this
system has also been demonstrated in rat vsmc and glomerular mesangial
cells (Makita et al. 1992; Chen et al. 1994).
The ability of the AT} receptor to be regulated by more than one
signal transduction system presents an interesting possibility that receptor
and second messenger cross-talk is an important component of ATa receptor
regulation.
1A.5.1.4 ATi receptors are regulated by steroid hormones
Steroids are potential feedback modulators of the response to All and,
as such, have been examined as influences on AH receptor regulation. Early
studies, however, failed to find such a role for any of more than 20 steroids
on bovine adrenocortical cells in culture (Campanile & Goodfriend, 1981),
although these studies did not involve prior incubation of the cells with
steroids, unlike the majority of regulation experiments where prior
incubation with the test substance is normal.
Since these experiments, both mineralocorticoids and glucocorticoids
have been shown to be capable of regulating ATa receptors in tissues other
than adrenocortical cells. Aldosterone increases All binding site numbers in
rat vascular smooth muscle cells (Ullian et al. 1992), and also upregulates
ATla mRNA levels in the same tissue (Sato et al. 1994). The influence of
glucocorticoids has been more extensively investigated, with upregulation
observed of AH receptor and ATla mRNA levels in rat vascular smooth
muscle cells (Gruenfeld & Eloy, 1987; Sato et al. 1994; Ullian & Walsh, 1995).
This regulation can be explained by the presence of glucocorticoid response
elements in the rat AT}a gene promoter (Guo et al. 1995). Glucocorticoids are
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also involved in the upregulation of ATi receptors in the paraventricular
nucleus after exposure of rats to stress paradigms (Aguilera et al. 1995).
Vascular ATlb mRNA levels remain unaffected by glucocorticoids
(Matsubara et al. 1994); however, dexamethasone has recently been shown to
downregulate rat adrenal ATlb mRNA expression (Chansel et al. 1996).
Glucocorticoid-induced downregulation of AT} receptor levels has also been
shown in pancreatic acinar cells (Chappell et al. 1992) and a hepatoma cell
line (Wintersgill et al. 1995), and Cortisol induces downregulation of ATX
receptors in foetal kidney (Robillard et al. 1994; Segar et al. 1995). This
complex tissue- dependent response to steroid hormones serves to
emphasise the complex nature of AT} receptor regulation.
1.4.5.1.4 ATi receptors can be regulated by growth factors
Growth factors, including IGF-1, PDGF, bFGF and EGF have been
reported to increase expression of ATi mRNA and receptor protein in
cultured rat vsmc (Fujiyama et al. 1993; Guo & Inagami, 1994) and bovine
adrenocortical cells (Langlois et al. 1994). This shows a highly interesting
parallel with the growth properties displayed by All. In vitro differentiation
of a neuroblastoma cell line, NG108-15, also causes a significant
upregulation of ATx receptors (Tallant et al. 1991).
1.4.5.1.5 ATi receptors can be regulated by other physiological changes
Many physiological changes have been shown to affect the levels of
AD receptors. For example, high levels of glucose, compatible with those
found in diabetics, have been shown to downregulate AH receptor number
in rat aortic vsmc (Williams et al. 1992); this could be important in the
unresponsiveness of the vasculature observed in diabetes.
ATi receptor mRNA expression can also be affected by ACE inhibitors
independently of their blood-pressure lowering effect, shown by
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experiments on the adrenal gland, cardiac myocytes and aortic smooth
muscle (Kitami et al. 1992; Negoro et al. 1994). This regulation is most likely
due to the alteration in AH levels induced by these drugs. Myocardial
infarction produces an almost two-fold increase in ATi receptors (Meggs et
al. 1993), and experimental renovascular hypertension increases rat ATlb
mRNA expression (Llorens-Cortes et al. 1994). Adding to the cardiovascular
influences which regulate AH receptors, a recent observation (Cahill et al.
1995) indicates that enhanced NO generation in rat vsmc leads to a decrease
in AH receptor protein. This gives evidence for a possible mechanism of
cross-talk between the constricting and dilating factors in the vasculature.
Sex hormones can also regulate AT} receptor levels. LH increases,
while FSH and testosterone decrease, ovarian AH receptor protein levels
(Nielsen et al. 1995). Oestrogen also elicits differential regulation of ATla and
ATlb mRNA levels in the pituitary, only the latter showing an increase in
response to this hormone (Kakar et al. 1992).
ATx receptor regulation thus involves the interplay of many stimuli
and, in rodents, differential regulation of the two ATb gene products.
1.4.5.2 Regulation of AT2 receptors
Much less is known about the regulation of the AT2 receptor in
comparison with the ATi subtype. In keeping with the proposed growth-
modulatory role of this receptor (Shanmugam et al. 1995; Nahmias &
Srosberg, 1995; Nakajima et al. 1995), AT2 receptor mRNA levels vary in a
growth-dependent manner (Kijima et al. 1995), being inversely related to the
mitogenic activity of the cells in which it is expressed (Inagami et al. 1995).
Peptide growth factors (PDGF and EGF) induce downregulation of AT2
receptors in rat aortic smooth muscle cells (Kambayashi et al. 1993a; Kijima et
al. 1995), while stimulating growth of the cells and increasing levels of AT^
receptor. Insulin, which can also act as a growth factor, has also been shown
to upregulate AT2 mRNA (Ichiki et al. 1995). AT2 receptor numbers also
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increase in wound healing (Viswanathan & Saavedra, 1992) and in injured
tissues after balloon catheterisation (Pratt et al. 1992), although, conversely,
Viswanathan et al. (1992) showed only an increase in ATi receptors. The AT2
receptor has been reported to be involved in apoptosis (Yamada et al. 1996),
and the AT2 receptor was also found to be downregulated in R3T3 cells upon
reaching confluence (Ichiki et al. 1995). The gene is also developmentally
regulated, as evidenced by the fact that its expression is decreased or
abolished in many tissues shortly after birth (Ichiki & Inagami, 1995).
Pregnancy is associated with downregulation of uterine All receptors (Yang
et al. 1994). A recent study in pregnant women by de Gasparo et al showed
that this was due to a decrease in expression of the AT2 receptor (De Gasparo
et al. 1994); the small number of ATi receptors are not affected and so the
proportion of ATpAT2 is increased. Both AT2 and AT2 receptors are
upregulated by differentiation of the NG108-15 cell line (Tallant et al. 1991),
but the latter to a greater extent, suggesting their involvement in the
differentiation process. When N1E-115 cells were treated with All in a study
by Reagan et al. (1993), a downregulation of AH receptors was observed; the
AT2 receptors were downregulated to a greater extent than the AT: receptors,
although the latter were downregulated more quickly.
When the existence of two AH receptor subtypes was initially
proposed, it was thought that they would be oppositely regulated. In other
words, an increase in AT} would be accompanied by a decrease in AT2 and
vice versa. This has not, so far, proved to be the case and it will be interesting
to see what results future experiments on the mechanisms of AT2 receptor
regulation will yield.
1.4.5.3 Mechanisms and significance ofAll receptor regulation
All receptors can be regulated in a tissue, species, age and subtype-
specific manner, and at different stages in their production (translation,
transcription etc).
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Stimulus Human AT2 Rat AT2 Mouse AT2
PDGF, EGF ^ (rat vsmc; 3, 6)
insulin 4s (R3T3 cells; 5)
wound healing 4s (dermis, 2)
confluence 4s (R3T3 cells; 5)
pregnancy ^ (myometrium; 4)
differentiation ^ (N1E-115 cells; 1)
Table 1.3
Regulation of the AT2 receptor. Again only direction of regulation,
and not degree, is shown. References in parentheses are listed below: 1:
Reagan et al, 1990; 2: Viswanathan et al, 1992; 3: Kambayashi et al, 1993a; 4: de
Gasparo et al, 1994; 5: Ichiki et al, 1995; 6: Kijima et al, 1995.
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Regulation of a receptor can be achieved at three levels. The first stage
is to control the activity of the receptor by altering its phosphorylation; this
contributes to observed changes in affinity. The second is by internalisation
of the receptor, and this is apparent in the initial stages of all
downregulation. These are short-term measures for reactions to acute
stimuli; included in these are changes in mRNA production and stability.
For chronic regulation, more wide-reaching effects are necessary; these
include de novo synthesis of new receptors. This comprises the third stage of
receptor regulation. Depending on the nature and length of stimulus
applied, some or all of these stages may be affected. For example, in the
regulation of ATi receptors in the human adrenocortical cell line H295, AH
stimulation results in a rapid downregulation of the mRNA and protein,
with recovery occurring after 24-48h stimulation (Bird et al. 1994). The initial
downregulation is achieved through internalisation of the receptor and
decreasing of message stability, while the recovery phase is dependent on de.
novo receptor protein synthesis (Bird et al. 1995a), indicating the involvement
of both transcriptional and translational control. A similar complexity of
mechanism is seen in the downregulation of AT} receptors in rat vsmc by AH
(Lassegue et al. 1995). Different regulatory agents may affect these stages to
varying extents, as shown by Makita et al. (1992), where the downregulation
induced by All was shown to differ from that induced by cAMP by the fact
that blockade of de novo protein synthesis by cycloheximide abolished the
downregulatory effect of All but not cAMP.
The differential regulation of AT! receptor subtypes in different
tissues indicates distinct functional specificities (Du et al. 1995) and could
serve as a mechanism by which All-dependent functions are locally
regulated (Aguilera & Catt, 1981). Little is known about the mechanisms of
AT2 receptor regulation, and it is difficult to speculate on its significance,
although if it is involved in mediating apoptosis then abnormalities in its
expression and function could have wide-reaching implications.
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The homologous and heterologous downregulation of AT} receptors
at both the protein and mRNA levels, by any or all of the mechanisms
mentioned, may participate in the co-ordinated physiological adaptation of
vascular tone and electrolyte balance (Lassegue et al. 1995). Alterations in AH
receptor expression may provide the pathological basis for abnormalities in
blood pressure, electrolyte and fluid volume homeostasis (Du et al. 1995); the
complex nature of AD receptor regulation makes it apparent that a clear
understanding of how this is achieved is necessary if we are to
pharmacologically modify it in any way.
1.5 Use ofanimal models for studying the action ofAll
In this section I will discuss the animal cell culture models I have used
predominantly in this thesis, and justify the choice of these models in
comparison to the others available. This will encompass primary cultures
only; a consideration of the role of tumour-derived cell lines can be found in
Chapter 6.
1.5.1 The bovine adrenal cortex
During this thesis I have used both zona glomerulosa and zona
fasciculata/reticularis cells in primary culture. The zona glomerulosa has
been the most commonly used model for studying All action, whether
looking at receptor binding, physiological response or mRNA expression, as
it is the main site of All action in vivo in the adrenal gland. Although many
investigators have used primary cultures of bovine zona glomerulosa cells,
as well as bovine zona fasciculata/ reticularis cells, an equally large number
have investigated the rat zona glomerulosa. This is principally because
physiological and dietary investigations can be carried out in the rat,
whereas this is not easily possible in cattle.
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The rodent adrenal model, however, has a number of limitations. Rat
zona glomerulosa cells do not divide in culture, unlike bovine cells, which
can lead to problems for longer-term in vitro studies. There is also a major
difference in the steroids produced in adrenal cortexes of the two species,
and it is the bovine adrenal cortex, which produces Cortisol as the major
glucocorticoid, which parallels the human situation. The major
glucocorticoid produced in the rat adrenal cortex is corticosterone, this
difference making it a less suitable model for human steroidogenesis.
Another reason for working with the bovine adrenal cortex is that the
bovine zona fasciculata, like the human zona fasciculata, responds to All by
secreting Cortisol (McKenna et al. 1978; Clyne et al. 1993). The rat zf, however,
is unresponsive to AH. Additionally, analysis of the ATa receptor, discussed
in 1.4.4.1, indicates that the non-divided nature of the bovine ATa receptor is
more similar to the human than is the rat. The bovine model has one final
advantage over the rat : the ease of obtaining the tissue. It is for a
combination of these reasons that the bovine adrenal cortex was used as a
model for this thesis.
1.5.2 The rat mesenteric artery (vascular smooth muscle)
Whereas the bovine species is more similar to man where
steroidogenesis is concerned, the rat is generally accepted to be a close
model for the human cardiovascular system. Again, physiological
manipulations are easier to perform, and rat aortic and mesenteric artery
smooth muscle preparations have been frequently used for studies of AD
binding and actions, especially in vitro (Aguilera & Catt, 1981; Lyall et al.
1992). Bovine vascular smooth muscle has been employed in studies of AH
action (Gruetter et al. 1988; Murray et al. 1990); however, this has been mostly
large vessel smooth muscle cells and as discussed earlier (1.3.2), the elastic
arteries are not the most responsive to All. The rat model would therefore
seem to be the better one, as more data is available for comparison.
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However, the different number of ATi receptor genes in the rat and human
must be considered.
1.6 Aims of the thesis
1. To establish a modified primary culture system for bovine
adrenocortical zona glomerulosa cells, quicker and easier than
established methods.
2. To resolve previously observed discrepancies (suggesting
differences between the receptors) in the pharmacological
characteristics of the type 1 angiotensin 13 receptor in bovine
adrenal zona glomerulosa and rat vascular smooth muscle by the
use of Schild analysis to obtain pA2 values.
3. To PCR-amplify, using primers designed against the published
sequence, the bovine adrenal ATX receptor coding region and to
generate and sequence a clone of this region, and from the clone to
purify a DNA sequence suitable for use as a probe in Northern
blots.
4. To use semi-quantitative Northern blot analysis to study the
regulation, by AD, signal transduction systems and steroids, of
AT} receptor mRNA expression in primary cultures of bovine zona
fasciculata/reticularis cells. Northern analysis of ATi mRNA was
chosen rather than study of receptor protein by ligand binding for
two main reasons : to avoid possible distortion of ligand binding
results through internalisation of receptors after exposure to All,
and to obtain information on the transcriptional regulation of ATi
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receptor mRNA levels, to complement what is already known
about the regulation of the ATi receptor protein.
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Chapter 2 : Materials and Methods
2.1 Materials
All chemicals were AnalaR grade and except where otherwise stated
were obtained from BDH Merck or Sigma Chemical Co.
Aldrich Chemical Co. Ltd., Gillingham, Dorset
1,1,2-trichlorotrifluoroethane, toluene, tri-n-octylamine.
Amersham International PLC, Little Chalfont, Buckinghamshire
[a-33S]dATP, [a-32P]-dCTP, cortisol-3-CMO-2(125I)-iodohistamine, myo-3H-
inositol, Na125I, Sequenase kit (from USB).
Amicon Ltd., Stonehouse, Gloucestershire
Microconcentrator columns, Micropure inserts.
Applied Biosvstems, Warrington
ULTma DNA polymerase.
BDH Merck Ltd., Lutterworth, Leicestershire
Absolute ethanol, acrylamide solution (40%, stabilised), chloroform,
dimethylformamide, dimethylsulphoxide, ethyl acetate, Ficoll, formamide,
formic acid, glass Allihn, funnels, glycerol, isopropanol, lithium chloride,
PEG, perchloric acid, polyvinylpyrrolidone, Triton X-100, urea.
Bio-rad Laboratories Ltd., Hemel Hempstead, Hertfordshire
AG1X8 anion exchange resin, (3-mercaptoethanol.
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Boehringer Mannheim UK (Diagnostics and Biochemicals) Ltd., Lewes, E.
Sussex
Adenosine triphosphate, agarose, caesium chloride, deoxynucleotides,
EDTA, Klenow enzyme, X phage DNA, positively charged nylon membrane,
proteinase K, restriction enzymes, trypsin.
Ciba Laboratories, Horsham, W.Sussex
Synacthen 250pg (ampoule; ACTH 1-24).
Fisons Scientific Equipment, Loughborough, Leicestershire
Phio-Bio Tris-equilibrated phenol.
Gibco BRL (Life Technologies) Ltd., Paisley
Amphotericin B, Dulbecco's modified Eagle medium (DMEM), Earle's
balanced salts (EBS), Ham's F-10, inositol-free DMEM, nuclease-free bovine
serum albumin (BSA), penicillin/streptomycin, Seachem agarose, T4 DNA
ligase, T4 DNA polynucleotide kinase.
Greiner Labortechnik Ltd., Stonehouse, Gloucestershire
Sterile 30mL and 50mL plastic containers.
Havman Ltd., Witham, Essex
Absolute ethanol.
ICN Flow (ICN Biomedicals) Ltd., Thame, Oxfordshire
Linbro tissue culture-treated plastics (6, 12, 24, 96-well plates), soybean
trypsin inhibitor.
Lockertex, Warrington
Nylon gauzes (20, 30, 100, 250um pore).
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Mackav & Lynn Ltd., Edinburgh
Bibby Sterilin sterile 30mL plastic containers, Corning tissue culture
plasticware (25, 75cm flasks), Neubauer improved haemocytometer,
Whatman 3MM chromatography paper.
New England Biolabs (UK) Ltd., Hitchin, Hertfordshire
Restriction enzymes (BamHI, BSpMI, Dral, EcoRI, HinDIH, Muni, Sail, SSpI).
New England Nuclear (DuPont NEN), Stevenage, Hertfordshire
RIAfluor scintillation fluid.
NIBSC, Potters Bar, Hertfordshire
Angiotensin II (asp^val0; MRC standard 64/15), insulin-like growth factor 1
(International reference standard 87/518).
Oswel DNA Service, Southampton, Hampshire
All PCR, random and sequencing primers.
Parke-Davis, Pontvpook Gwent
Arginine vasopressin (as pitressin).
Pharmacia Biotech Ltd., Milton Keynes
DEAE Sephadex A25, dextran, NAP 5 & 25 columns, Percoll.
Promega Corporation, Southampton, Hampshire
Taq DNA polymerase.
Qiagen Ltd., Dorking, Surrey
Qiaex kit.
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SanofiWinthrop Ltd., Guildford, Surrey
Noradrenaline (tartrate; as levophed).
Scottish Antibody Production Unit (SAPU), Carluke, Lanarkshire
Antisera to Cortisol, non-immune sheep serum.
Sigma Chemical Co. Ltd., Poole, Dorset
8-bromo-cyclic AMP, A23187 (calcium ionophore), agarose, aldosterone,
ammonium formate, ammonium persulphate, ampicillin, bromophenol blue,
BSA (cell culture grade), charcoal, Chloramine T, Cortisol, CPSR-1, D-
glucose, elastase (porcine), ethidium bromide, FCS, glyoxal, guanidinium
thiocyanate, histamine, Hoechst 33258 dye, horse serum, hydrogen peroxide
(30% v/v), inositol, isobutylchloroformate, light mineral oil, lysozyme,
methylene blue, n-lauroyl sarcosinate (sarcosyl), phorbol myristate acetate
(PMA), RNAse A, salmon sperm DNA, saralasin, Sephadex G-10, G-25 and




Worthington : Lome Laboratories Ltd., Twyford, Berkshire
Collagenase (type 1).
The following were obtained from non-commercial sources. The
angiotensin II receptor antagonists DuP753 and PD123177 were obtained
from the DuPont Experimental Station, Wilmington, Delaware, USA. E.Coli
cells strain DH5, the cloning vector pSP72poly4, and a 1.25kb cDNA
fragment containing the protein coding region of rat (3-actin were kind gifts




2.2.1 Cell culture methods
2.2.1.1 Bovine adrenal cortex zona glomerulosa
Bovine adrenal glands were obtained (from freshly slaughtered 1.5 -
2-year-old steers) on ice from the local slaughterhouse and trimmed of fat.
At this stage the glands were dipped in 70% ethanol, transferred to a class 2
sterile cabinet and aseptic technique was employed. Following fine trimming
of adherent fat, 100pm slices were cut from the glands using a Stadie-Riggs
microtome. Outer slices, comprising the capsule and the zona glomerulosa,
with the outermost part of the zona fasciculata (although this was not
obviously visibly present), were placed in a 50mL plastic container with
~15mL EBS/0.2%BSA until about lOg had been collected. The slices were
then chopped very finely with sharp scissors (1mm fragments) and washed
with EBS/0.2%BSA before digestion with 50mL collagenase type I (2mg/mL
(fo\lowing -»ne Mended of
in EBS/2%BSA) for 40min at 37°C. The tissue was dispersed after 20min by
A.
pipetting up and down using a 5mL pipette with a wide bore, and again
after 40min using a finer tip. The cell suspension was then filtered through
250 and 100pm mesh nylon gauzes before being centrifuged (30min, 450g) to
pellet the cells. The supernatant was discarded and the pelleted cells
resuspended in EBS/0.2%BSA and passed through a 30pm gauze to yield a
suspension of single cells. This was further purified by one of two methods,
either the Percoll density gradient method as in Shepherd et al. (1992), or a
modification of the gel filtration method described in 2.2.1.2.
The first method involved layering the cells (in a volume of
approximately 2mL) onto a discontinuous Percoll density gradient (75,40,30
& 20% Percoll in EBS/0.2%BSA) and centrifuging for 20min at 800g. The
zona glomerulosa cells were found at the 30-40% Percoll interface and
removed using a glass Pasteur pipette. They were washed twice with
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EBS/0.2%BSA and spun (450g/ lOmin) to remove contaminating traces of
Percoll. The cells were then filtered again through a 20pm mesh nylon gauze,
made up to a volume of 20mL in growth medium (Ham's F-10
supplemented with 10%CPSR-1, lOOIU/mL penicillin, lOOpg/mL
streptomycin and 25pg/mL amphotericin B) and counted using a
haemocytometer. Cells were plated out into 96-well microtitre plates at a
density of 20,000 cells/well (in 200pL growth medium/well); yield was
typically 10X106 cells. The cells were maintained in an incubator at 37°C with
a humidified atmosphere of 95% air: 5% CO2; medium was replaced every
second day.
The second method used for purification of the zg cells was a
modification of the Sephadex column used in 2.2.1.2. The cell suspension
was passed through a similar column, made up of Sephadex G-10 on top of
G-25 (superfine); cellular debris passed through the column on gentle
suction and the cells were retained. The cells were freed by resuspending
the gel in about 50mL EBS/0.2% BSA and filtering through a 20pm mesh
nylon gauze, which retains the Sephadex gel but permits the cells to pass
through. The cells were pelleted by centrifuging (30min, 450g), resuspended
and counted as previously. Yield was similar to the Percoll method and the
cells were maintained identically, before being used for experiments as
described in 2.2.2.1.
2.2.1.2 Bovine adrenal cortex zona fasciculata/reticularis
Bovine adrenal glands were obtained and trimmed as described in
2.2.1.1. 100pm slices were then taken with a Stadie-Riggs microtome as
before. The outer slices were discarded; successive inner slices were placed
into a 50mL plastic container containing EBS/0.2% (w/v) BSA. Slices
appearing to contain medulla (identified by a distinct colour change) were
discarded. When about 5g of tissue had been collected, the slices were
chopped using sharp scissors into l-2mm fragments, washed in
66
EBS/0.2%BSA and digested for 2 hours in a 50mL solution of collagenase
type I (2mg/mL in 2%BSA) at 37°C, with frequent shaking (30 minute
(fallow;^ -tv-e of Willio/is e+ <*l (i<?,8cO)
intervals) to disperse the cells. The resultant cell suspension was then filtered
through successive 250 and 100pm mesh nylon gauzes to remove undigested
tissue and then centrifuged (20min, 450g) to pellet the cells. After discarding
the supernatant, the cells were resuspended in EBS/0.2%BSA and filtered
through a 30pm gauze to give a single cell suspension, which was then
purified using the column filtration method of McDougall et al. (1979). The
cells were drawn, using gentle suction, through a column consisting of a
sintered glass Allihn funnel (100mm x 20mm disc; 16-40pM pore size)
containing 5mL Sephadex G-50 (fine) layered on 15mL Sephadex G-10 (fine).
This removed red blood cells and other cell debris which flowed through the
column, leaving the intact cells trapped in the Sephadex gel. The cells were
removed from the gel by resuspending it in approximately 50mL of
EBS/0.2%BSA and filtering this through another 30pm pore nylon gauze to
trap the gel beads while allowing the cells to pass through. The resulting
suspension was then centrifuged (30min, 450g) to pellet the cells. The
pelleted cells were resuspended in 50mL growth medium (identical to that
used for the zg cells; 2.2.1.1). Yield was determined by use of a
haemocytometer and was normally 60-80X106 cells. The cells were then
plated out in either 12-well plates at a density of 4X106 cells /plate
2 6
(lmL/well), or in 25cm cell culture flasks at a density of 5X10 cells/flask
(5mL/flask). Medium was changed daily, serum being withdrawn when
required when experiments commenced on day 2 in culture (day 0 = day of
isolation). The cells were maintained as described for the zg cells in 2.2.1.1,
and used as described in section 2.2.2.9 for experiments.
2.2.1.3 Bovine pulmonary artery smooth muscle
Sections of bovine pulmonary artery (approximately one inch long, as
near to the heart as possible) were obtained on ice from the local
* ne#nod adapted fTOM fVBSHno^ 198?
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slaughterhouse. Tissue was obtained within 30 minutes of slaughter, from 1-
2-year-old steers, and was transported to the laboratory in EBS containing
antibiotics (penicillin/ streptomycin as described below)
Under sterile conditions, the section was cut into an oblong strip and
placed endothelium-side up on a glass plate. The endothelium was scraped
off using a sterile scalpel and the artery scored in lmm-apart lines. Strips of
tissue were then cut away from the artery, comprising the innermost two-
thirds of the tissue. These strips were cut into l-2mm lengths and placed
inner side down in 6-well plates. 5-6 of these tissue explants were put in each
well. The explants were left uncovered for 30 minutes to ensure attachment
to the plate. lmL of growth medium was then put into the wells (growth
medium : DMEM + 10% FCS + 200IU/mL penicillin, 200ug/mL
streptomycin and 50ug/mL amphotericin B). The plates were then covered
and placed in an incubator, and cultured at 37°C in a humidified atmosphere
of 5% CO2, 95% air. The medium was replaced every two days; after two
weeks the concentration of antibiotics in the medium was halved. About two
weeks after initial isolation, cells started to grow out of the explants and
when sufficient cells had appeared, the explants were removed using sterile
forceps. When the cells reached confluence, they were passaged.
For passaging, the medium was discarded and the cells washed with
lml Versene (0.05% trypsin, 0.2% EDTA, 0.085% NaCl in PBS). This Versene
was removed and a further lml added. This was left to incubate at 37°C for
2-3 minutes until the cells had detached from the bottom of the flask. A little
growth medium was then added to the flask and the mixture centrifuged
(20min, 450g). The pellet was resuspended in an appropriate volume of
growth medium and the cells split in a ratio of 1:3 to 1:5 with respect to
surface area. For experiments the cells were passaged as described (using
3ml Versene for a 75cm flask) and counted before being plated into 24-well
plates at a density of 50,000 cells/well (0.5mL/well). The cells were then
allowed to grow to confluence before being used, routinely between
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passages 4 and 7. Identity of the cells was confirmed with
immunohistochemical staining for smooth muscle actin and myosin.
2.2.1.4 Rat mesenteric artery smooth muscle
Mesenteries were excised by blunt dissection from 6 male Sprague-
Dawley rats (150-200g) and placed in sterile dishes containing DMEM with
lOOIU/ml penicillin, lOOpg/ml streptomycin and 25jj.g/ml amphotericin B.
The dishes were then transferred to a class 2 sterile cabinet and the rest of
[according "to l| t+" al_, /R3 2)
the procedure was carried out under sterile conditions. Fat was cleaned off
the arteries using fine forceps and the small arterioles were trimmed off. The
trimmed mesenteries were then transferred to 10ml of an enzyme solution
(1.25mg/ml collagenase type I, 0.25mg/ml elastase and 0.05mg/ml soybean
trypsin inhibitor in DMEM supplemented with antibiotics as before) for
lOmin at 37° C. The arteries were then removed from the enzyme mix and
any remaining adventitia and fat were removed by fine trimming; the
endothelium was also removed at this stage by rubbing the arteries along
their length between the arms of a pair of fine forceps. The arteries were then
cut into l-2mm pieces and transferred into 10ml fresh enzyme solution and
incubated at 37°C until a single cell suspension was achieved. This normally
took about 20mm, with the suspension being passed up and down through a
sterile Pasteur pipette every 10 min. The cells were then centrifuged (20min,
450g), the supernatant discarded and the pellet resuspended in lOmL growth
medium (DMEM containing 10% FCS, 10% horse serum, lOOIU/ml
penicillin, 100pg/ml streptomycin and 25pg/ml amphotericin B) and plated
2 r-TT» -
out into a 25cm flask. The cells were grown at 37°C in a humidified
atmosphere of 95% air : 5% C02. Medium was changed after 48hrs and the
cells grown to confluence.
When the cells reached confluence, they were passaged in the manner
described in 2.2.1.3, in a ratio of 1:4. Cells were routinely used between
passages 4 and 7; for experiments they were plated at the same density as the
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bovine vsmc. Identity of the cells as vascular smooth muscle cells was
confirmed by staining for smooth muscle actin, myosin and desmin.
2.2.2 Biochemical methods
2.2.2.1 Stimulation of steroidogenesis in cultured cells
Bovine adrenal zona glomerulosa cells were plated into 96-well plates
at a density of 20,000 cells/well and cultured for 5 days (including day of
isolation). The medium was then removed and the cells washed three times
with 200pL/well EBS/0.2% BSA/0.1% glucose. After washing, 120pL
growth medium (as in 2.2.1.2) was put into each well and antagonist, if
required, or growth medium for controls, was added in a volume of 15pL
and mixed in by swirling. The plates were returned to the incubator for 5
minutes to allow antagonist to bind to the receptor and then the agonist was
added and mixed, also in a volume of 15pL. The plates were then incubated
at 37°C for three hours and the medium collected into 0.5mL tubes; these
were stored at -20°C prior to measurement of steroid secretion by RIA. Cells
were taken from three wells per plate for protein analysis (see 2.2.2.4).
2.2.2.2 Radioimmunoassay for aldosterone
Aldosterone secretion from zona glomerulosa cells was measured
using an "in-house" radioimmunoassay optimised in the Department of
Medicine, Western General Hospital, Edinburgh, (adapted f/cM et ad, iSgo)
Standards representing 0, 0.05, 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.4, 12.8, 25.6
& 51.2nM aldosterone were prepared in Ham's F-10 nutrient medium, as
well as a standard of 640nM to estimate non-specific binding (NSB). Samples
C^oali'+v Con^ol)
of 0.5. 5 and 20nM were used as QC samples to estimate interassay variation
and intra-assay drift (found to be both less than 10%). Standards, QC and
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NSB samples were frozen in aliquots of 150pL and used only once. NSB was
typically less than 5%.
125
Aldosterone was iodinated with I as described in 2.2.2.7 and used
in the assay at 4000cpm/100pL. This tracer and the antibody (used routinely
at a titre of 1:150 dilution from 1:100 stock) were diluted in 0.1M phosphate
buffer, pH 7.4, containing 0.1% (w/v) sodium azide and 0.1% (w/v) BSA.
25pL standard or sample was mixed with lOOpL antibody and 100pL
aldosterone tracer in LP4 assay tubes and incubated overnight at 4°C.
Separation of bound from free tracer was effected by the addition of 500pL
cold (4°C) charcoal suspension (0.6% (w/v) activated charcoal, 0.06% (w/v)
dextran T70, 0.04% gelatine in 0.1M phosphate buffer pH7.4), vortexing and
centrifugation (450g, 20min, 4°C). The supernatant, containing antibody-
bound aldosterone, was aspirated and discarded and the free iodinated
aldosterone, bound to charcoal, remaining in the pellets was counted on a
Nuclear Enterprises gamma counter (NE1600) for 3 minutes. A specimen
standard curve for this assay is shown in Figure 2.1. Curves were fitted to a
4-parameter logistic model by the gamma counter.
2.2.2.3 Radioimmunoassay for Cortisol
An 'in-house' method developed by staff at the Department of
■*
Medicine, Western General Hospital, Edinburgh, was used to determine
secretion of Cortisol from cultured adrenocortical cells. The assay used a
polyclonal antibody to bind to the Cortisol and a second polyclonal antibody
to separate the free and bound phases.
Standards representing 0, 1, 2, 5, 10, 20, 40, 80, 160, 320, 640, 1280,
2560, 5120 nM Cortisol were prepared in EBS/0.2% BSA/0.1% glucose and
frozen in 50uL aliquots. Quality control samples representing 8, 80 and 800
nM were also prepared. Inter- and intra-assay variations were routinely
found to be <10%.
* Mod»f"icccHo*-» kxf Williorfs (o/ijXjWislTed) of of -tSeHy,
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Figure 2.1
Typical standard curve for the aldosterone RIA described in 2.2.2.2.
Standards in EBS/0.2% BSA, 0.02-51.2nM were assayed in duplicate and the
curve fitted to a four parameter logistic model. Label binding in the absence





Typical standard curve for the Cortisol RIA described in 2.2.2.3. Standards in
EBS/0.2% BSA, l-5120nM, were assayed in duplicate and the standard curve
fitted to a four-parameter logistic model. Label binding in the absence of
Cortisol was typically 60-70% of total.
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10j_tL of sample/standard were pipetted into polypropylene tubes. To
these were added 50pL 12;T-cortisol (cortisol-3-CMO-(2-(125I)iodohistamine))
(diluted in assay buffer : lOOmM citrate-phosphate pH 4.0 containing 0.02%
(w/v) gelatine and 0.0013% (w/v) sodium azide; to yield ~10,0OOcpm/5O|j.L)
and 50pL primary antibody (used at a dilution of 1:800; final dilution =
1:3200).
Two tubes containing label alone were also prepared. The tubes were
then well mixed and incubated for 4 hours at room temperature. 50pL each
of the second antibody (initial dilution of 1:15 in assay buffer) and non¬
immune sheep serum (initial dilution of 1:200 in assay buffer) were then
added to the tubes, mixed well and incubated overnight at 4°C. 2mL of cold
assay buffer were then added, the tubes vortexed and then centrifuged for 45
minutes at 3,000rpm at 4°C. The supernatant was then tipped off, the tubes
blotted dry on some cellulose wadding and then counted for 120 seconds in
a gamma-counter (LKB 1621 Multigamma). A specimen standard curve is
shown in Figure 2.2. The data were analysed using RIA-calc software, the
curve being fitted to a 4-parameter logistic model.
2.2.2.4 Protein estimation
Protein was analysed by the method of Bradford (1976) using a
method adapted for a Cobas Fara centrifugal analyser. This was used to
normalise responses (e.g. steroid secretion) to the protein content in a
particular well. Briefly, at the end of an experiment cells were rinsed in 0.9%
saline and then solubilised and detached from the plate by addition of
0.5mL 1% Triton X-100 and gentle scraping. Samples were then diluted 1:10




2.2.2.5 I-All binding experiments with cultured cells
Bovine adrenal zona glomerulosa cells were added to 24-well culture
plates at a density of 200,000 cells/well in lmL growth medium. The cells
were cultured for 5 days including the day of isolation. Medium was
changed on the first and third days. The cells were then washed three times
with EBS/0.1% BSA, lmL/well. After this, 0.8mL EBS/0.1% BSA was added
to each well and the plates were incubated at room temperature for 20
minutes.
O.lmL of either EBS/0.1% BSA, agonist/antagonist or 10pM AH (for
non-specific binding) was then added. The plates were then swirled to mix
the solutions and the 123I-AII was added in a volume of O.lmL;
100,OOOcpm/well (typically 0.05pmoles). The plates were again swirled and
incubated at room temperature for 150 minutes to allow equilibrium to be
reached.
At the end of the incubation period, the EBS/0.1% BSA/AII solution
was removed from the wells and discarded. The cells were rapidly washed
with 3XlmL ice-cold PBS, the rinses also being discarded. lmL 1% Triton X-
100 was then added to each well and the cells removed by gentle scraping
with the plunger of a 2mL plastic syringe. The cell suspension was
transferred to LP4 polypropylene tubes and counted for 60 seconds in a
Nuclear Enterprises gamma counter (NE1600). Non-specific binding was
typically less than 5%.
2.2.2.6 Measurement of phosphatidylinositol turnover
Stimulation of phosphatidylinositol turnover by All and other
agonists was measured in vascular smooth muscle cells as a means of
quantifying the magnitude of agonist stimulation in the absence of being
able to measure an end-organ contractile response. Methods developed 'in-
house'by I.M. Bird. (Bird Oye -e>" oJ.
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2.2.2.6.1 Labelling of cells
Rat or bovine vascular smooth muscle cells were plated into 24-well
plates at a density of 50,000 cells/well (0.5mL/well) in normal growth
medium and incubated for 24 hours at 37°C. The medium was then removed
and replaced with 0.5mL serum-free medium (see 2.2.1.3) prepared using
inositol-free DMEM containing H-inositol to a concentration of 10(iCi/mL.
The plates were then replaced in the incubator and left for 72 hours to allow
steady-state turnover of labelled phospholipids to be reached. The cells were
then ready for experiments.
2.2.2.6.2 Stimulation ofphosphatidylinositol turnover
The labelled medium was removed from the cells after 72 hours and
replaced with 0.5 mL/well EBS/0.2% BSA/0.1% glucose. The cells were then
incubated at 37°C for 15 minutes to wash away extracellular inositol. This
medium was removed and replaced with 0.45mL EBS/BSA/glucose
containing unlabelled inositol (lOmM) and lithium chloride (lOmM). After
15 minutes incubation as before (to allow the 'cold' inositol to chase out the
H-inositol, and the lithium to inhibit phosphatases), agonists/antagonists
were added as required in a volume of 50pL and the cells were incubated at
37°C for 20 minutes. Except in the case of two wells taken for protein
analysis, 250pL cold 15% perchloric acid was then added per well to
terminate the stimulation. The inositol phosphates were then extracted as
described below.
2.2.2.6.3 Extraction of inositol phosphates and quantitation of turnover
The cells were scraped from the wells using the plunger of a 2mL
plastic syringe and transferred to a 1.5mL Eppendorf tube. The wells were
rinsed with 0.5mL distilled water and this rinse was also transferred. The
samples were then centrifuged in a microfuge for 3 minutes at 6,500rpm and
the supernatant, containing the inositol phosphates, transferred to a glass
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tube. 1.5mL of a freshly-prepared mixture of 1:1 trichlorotrifluoroethane/tri-
n-octylamine was then added to each tube and the samples vortexed
thoroughly until the samples appeared milky. The tubes were then
centrifuged (3 minutes, 3,000rpm) to separate the phases. 0.9mL of the
aqueous upper phase was removed to a clean 1.5mL Eppendorf tube.
lOOpL of lOmM EDTA was then added and each tube mixed well. The
samples were passed through polypropylene columns (with a sintered glass
base disc, 1cm diameter) containing 0.5mL AG1X8 anion-exchange resin
(previously equilibrated with distilled water) and eluted with 2X 2mL 1M
ammonium formate/0.1M formic acid buffer. The eluates were collected into
5mL scintillation vials and 3mL scintillant (HydroLuma) was added to each
vial. These were securely capped and shaken well to ensure mixing of the
phases. The vials were counted for 10 minutes in a Canberra-Packard
CA1900 liquid scintillation counter programmed to obtain DPM values.
2.2.2.7125Iodination of aldosterone
125
Aldosterone was labelled with I for use in radioimmunoassay using
the Chloramine T/histamine method as detailed below. (UonteT eV <xij IRKZ)
Firstly, 400uL aldosterone (in the 3-methyl-mono-oxime form; a
0.725mg/mL solution in ethanol) was dried down in a glass tube under
nitrogen and redissolved in 50pL dimethylformamide cooled to 10°C. The
tube was maintained at 10°C in a water bath containing ice and to the
redissolved oxime was added lOpL tributylamine (85pL stock diluted in
5mL dimethylformamide) and lOpL isobutylchloroformate (45.4pL stock
diluted in 5mL dimethylformamide). The mixture was then vortexed and
kept at 10°C for 20 minutes.
Next, the histamine was 125I-iodinated. lOpL Na123I (~lmCi) was put
in a conical based glass tube and to this was added 10pL histamine (2.2mg in
lOmL 0.25M phosphate buffer pH 7.4) and lOpL Chloramine T (50mg in
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lOmL 0.25M phosphate buffer pH 7.4). The tube was vortexed for 15 seconds
and then 10pL sodium metabisulphite (120mg in lOmL 0.05M phosphate
buffer pH 7.4) was added before vortexing again and cooling to 0°C on ice.
The iodinated histamine was then reacted with the activated aldosterone as
follows.
280uL cooled dimethylformamide was added to the activated
aldosterone and vortexed. 50pL of the diluted aldosterone solution was then
added to the ice cold iodination mixture. lOpL 0.2M NaOH was then added,
the tube well vortexed and incubated at 0°C for two hours. After this time,
lmL 0.1M HC1 and lmL redistilled ethyl acetate were added to the 125I-
iodination mixture. The tube was capped, vortexed for 5 seconds and the
upper (organic) layer was removed and discarded. lmL 0.1M NaOH and
lmL potassium iodide (lOOmg in lOmL 0.5M phosphate buffer pH 7.4) were
then added and the mixture vortexed before being extracted with ethyl
acetate as described below.
125
250pL redistilled ethyl acetate was added to the I-iodination
mixture and the tube was capped and vortexed for 1 minute. The lower
aqueous layer was removed to a second conical-based tube and the organic
layer was transferred to a clean glass tube. The aqueous layer was extracted
a further two times, and the organic layers combined.
The 125I-iodinated aldosterone (aldosterone-3-CMO-(2-(125I)-
iodohistamine) was then purified by thin layer chromatography. The organic
extract was applied in a narrow band approximately one inch from the
bottom edge of a 200x200mm silica TLC plate (Merck; silica gel 60) and run
in a solvent consisting of toluene:ethanol:acetic acid (75:24:1) for
approximately two hours. The plate was then removed from the tank and
allowed to dry before being wrapped in cling film and exposed to Kodak X-
ray film (X-OMAT AR5) for 15-20 minutes. The position of the 12oI-
aldosterone band was marked on the TLC plate. Two bands were observed;
the lower band of which was known to be the immunoreactive compound,
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with a Tf of 0.2-0.24. The silica containing this band was carefully scraped off
and transferred via a glass funnel to a glass scintillation vial. The 125I-
aldosterone was eluted with 3mL ethanol for one hour at room temperature.
The ethanol was then filtered through a glass Pasteur pipette plugged with a
small piece of cotton wool and containing 2cm celite to remove the silica. The
125column was washed with 3XlmL ethanol. The final I-aldosterone product
was stored at -20°C.
2.2.2.8 Iodination of Angiotensin II
125
This I-iodination provided labelled AH for use in ligand binding
studies, and was also carried out using the Chloramine T method.
10pL of 10mg/mL AD was mixed with IOjiL 0.5M phosphate buffer
125
pH 7.4 in a polypropylene tube. To this was added 10pL Na I; this was
mixed before adding lOpL Chloramine T (lOmg diluted in lOmL 0.5M
phosphate buffer pH 7.4). This was again mixed and incubated for 60
seconds at room temperature. To stop the 12°I-iodination reaction, 10pL
sodium metabisulphite (20mg diluted in lOmL 0.5M phosphate buffer pH
7.4) was added and mixed before adding 500pL 0.1M phosphate buffer (pH
7.4) and mixing the contents of the tube a final time.
125 rThe I-iodinated AH was then purified by gel chromatography
through a column of DEAE Sephadex A25 equilibrated with 0.1M phosphate
t"t 125buffer pH 7.4. The I-iodination mixture was applied to the column,
allowed to drain into it and then washed into the column with lmL of
buffer. Buffer was then pumped through the column using a low pulsatile
peristaltic pump at a flow rate of 0.25mL/minute. Fractions were collected
every 4 minutes for 5 hours into numbered polypropylene vials. 10pL
aliquots from these fractions were counted for 60 seconds in a gamma
counter to locate the 12oI peaks. The first to appear was the unreacted 12:>I-
iodine and was discarded. The second, which eluted at approximately 4
hours, corresponded to the mono-i2:T-iodinated AH; the highest activity
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fraction plus the two fractions on either side of the peak were collected and
pooled; all other fractions were carefully discarded. The pooled fractions
were made up to 50mL with 0.1M phosphate buffer pH 7.4 containing 0.1%
(w/v) sodium azide and 0.5mL Trasylol (200 kallikrein inhibitor units/mL).
lmL aliquots were transferred into plastic tubes (LP4), capped and stored at
-20°C. Specific activity of the 123I-AII was routinely ~1000Ci/mmol.
2.2.2.9 Stimulation of cultured cells to monitor regulation of AT} receptor
expression
Bovine adrenal zona fasciculata/reticularis cells were plated into
2 625cm cell culture flasks at a density of 5X10 cells/flask, in 5mL growth
medium. The cells were cultured as described in 2.2.1.2, with the medium
being changed after 24 hours. On the second day after isolation, the medium
was removed and the cells washed in sterile EBS. They were then incubated
for 6 hours in serum-free medium (containing antibiotics as in 2.2.1.1) before
commencing experiments.
After 6 hours, the serum-free medium was removed and 5mL of
serum-free medium, either alone or containing agonists at the chosen
concentrations was added. The cells were then incubated, normally for 48
hours. Medium was replaced every 24 hours. Experiments were designed so
that all incubations finished at the same time. Therefore, if time points less
than 48 hours were to be used, the agonists were added to the cells at the
requisite time before the end of the experiment. At the end of the experiment
the medium was removed and in some cases reserved for assay of Cortisol
secretion. The cells were then processed for RNA extraction as detailed in
2.2.3.2.
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2.2.3 Molecular biology methods
2.2.3.1 DNA isolation from tissue
DNA was isolated from bovine spleen using a method based on a
protocol (Sambrook et al. 1989) for preparing high molecular weight DNA.
250mg of bovine spleen (obtained fresh, on ice, from the local abattoir within
30 minutes of slaughter) was minced finely in cold PBS and homogenised
(30 seconds, Polytron homogeniser, followed by one pass in a Dounce
homogeniser). Remaining particulate matter was pelleted by a short spin (30
sec, lOOOrpm) and the supernatant centrifuged at 200g for 10 minutes at 4°C
to pellet the nuclei. These were resuspended in 3mL digestion buffer (50-mM
Tris HC1; pH8.0, lOOmM EDTA, lOOmM NaCl, l%(v/v) SDS), 175jiL
lOmg/mL proteinase K was added and the tissue incubated at 55°C for 4
hours. 200pL of 20|ig/mL DNase-free RNase was then added and incubated
at 37°C for a further hour, after which 375uL 2M P-mercaptoethanol and
6mL phenol were added and the tube contents mixed on a vertical rotator for
15 minutes. The phases were separated by centrifuging at 3000rpm for 10
minutes (Heraeus Omnifuge) and the aqueous phase transferred, along with
the interphase, to a fresh tube. This procedure was then repeated, but
without the addition of P-mercaptoethanol. 3mL of phenol and 3mL
choroform were then added to the aqueous phase and rotated as before for 5
minutes, after which the phases were separated as before. The aqueous
phase was then transferred to a clean tube (leaving behind the interphase)
and 6ml chloroform was added, mixed and the aqueous phase separated as
before. The DNA was precipitated by the addition of 6mL isopropanol and
inverting several times. The DNA was pelleted by centrifuging at 500g for 10
minutes and resolubilised in 3mL TE (lOmM Tris.HCl; ImM EDTA pH 8.0)
by incubating at 37°C overnight. After this the DNA was reprecipitated by
adding 0.5 volumes 6M ammonium acetate and 2 volumes isopropanol and
mixing well. The tube was centrifuged as previously to pellet the DNA,
which was then washed with 1.8mL 70% ethanol followed by air drying
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briefly. The pellet was finally resolubilised in 3mL TE pH8.0 by warming at
37°C for 30 minutes before being analysed for integrity (by running an
aliquot on a 0.7% agarose 0.5X TAE gel) and quantitated by measuring
absorbance at 260/280nm. (lOD at 260nm = 50pg DNA; ratio 260:280 should
be 1.6-1.8).
2.2.3.2 Agarose gel electrophoresis of nucleic acids
Generally, the quality of nucleic acids after PCR, assembly of cloning
vector, RNA isolation etc. was checked by electrophoresis through a 0.7%
(w/v) 0.5X TAE agarose gel containing 0.5pg/mL ethidium bromide, to
et- oJ, Rgq)
allow visual detection under UV light. A small amount of sample was mixed
with loading buffer (0.25% (w/v) bromophenol blue, 40% (w/v) sucrose,
60mM EDTA pH 8.0). The gel was prepared by melting 0.8g agarose
(general molecular biology grade) in 75mL distilled water using a
microwave oven, cooling to approximately 50°C, adding 0.75mL 50X TAE
(Tris-acetate-EDTA buffer : when IX = 0.04M Tris.acetate; 0.001M EDTA)
and 3.75pL lOmg/mL ethidium bromide and pouring into a gel-forming tray
(apparatus was either Pharmacia GNA100 or Bio-rad wide mini sub-cell). A
comb with the appropriate number of wells was placed in the tray and the
gel was left for 30 minutes to set. Once set, the gel was transferred (with
tray) to a gel-running tank containing sufficient 0.5XTAE buffer to cover the
gel. The samples were loaded into the wells and the electrophoresis was run
at constant voltage (100V) for approximately 45 minutes, or until the blue
dye had migrated half way down the gel, submerged in 0.5X TAE buffer.
The nucleic acids could then be visualised by viewing the gel on a
Spectroline UV transilluminator and could be photographed (Polaroid film)
if required. X DNA size markers were also run on each gel. When running
RNA samples, the tank, tray and comb were treated with 3% (v/v) hydrogen
peroxide for 15 minutes to destroy any contaminating RNAses; the gel and
running buffer were prepared using RNAse-free water.
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2.2.3.3 DNA quantitation by fluorimetry
This method was used for accurate quantitation of DNA. It uses a
Hoefer TKO 100 fluorimeter and is based upon the fact that DNA fluoresces
in the presence of Hoechst 3328 dye (method as per Hoefer manual).
After warming up for 30 minutes, the scale on the fluorimeter was
adjusted to 50%. 2mL of TNE + dye mix (0.2pg/ml Hoechst 3328 Dye, lOmM
Tris.HCl; pH7.4, ImM EDTA, 0.2M NaCl) was placed into the cuvette, mixed
by inversion, the sides of the cuvette were wiped and it was then placed in
the fluorimeter. The fluorimeter was then zeroed. This step was repeated
several times until consistent readings were obtained (+/- 5 units). The DNA
standard was then set: 2mL of TNE + dye was placed in the cuvette and 2pL
of 250ng/ pL X DNA was added and mixed well by inversion. A reading was
then taken and the scale knob adjusted to read 250. This step was then
repeated, using fresh dilutions each time, until consistent readings of 250 +/-
5 units were obtained. The machine was now ready to be used to measure
the DNA concentration of samples. 2mL TNE + dye mix was placed in the
cuvette, 2pL DNA sample added and the two mixed well, again by
inversion. A reading was then taken. Readings over 700 units were deemed
to be outside the linear range, and the sample was diluted before being re¬
read. More than one reading was taken for each sample to ensure consistent
results were obtained.
2.2.3.4 Restriction enzyme digestion
2.2.3.4.1 General restriction digest conditions
DNA was digested at a concentration of 0.1-0.5pg/mL to a four-fold
enzyme/time excess (twice the theoretical enzyme units needed to complete
the digest (1 unit/ pg DNA in 1 hour) and twice the time needed). Digests
were carried out in the buffer recommended by the manufacturer (supplied
with the enzyme) at 37°C. Enzyme never comprised more than 10% (v/v) of
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the reaction mix to avoid glycerol interference with digestion. At the end of
the digestion period (normally 2 hours) 0.5pg DNA was checked on an
agarose gel to monitor completeness of the reaction. Reactions were stopped
by addition of a lOmM EDTA excess (2.5pL 0.4M EDTA pH 8.0 per 50pL
reaction) and heat-inactivation at 65°C for 10 minutes. (Sawb/do^ eh aly IdS9)
2.2.3.4.2 Preparation ofDNA size markers
These were prepared from A, phage DNA by digestion with EcoRI and
HinDIII using the following reaction conditions : 200pL of XDNA
(0.25pg/pL) was digested with 25 Units each of EcoRI and HinDIII (each
10U/ pL) in Boehringer reaction buffer B, in a total reaction volume of 250pL.
Digestion was at 37°C for 5 hours. After this time 2.5pL was checked on an
agarose gel for completion of the digest. If the reaction was complete, 12.5pL
0.4M EDTA was added and the reaction was heat-inactivated at 65°C for 10
minutes. The DNA was then precipitated by the addition of 125pL 6M
ammonium acetate and 750pL isopropanol and spun for 5 minutes at
maximum speed in a microfuge. The pellet was washed with 180pL 70%
ethanol and briefly air dried before reconstituting in 167pL TE and 33pL 6X
sample loading buffer. These markers gave fragments of DNA of the
following sizes : 21226, 5148, 4973, 4277, 3530, 2027, 1904, 1584, 1330, 983,
831, 564,125 base pairs.
2.2.3.5 Polymerase chain reaction
(Sanbrccic eh oJ, 1*389)
The polymerase chain reaction was used to amplify the coding region
of the AT} receptor gene (a fragment of 1077bp in length) from bovine DNA.
The primers were designed to amplify the entire coding region of the AT}
receptor (this was possible as there are no introns in the coding sequence)
and had EcoRI (forward) and BamHI (reverse) restriction sites incorporated
into them to permit generation of 'sticky ends' for insertion of the ATI
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fragment into the cloning vector. A positive control reaction amplifying
G3PDH from bovine DNA (primers : forward : 5'-
ACCACAGTCCATGCCATCAC-3'; reverse : 5'-
TCCACCACCCTGTTGCTGTA-3') was also used. During optimisation of the
AT] PCR procedure the following were varied : annealing temperature (64,
65, 66°C); starting amount of DNA (0.5, 0.1, 0.02 and O.Olqg); number of
cycles (30, 32 and 35) and type of DNA polymerase (Taq and ULTma, a
proof-reading enzyme). The conditions chosen were : annealing temperature
65°C; initial DNA 0.02pg; 32 cycles and Taq polymerase. ULTma, although
more accurate, proved unreliable under all conditions tested, possibly due to
excessive 3'-5' exonuclease activity and lack of processivity.
General reaction conditions were as follows. 20ng bovine genomic
DNA was amplified in a 25pL reaction containing lpM of each of forward 5'-
(TGGAATTCAAAATGATCCTCAACTCTTCC)-3' and reverse 5'
(CTGGGATCCGGTTTCAAGTGTGTTACTCAACC)-3' primers, 0.2mM each
dATP, dCTP, dGTP and dTTP, ImM MgCl2 and 0.25 Units Taq or ULTma
polymerase (added after initial heat denaturation : 'hot starf conditions).
The reaction buffer was lOmM Tris.HCl pH 8.3, 50mM KC1, O.lmg/mL
gelatine. 25pL light mineral oil was layered on top of each reaction tube and
the tubes were then transferred to a Hybaid Omnigene PCR machine. The
reactions were heat denatured at 94°C for 5 minutes before proceeding with
a run of 32 cycles of denaturation (94°C, 1 minute), annealing (65°C, 1
minute) and extension (72°C, 1 minute, 30 seconds) followed by one cycle of
72°C for 10 minutes and 25°C for 1 minute. The PCR reactions were then
extracted by the addition of 50pL chloroform, mixing and centrifuging to
separate phases. The aqueous phase was transferred to a clean tube; 5pL of
this was used for analysis on an agarose gel to check that amplification of
the correct fragment size of DNA had occurred. The ATX PCR reaction
yielded a band of 1114bp while the control GAPDH reaction yielded
fragments of 700bp and 300bp. The remainder of the reaction was stored at
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4°C until purification. Product from multiple reactions was pooled. To
investigate the effect of purification of fragment on cloning efficiency, two
different purification strategies were used; the AT; PCR product was
therefore split into two pools, AT} (D and (D. Pool (D was extracted with
successive volumes (1 X reaction volume) phenol, phenol+chloroform and
chloroform, spinning each time (2 minutes, full speed in a microfuge) to
separate phases and taking the aqueous phase to a clean 1.5mL tube. The
DNA was then precipitated by the addition of 0.5 volume 6M ammonium
acetate and 2 volumes isopropanol and incubating at -20°C for 30 minutes,
followed by spinning for 5 minutes at full speed in a microfuge (4°C). The
pelleted DNA was then washed in 70% ethanol, air dried and resuspended
in 17.6pL water for the Klenow Kinase Ligase (KKL) procedure described in
2.2.3.6.
Pool (D was purified by passing through an Amicon
microconcentrator, as in the second part of protocol 2.2.3.8.1. The
concentrated DNA was made up to 17.6pL with sterile water for the KKL
procedure.
2.2.3.6 Klenow kinase ligase procedure
This procedure was used to concatemerise the PCR product. This
generated restriction sites in the middle of the molecule rather than at the
ends, and therefore increased the efficiency of the restriction enzymes used
(Lorens, 1991). DNA purified after PCR was resuspended in 17.6|_iL of sterile
water and the following were added : 2.5pL 10X KKL buffer (300mM Tris
HC1 PH 7.8, lOOmM MgCb lOOmM DTT, 5mM ATP), 0.5pL dNTP mix (as
for PCR), l.OuL Klenow polymerase (5U/|j.L), 0.4|TL T4 polynucleotide
kinase (lOU/pL) and 2.0pL T4 DNA ligase (lU/pL). The reaction was
incubated at 25°C for 2 hours, then heat-inactivated for 10 minutes at 70°C.
l.OpL was checked on an agarose gel to confirm that concatemerisation had
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occurred, after which the product was digested with EcoRI and BamHI
restriction enzymes as below.
2.2.3.7 Restriction digest of PCR product and vector.
Either 25pL KKL reaction mix (AT2 (D and ©) or 25pL 0.2pg/pL
cloning vector (pSP72poly4) were digested with EcoRI and BamHI to
generate compatible 'sticky ends'. The DNA was mixed with 5pL 10X
Boehringer restriction buffer B, 2.5pL of each of EcoRI and BamHI (10U/pL)
and 15pL sterile water. Digests were incubated for 2 hours at 37°C; 2.5,uL
was checked on an agarose gel for completeness of digestion.
lOOng DNA was reserved from the AT} pools at this stage for use in
ligations (ATi © and © 'pre'). AT: (D and © DNA was purified by
preparative electrophoresis and gel extraction using the Amicon system, as
described in section 2.2.3.8.
Vector DNA was precipitated by addition of 0.5 volumes 6M
ammonium acetate and 2 volumes isopropanol and incubating at -20°C for
30 minutes, centrifuging, washing and resuspending in 25pL TE. This was
then purified by preparative electrophoresis and Qiaex extraction as
described in 2.2.3.8.
At this point the ATX and vector DNA was quantitated by fluorimetry
(2.2.3.3) and 50ng run on an agarose gel to check integrity. All DNA samples
were stored at 4°C until use.
2.2.3.8 Purification of AT} insert and vector DNA for cloning
2.2.3.8.1 Preparative electrophoresis
Both the PCR product and the vector into which the PCR product was
to be inserted were purified using this method. The DNA was
electrophoresed on a high grade, low melting point agarose (Seachem GTG
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enzyme grade); a 75mL 0.5X TAE gel was used as described in 2.2.3.2, using
a 5-tooth comb enabling large volumes (30pL) to be run. Before use the tank,
gel tray and comb were washed with neutral detergent and treated with 3%
(v/v) hydrogen peroxide to ensure removal of nucleases. The DNA sample
(after KKL procedure and/or restriction digest to generate 'sticky ends') was
loaded into a single slot of the comb and run at 50-60mA until the
bromophenol blue in the loading buffer had migrated halfway up the gel.
The gel was then placed under long-wave (312nm) UV light, the required
band sliced out with a sterile scalpel, placed into a preweighed, sterile
Eppendorf tube and the weight of agarose removed determined. At this
point the gel was photographed to show the position of the excised bands;
doing this before excision of the fragments can damage the DNA and lead to
reduced ligation and transformation efficiencies. The DNA was then eluted
from the agarose fragment in one of two ways, each detailed below.
2.2.3.8.2 Extraction ofDNA from agarose : Qiaex resin
This method followed the manufacturer's (Qiagen) protocol. 300pL of
solubilisation buffer QX1 was added to the Eppendorf tube containing the
excised gel fragment for each lOOmg of gel. 10uL of well-vortexed Qiaex
suspension was then added and the agarose solubilised by incubating at
50°C for 10 minutes. The sample was vortexed every two minutes to keep the
resin in suspension. The tube was then centrifuged in a microfuge at full
speed for 30 seconds. The resultant pellet contained the DNA bound to the
Qiaex resin. This was resuspended by the addition of 500pL of QX2 buffer
and vortexing, followed by centrifugation to pellet the resin. This step was
repeated once with buffer QX2 and twice with buffer QX3. All traces of
supernatant were then removed and the pellet was briefly air dried. The
DNA was eluted from the Qiaex resin by the addition of 20pL TE,
resuspension by vortexing and incubation for 5 minutes at room
temperature, with periodic vortexing to keep the resin in suspension. The
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sample was then centrifuged as before and the supernatant carefully
transferred to a fresh tube. The elution procedure was then repeated and the
eluates combined. The purified DNA was then checked for integrity on an
agarose gel and quantified by DNA fluorimetry (2.2.3.3).
2.2.3.8.3 Extraction ofDNA from agarose : Amicon columns
This method used Micropure inserts in Microcon microconcentrators
to extract DNA from agarose slices and to wash and concentrate the product
as per the manufacturer's instructions. The excised agarose fragment from
the preparative electrophoresis was minced with a sterile scalpel until only
small (l-2mm) pieces remained. lOOpL TE pH 8.0 was then added to the tube
and a peroxide-treated Eppendorf pestle was used to homogenise the gel
into a slurry. The gel slurry was transferred into a Micropure insert inside an
assembled Microcon microconcentrator unit. The Eppendorf was rinsed with
lOOuL TE and this was also transferred to the insert. The unit was then
capped securely and spun in a microcentrifuge for 10 minutes (room
temperature, full speed). The liquid had then passed through the insert, but
was retained above the membrane of the microconcentrator.
The insert was then discarded and the Microcon concentration unit
transferred to a clean Amicon tube and filled with 450pL TE. The apparatus
was then capped and spun as before, with an additional spin if liquid
remained above the membrane after the first spin. This washing step
removed any enzymatic impurities released from the agarose with the DNA.
The wash step was then repeated. The high purity DNA was recovered from
the Amicon membrane as follows : 10uL TE was layered gently on top of the
membrane, the Microcon apparatus was removed from the tube and
transferred, upside-down, to a clean Amicon tube. The DNA was spun
down (30 seconds, top speed) and diluted with TE to a volume of 40uL (or
less if, for example, the DNA was to be subjected to KKL procedures).
The integrity of the recovered DNA was checked by agarose gel
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electrophoresis (2.2.3.2), and fluorimetry (2.2.3.3) was used to accurately
quantitate the DNA. The recovered DNA was stored at 4°C until use.
The second half of this protocol i.e. the concentrating of DNA (from
volumes of up to 500pL) could be used independently of the gel extraction
protocol. Dilute or impure DNA was placed directly into a Microcon
apparatus, spun down (10 minutes, full speed) to concentrate the DNA, the
DNA was then washed twice as described and the concentrated DNA
recovered as above.
2.2.3.9 Ligation of ATi insert into pSP72poly4 vector
Ligations were carried out using several different ratios of insert (ATx
pools (D and © 'pre' and 'posf) to vector. AT: DNA, purified in different
ways as described in 2.2.3.5, was ligated into the vector at molar ratios of 5:1
and 20:1. lOng vector DNA (2.5kb long) were used in each ligation which
meant that the amounts to be used for 5:1 and 20:1 ratios were 20ng and
80ng insert (lkb) respectively. The two DNA samples were mixed with 4uL
5X ligation buffer (from BRL), lpL lOmM ATP, 1 unit T4 DNA ligase and
made up to a volume of 20uL with sterile water. A vector self-ligation
control was included, where the insert was replaced with water; a non-
ligated control (no ligase) was also included. The reactions were incubated at
room temperature for 4 hours and then used in transformations.
2.2.3.10 Preparation of competent bacteria
E.coli strain DH5 (Hanahan, 1983) was made competent using the
method of Chung et al. (1989). Briefly, lmL of a fresh overnight culture of
bacteria was inoculated into lOOmL L-broth supplemented with lOmM
MgS04 and 0.2% (w/v) glucose. This was incubated at 37°C, 225rpm for 2
hours to give an A600 of 0.2-0.3. The cells were then cooled to 4°C on ice-
water and centrifuged for 5 minutes at lOOOg, 4°C using a pre-cooled swing-
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out rotor. The cells were resuspended by the addition of lOmL of ice-cold
Miller transformation solution (L-broth containing 10% (w/v) PEG 8000, 5%
(v/v) DMSO, 50mM MgCl2 at a final pH of 6.5) and gentle swirling. At this
stage, the cells were competent. Aliquots of 440pL were snap-frozen in
1.5mL Eppendorf tubes in a dry ice-ethanol bath and stored at -70°C until
use.
2.2.3.11 Transformation of bacteria with cloning vector
Competent cells were thawed slowly on ice-water and gently
resuspended. ATX PGR product, ligated to pSP72poly4 as in 2.2.3.9, was
diluted to 100pL with TE (from a ligation reaction volume of 20uL). 40pL of
the diluted reactions were pipetted into chilled 15mL polypropylene tubes.
100pL of competent cells were added to each tube and swirled to mix; the
tubes were then incubated for 30 minutes at 4°C. 0.9mL of prewarmed SOC
medium (2% (w/v) bactotryptone, 0.5% (w/v) yeast extract, lOmM NaCl,
2.5mM KC1, lOmM MgCl;?, lOmM MgSC>4 and 20mM glucose) was then
added, the tubes securely capped and incubated for 1 hour at 37°C, 225 rpm,
to allow expression of ampicillin resistance. lOOpL transformation mix was
then plated out onto L-agar ampicillin plates (with lOOpg/mL ampicillin);
the remaining mix was centrifuged at 3000rpm for 10 minutes, 700u.L of the
supernatant removed and the remainder used to resuspend the pelleted
cells; these were plated out in the same manner. The plates were incubated,
upside-down, overnight at 37°C. Colonies on each plate were then counted;
if there was an increase in numbers in the ATi ligations compared to the self-
and non-ligated controls, colonies were picked and processed for minipreps
(see 2.2.3.11). Table 2.1 shows the transformation efficiencies resulting from
the different ligations performed.
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2.2.3.12 Alkaline lysis minipreps of DNA
This rapid method of assessing whether the plasmid inserted into the
competent cells contained the required insert was based on that of Birnboim
and Doly (1979).
2mL of L-broth containing 0.2% (w/v) glucose and lOOpg/mL
ampicillin was inoculated with a single bacterial colony from a plate
containing putative transformants and grown to saturation overnight at 37°
C. 1.5mL of the culture was then transferred to an Eppendorf tube and spun
in a microfuge at full speed for 20 seconds to pellet the cells. The remaining
culture was kept at 4°C. The pellet was resuspended in lOOpL of 'lysis
buffer' (25mM Tris.HCl pH8.0, lOmM EDTA, 10% (w/v) glucose, 2mg/ml
lysozyme) and left at room temperature for 10 minutes. 200pL fresh sodium
hydroxide/SDS solution (0.2M-NaOH, l%(w/v) SDS) was then added and
mixed immediately by vortexing gently and placed on ice for 5 minutes.
150pL 3M potassium acetate pH 4.8 was then added to the suspension and
vortexed vigorously for 10 seconds to ensure mixing was complete. The tube
was then placed on ice for a further 5 minutes and spun for 1 minute at full
speed in a microfuge to pellet the cell debris and chromosomal DNA. The
supernatant was then transferred to a clean tube; 0.9mL isopropanol was
added and the tube left at -20°C for 15 minutes to precipitate nucleic acids.
The solution was spun for 2 minutes at room temperature to pellet the
plasmid nucleic acids, which were resolubilised in 40pl TE (10 minutes, 37°
C). To the resolubilised nucleic acids 20,ul 6M ammonium acetate and 120fj.L
isopropanol was added, the solutions were mixed by inversion and
incubated at -20°C for 15 minutes. The nucleic acids were spun down as
before and the pellet washed with 180|YL 70% ethanol and air dried for 10
minutes, before resuspending in 20pL TE containing RNAse A (50pg/mL).
Yield of DNA was usually l-5pg. Of this 2pL was digested with appropriate
restriction enzymes (to excise the insert from the Table 2.1 shows the
frequency of successful ligations for the different ATi pools used. If the
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Ligation Transformants/pg DNA Successful ligations / 5
non-ligated 5.9 x 104
vector self-ligated 3.6 x 104
ATi G) 'pre' 5:1 5.6 x 104 0
ATX © 'pre' 20:1 1.1 x 104 0
ATX © 'posf 5:1 1.4 x 10° 0
ATx © 'posf 20:1 3.9 x 104 1
AT} © 'pre' 5:1 2.6 x 104 0
ATi © 'pre' 20:1 1.6 x 10d 0
ATa © 'posf 5:1 8 x 104 5
ATi © 'posf 20:1 6 x 104 5
control 2:1 1.2 x 10°
control 5:1 2.1 x 10°
N.B. 1. The competence of the E.Coli cells was checked and found to be
sufficient at 7.4 x 106 transformants/ pg DNA.
2. The terms 'pre' and 'post7 refer to ATi DNA taken before and after
gel purification of the insert respectively.
3. The control insert was a 2.7kb EcoRI-BamHI fragment excised from
another plasmid, pR2P4.3.
Table 2.1
Transformation efficiencies and frequencies of successful ligations for
the two ATa pools before and after gel purification of the ATi PCR product. __
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presence of the insert was confirxned/ other restriction digests were
performed to confirm that the DNA inserted contained the right sequence.
Large quantities of bacteria containing the AT} plasmid could then be
prepared as described below.
2.2.3.13 Large scale plasmid preparation and purification of DNA
This method was based on that of Birnboim and Doly (1979) and was
used for preparing large quantities of high-quality DNA from the restriction-
mapped positive ATi clones. The resultant DNA was of sufficient standard
to be used for sequencing and preparation of probes for Northern blots.
lOmL L-broth supplemented with 0.2% (w/v) glucose and lOOpg/mL
ampicillin was inoculated with 200pL culture reserved from a positive
miniprep and grown to saturation overnight at 34°C. This culture was then
used to inoculate 500mL L-broth supplemented as above and the new
culture was grown for 16-24 hours at 34°Q 250rpm in an orbital shaker. The
lower temperature was used to facilitate plasmid replication over bacterial
division. The cells were harvested by centrifugation for 10 minutes, 4°C,
5000rpm and resuspended in 4mL glucose/Tris/EDTA solution (25mM Tris
HC1 pH 8.0, lOmM EDTA, & 50mM glucose). This solution was transferred
to a clean tube and 2mL fresh lysozyme solution (lOmg/mL) added and
mixed gently. The tube was left on ice for 15 minutes. lOmL freshly
prepared NaOH/SDS solution (0.2M NaOH, l%(w/v) SDS) was then added
and mixed gently until a clear, homogeneous solution was obtained. The
tube was then left for a further 10 minutes on ice before adding 7.5mL
potassium acetate solution (pH 5.5; 3M potassium acetate, 1.18M formic
acid). The solution was incubated for a final 10 minutes on ice and then
centrifuged for 15 minutes, 4°C, 13,000rpm to pellet the bacterial DNA.
The supernatant (containing plasmid DNA) was carefully decanted
into a clean tube and the DNA precipitated by the addition of 1 volume of
cold isopropanol and incubation at -20°C for one hour. The mixture was then
94
centrifuged for 10 minutes (4°C, 13,000rpm) to pellet the DNA. This was
then dissolved in 9mL TE before being purified by caesium chloride
gradient centrifugation.
The 9mL DNA solution was transferred to a 15mL polypropylene
tube containing exactly 9.9g CsCl. After warming gently to effect complete
solubilisation, 0.45mL lOmg/mL EtBr was added. This solution was then
carefully transferred to an llmL Beckman polyallomer quick-seal centrifuge
tube and balanced to within 0.05g of another sample tube or balance tube (of
TE/CsCl/EtBr) and heat-sealed. The tubes were then spun in an NVT65
rotor for 24 hours, room temperature, 55,000rpm.
After centrifugation, the plasmid DNA was visible as a reddish band
which fluoresced under UV light. The band was removed using a 19G
needle and 2mL plastic syringe as shown below :
needle to allow air in
chromosomal DNA
plasmid DNA
needle, bevelled edge up
The DNA solution removed from the gradient was then purified from
contaminating CsCl and EtBr. The solution was made up to 2.5mL with TE
and passed through a NAP-25 column. It was then eluted into a clean 15mL
tube by passing 3.5mL TE through the column. Intercalated EtBr was then
removed by extracting the solution successively with 1 volume
phenol+chloroform and 1 volume chloroform. To maximise yield, the
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phenol+chlorofrom was extracted with 1 volume TE and this was combined
with the aqueous phase from the chloroform extract. The DNA was then
precipitated with 0.1 volume 3M sodium acetate pH 5.5 and 2 volumes cold
isopropanol, incubating for 1 hour at -20°C. The tube was centrifuged for 10
minutes, 4°C, 4000rpm to pellet the DNA, which was washed in lmL 70%
(v/v) ethanol and spun again. The pellet was then air dried for 10 minutes
and resolubilised in 0.5mL TE, then transferred to a 1.5mL Eppendorf tube
and stored at 4°C. lpL was checked on an agarose gel to examine integrity;
an accurate quantitation was obtained by fluorimetry. The concentration was
adjusted to lpg/pL and the correct identity of the plasmid checked by
restriction mapping similar to that performed after minipreps.
2.2.3.14 Sequencing ofAT: receptor clones
To ensure that the clones of the AT} receptor generated were entirely
homologous with the published sequence, it was necessary to sequence
them. This was^accomplished by the Sanger dideoxynucleotide method,
using the Sequenase kit from USB. Multiple primers were used at sites
throughout the coding sequence in order to generate complete sequence on











5' -GATGTGTTAATTCAGTTGG-3' ATi ©
reverse i.e. 3'-5'
5' -CAATACGCAAACCGCCTC-3' pSP72 reverse
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5' -CTGGGATCCGGTTTCAAGTGTGTTACTCAACC-3' PCR BamHI
5'-CTTCAATTTTACAGTCAC-3' ATi ©
5'-GGATTCGTAATGGAAAGC-3' ATi ©
5' -AGGTTGAAACTGACACTG-3' ATi ©
For most of the reactions, dGTP was used. Occasionally, however, it was
necessary to sequence using its analogue dITP to resolve compressions
occurring in the sequence due to CG repeats. The reaction is described for
one primer but normally up to four primer reactions were run
simultaneously.
The double-stranded DNA was denatured as follows. For each
sequencing reaction (i.e.use of one primer) 5|ig AT} DNA was needed. To
this, 0.1 volume 2M NaOH/2mM EDTA solution was added and the mixture
was incubated at 37°C for 30 minutes. O.lvolume 3M sodium acetate and two
volumes 100% ethanol were then added, mixed and the samples incubated at
-70°C for 30 minutes. The samples were centrifuged at 4°C for 30 minutes
and the pelleted DNA was then washed by the addition of 0.5mL 70%
ethanol, inversion and a further spin for 5 minutes. The wash was also
discarded, the pellet air dried for 5 minutes and resuspended in 7\xL sterile
water.
The sequencing reactions were performed as detailed in the
Sequenase kit protocol. Briefly, 5pg (7pL) denatured template DNA (from
the ATi clone) was mixed in a 1.5mL Eppendorf tube with 2pL 5X reaction
buffer (200mM Tris.HCl pH 7.5, lOOmM MgCl* 250mM NaCl) and lpL
primer (lpmol/pL). The tube was heated to 65°C for 2 minutes to anneal the
primers to the DNA and left to cool slowly to <35°C over 30 minutes. 2.5pL
of each termination mixture (8uM ddA,C,G/I orTTP; 80|iM dA,C,G/I and
TTP in 50mM NaCl) was pipetted into a 1.5mL Eppendorf tube and
prewarmed to 37°C. To the annealed DNA, lpL 0.1M dithiothreitol, 2pL
labelling mix (1.5pM dG/I,C,TTP), 0.5pL [35S]-dATP and 2pL 1:8 diluted
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Sequenase enzyme (buffer is lOmM Tris.HCl pH7.5, 5mM DTT, 0.5mg/mL
BSA). After each addition, the tube contents were mixed by pipetting up and
down. The reaction was incubated for 2-5 minutes at room temperature, after
which 3.5pL of the labelling reaction was transferred to each of the
termination tubes. The termination reactions were allowed to proceed for 5
minutes at 37°C, after which they were stopped by the addition of 4pL stop
solution (95% formamide, 20mM EDTA, 0.05% bromophenol blue, 0.05%
xylene cyanol FF). The reactions were stored at -20°C until being run out on
a polyacrylamide gel.
Gradient gels were formed between 600mmxl50mm glass plates to a
width of 0.7mm. The plates used were washed with distilled water and
phosphate-free detergent, water alone and then ethanol to ensure cleanliness
and absence of grease. The inner side of one plate was silicoriised to make
separation of the plates after running the gel easier. The plates were then
taped together and the gel poured. The gradient to be used was 0.5-4.OX TBE
(Tris-borate-EDTA; when 0.5X = 0.045M Tris.borate; 0.001M EDTA) in a 6%
acrylamide gel. The 4.OX TBE solution also contained 5% sucrose to allow for
easier formation of the gradient. Both solutions contained 46% (w/v) urea to
denature the DNA. 8mL 4.0X TBE gel was prepared first (polymerised by
the addition of 16pL 25% (w/v) ammonium persulphate and 8pL TEMED.
The 0.5X TBE gel was prepared to a volume of 60mL, using 120pL and 50jiL
of ammonium persulphate and TEMED respectively to polymerise. To form
the gradient, 7mL of the 0.5X TBE gel was mixed with the 4.0X TBE gel and
poured between the plates. As it settled to the bottom, the remainder of the
0.5X TBE gel was poured slowly between the plates until it reached the top.
At this point a 24-well comb (treated as were the plates) was inserted into
the gel and the plates secured together by means of bulldog clips. The gel
was left for one hour to set. After this time, the clips were removed, the
comb removed and the top of the gel washed gently with distilled water to
remove any crystals of urea. The tape was then taken off and the gel
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transferred to the running tank (BRL). 0.5X TBE buffer was then added to the
bottom and top reservoirs, the comb replaced and the tank sealed up.
The samples were thawed if necessary and then heated to 75°C for 2
minutes to denature the DNA. They were then placed immediately on ice
and kept there while loading (2pL per sample) onto the gel. The gel was run
for 13,000volt-hours, until the xylene cyanol dye front had just reached the
bottom of the gel plate.
The gel was then removed from the tank and the plates separated.
The gel, still attached to the non-siliconised plate, was fixed in a tank
containing 10% (v/v) glacial acetic acid and 10% methanol in distilled water
for 15 minutes. After this, the gel was removed from the fix solution, drained
and then transferred to a piece of Whatman 3MM filter paper before being
dried for 2 hours at 80°C. The dried gel was then laid down to Kodak XAR-5
film overnight at room temperature to obtain an autoradiograph of the
sequence information.
The data were entered using a DNAstar (Madison, Wisconsin)
automated sequence reader and analysed using DNAstar software. Matching
sequences from different primers and sequences from the opposite strand
were also put together using the Sequencing Project Manager and the Align
program of the DNAstar software.
2.2.3.15 RNA isolation from cells in culture
It was ensured that all solutions, plastics and glassware used when
working with RNA were RNAse free. The method used was an adaptation of
the RNAzol method described by Chomczynski & Sacchi (1987). Briefly, cells
in 25cm flasks were rinsed with EBS to remove any traces of growth
medium and then lysed by the addition of lmL of RNAzol. The cells were
then scraped off the flask, pipetted up and down several times to ensure the
solubilisation of the RNA and then transferred to clean 1.5mL Eppendorf
tubes and kept on ice. lOOpL chloroform was then added and the tubes
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vortexed for 15 seconds and left on ice for 5 minutes. The phases were
separated by spinning at full speed in a refrigerated microfuge for 15
minutes, after which the aqueous phase was transferred into a clean tube.
The RNA was precipitated by adding 1 volume isopropanol and incubating
at 4°C for 30 minutes. RNA was then pelleted by spinning at full speed in a
refrigerated microfuge for 15 minutes. The pellet was washed with lmL 70%
ethanol, centrifuged again as before and briefly air dried before being
solubilised in lOOuL RNAse-free water. RNA samples were stored at -70°C.
Before use in Northern blots, they were run on a 0.7% agarose gel to confirm
their integrity, and quantified by measuring the A260 on a UV
spectrophotometer (lOD unit = 40pg RNA; A260 : A280 ratio should ideally
lie between 1.8 and 2.0).
2.2.3.16 Northern blotting
This method, for separating RNA samples by electrophoresis
followed by permanent transfer to a nylon membrane and hybridisation
with a labelled probe to a particular mRNA species, was adapted from that
of Thomas (1983) and consisted of three stages, each described below.
2.2.3.16.1 Sam-pie preparation and electrophoresis
Usually 25ug total RNA isolated from bovine adrenal cortex zfr cells
in culture was analysed, but as little as 15ug could be analysed if yield was
limiting. Samples were precipitated by the addition of 0.1 volume 3M
sodium acetate pH 5.5 and 3 volumes absolute ethanol. The samples were
incubated overnight at -20°C. A negative control (i.e. RNA which contained
no ATx mRNA; total RNA from either cultured thyrocytes or Swiss 3T3 cells
was used) was also prepared as were "copy controls". These were samples of
negative control RNA spiked with small amounts of AT} receptor coding
region DNA (the same DNA used to make the hybridisation probe). The
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amounts chosen represented 2 and 20 copies of AT\ mRNA per cell, based
upon the fact that mRNA comprised 2% of total RNA, and the assumption
that ATj mRNA was expressed at the low level of 1/100,000 mRNA
molecules. In terms of weight of RNA this represented detection of 5 and
50pg RNA in a total sample of 25pg. RNA and DNA markers (5pg each of
total RNA and X DNA markers) were also processed. After incubation at -
20°C, the samples were centrifuged for 15 minutes at full speed in a
refrigerated microfuge to pellet the RNA. The pellets were washed by the
addition of 180uL 70% ethanol, brief, gentle vortexing and spinning for 5
minutes as before. The RNAs were then air dried for 5 minutes and
resuspended by the addition of 3.7pL RNAse-free water. 12.3pL denaturing
mix was then added (for 20 samples : 54pL glyoxal, 32pL 0.1M phosphate
buffer and 160pL DMSO, made fresh before use) to each sample, care being
taken that the RNA was completely redissolved. The RNA samples were
then denatured by heating at 50°C for 1 hour, followed by immediate
cooling on ice. 4pL RNA loading buffer (lOmM Na Phosphate; pH 7.0, 50%
(v/v) glycerol, 0.4% (w/v) bromophenol blue) was then added and the
samples loaded onto the gel.
A larger gel was used for the Northern blot electrophoresis than for
the analytical gels, with a higher percentage of agarose. Prior to use, the
tank, gel forming plates and comb were washed with neutral detergent and
treated for 15 minutes with 3% (v/v) hydrogen peroxide to remove RNAses.
The apparatus was then rinsed well with RNAse-free water and drained. A
1.2% (w/v) agarose gel (with no ethidium bromide, as this reacts with the
glyoxal denaturing reagent), containing lOmM phosphate buffer, was
poured into the tank between the gel forming plates and left to set. After
setting, the gel was submerged in lOmM phosphate buffer pH 7.0.
Recirculation of the buffer during the electrophoresis was necessary as the
phosphate buffer ionises during electrophoresis, and the glyoxal dissociates
from the RNA at pH>8.0.
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The samples were then loaded onto the gel. A lane was left between
the markers and the samples and controls to allow easy identification of
sample position. Recirculation of the buffer was not started until the
samples had fully entered the gel to avoid loss of the samples from the wells.
The gel was run at constant voltage (100V) for 3 hours, after which time the
bromophenol blue marker dye had migrated to within l-2cm of the end of
the gel. At the end of the run, the RNA was transferred to a nylon membrane
by capillary transfer as described below.
2.2.3.16.2 Capillary transfer
The capillary wick was formed as follows. A large glass plate was
balanced on top of a pyrex dish. Three pieces of Whatman 3MM were cut,
the same width as the gel (15cm) and three times as long. A small amount of
20X SSC (3.0M NaCl, 0.3M Na citrate) was poured on the plate and the first
piece of paper laid on top. Air bubbles were removed by rolling a glass
pipette over the plate. This process was repeated with the other two pieces;
the remainder of a 500mL bottle of 20X SSC was poured into the dish. The
gel was then placed, upside-down, on top of the wick and air bubbles
removed as before. The top left-hand corner of the gel was cut off to aid
orientation. A piece of positively-charged nylon membrane the same size as
the gel (15 X 15cm) was wetted in 2X SSC and gently placed on top of the
gel, positively-charged side down, and air bubbles were again removed.
Nine pieces of Whatman 3MM paper were cut to the same size as the gel.
One piece was wet in 2X SSC and gently placed on top of the membrane,
rolling out air bubbles as before. This was repeated with 5 more pieces, the
other 3 were placed on top dry. The sides of the wick were covered with
parafilm to ensure that transfer only took place through the gel and glass
pipettes were placed on two opposite sides of the setup to support the
transfer. Absorbent tissues were then placed on top of the Whatman paper
(three double stacks of about 3cm each), a smaller glass plate was put on top
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of these and weighted with a full 500mL bottle. Transfer was left to proceed
overnight.
The next day the transfer setup was disassembled, the position of the
wells was marked clearly on the membrane and the top left hand corner cut
off (as on the gel). The membrane was rinsed briefly in 6X SSC and then air
dried for 30 minutes before being baked at 80°C for 30 minutes to remove
the glyoxal. The RNA was then covalently bound to the membrane by
exposing it to 240mJ UV light at 312nm in a Bio-rad cross-linker.
To check that the RNA had been transferred and that it was still
intact, and to allow detection of the size markers, the two lanes containing
these samples were cut off from the blot and stained for 5 minutes in
methylene blue (0.04% (w/v) in 0.5M sodium acetate pH 5.5). Destaining in
distilled water revealed nucleic acids stained blue. If the correct pattern of
bands was observed, the blot was then subjected to hybridisation as
described below. Figure 2.3 shows the appearance of the stained DNA and
RNA markers correctly resolved and transferred.
2.2.3.16.3 Hybridisation with specific probe fragments ofDNA
The blot was wetted with 6X SSC and placed in a Techne
hybridisation bottle. If more than one blot was to be hybridised, two blots
could be placed in each tube. It was then prehybridised (blocked) in 20mL
prehybridisation solution (50% (v/v) deionised formamide, 5x SSPE (when
20X = 3M NaCl, 0.2M Na phosphate pH 7.4, 0.02M EDTA), 5x Denhardfs
solution (when 100X = 20mg/L Ficoll, 20mg/L polyvinylpyrrolidone,
20mg/L BSA), 0.5% (w/v) SDS, ImM EDTA and 100pg/ml heat-denatured
salmon sperm DNA) for 4 hours at 42°C. A Vogelstein random primed probe
(2.2.3.17.1) or an asymmetric PCR probe (2.2.3.17.2) was made using either
cloned bovine adrenal AT} receptor coding region DNA (lkb) or a 1.25kb
fragment of rat (3-actin cDNA. This was added to 20mL prehybridisation














Marker lanes from a representative Northern blot stained with
methylene blue to visualise nucleic acids. Lane 1 shows 5pg X DNA markers,
with the sizes indicated, and lane 2 shows the same amount of bovine
adrenal RNA. The 18 and 28S ribosomal bands are indicated. The nucleic
acids in both lanes are intact and transfer has occurred evenly, showing that
the quality of the blot is sufficient for hybridisation to proceed.
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membrane for 4 hours. The probe was then denatured by boiling for 10
minutes, cooling on ice and then the blot prehybridisation solution was
replaced with the boiled probe solution and hybridisation was carried out
overnight at 42°C.
Non-bound probe was then washed off the membrane using a
progression of low and high stringency 50mL washes as follows.
• Low stringency : 2X SSPE, 0.1% SDS; 2 washes at room
temperature followed by 2 washes of 15 minutes each at 65°C.
• High stringency : 0.2X SSPE, 0.1% SDS; 2 washes of 10 minutes
at 65°C and 2 washes of 30 minutes at 65°C.
The blot was then briefly air dried and wrapped in cling film while
still damp, before being laid down either to autoradiography (Kodak XAR-5
film, 2 enhancement screens, 72-96 hours at -70°C) or phosphorimaging
(Biorad Molecular Imager CS or BI screens, 24-48 hours, room temperature).
If, after exposing the blot, it was wished to reprobe it (for example, if
normalisation of ATI receptor mRNA signal to a 'housekeeping gene' - (3-
actin - was required), the bound probe was stripped from the membrane.
The blot was wetted with 2X SSC and placed in a hybridisation tube. It was
then washed with a 50mL solution of 5mM Tris.HCl pH 8.0, 2mM EDTA pH
8.0, 0.1X Denhardf s solution and 0.1% SDS for 1 hour at 68°C. The blot was
then air dried and either stored wrapped in cling film and a plastic bag or
was wetted with 6X SSC to continue with hybridisation as described above.
2.2.3.17 Preparation of probes for Northern blots
2.2.3.17.1 Preparation of'Vogelstein' random primed probe
32
This procedure for labelling specific fragments of DNA with P for
use in Northern blots was adapted from that of Hodgson and Fisk (1987).
50ng template DNA and 250ng random primers were made up to a
volume of 10pL with TE and denatured at 100°C for 5 minutes, then
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quenched on ice to avoid renaturation. The following reagents were added
(in this specific order) : 5pL labelling buffer (0.5M Tris HC1; pH 6.9, 0.1M
MgSO^ ImM DTT, ImM dATP, ImM dGTP and ImM dTTP), 5pL [32P]-
dCTP (lOpCi/pL), 26.5pL sterile water, lpL nuclease free BSA (lOmg/mL)
and 2.5jTL Klenow enzyme (2U/|j.L). The reagents were well mixed and
incubated at room temperature for 1 hour for labelling to take place. After
(done fcy r»f)0#»'ng Ori
this time lpL of the reaction was checked for incorporation of the label.-^^^.fr'^j^^ _
If the reaction was deemed to have worked, the labelling procedure
was then stopped by the addition of 2.5pL 0.4M EDTA pH 8.0. The labelled
probe was then purified from unincorporated nucleotides by sequential
phenol/chloroform extraction and passing the aqueous extract (made up to
500ptL with 150liL 20X SSPE and 300uL sterile water) through a NAP-5
column equilibrated with 6X SSPE. The probe was then eluted with lmL 6X
SSPE and lpL counted (with 3mL scintillant) in a scintillation counter to
ascertain the resultant activity of the probe. The probe was denatured before
use by heating at 100°C for 10 minutes and was used in hybridisation as
described in 2.2.3.16.3. Probes typically had a specific activity/pg template
DNA of 1-2X109 cpm and were used at a concentration of ~lX106cpm/mL.
Initially, probes were used in the manner described above. However,
despite precautions, background was sometimes a problem on the blots, as
can be seen in certain figures in Chapter 6. To resolve this, later probes were
preadsorbed for 4 hours before use against a blank piece of nylon membrane
in 20mL prehybridisation solution containing 200pL salmon sperm DNA as
before.
2.2.3.17.2 Preparation ofasymmetric PCR labelled probe
This method involved a modified PCR reaction similar to that
described in 2.2.3.5. However, the concentration of the 'forward' primer was
limited, so that in effect only the antisense strand was amplified, generating











Autoradiograph of a Northern blot comparing the sensitivities of
Vogelstein and asymmetric PCR AT] probes. 25pg bovine adrenal RNA was
run in the lanes indicated, and with both probes, whether 1/6 or 5/6 of the
probe was used, a 3.3kb species was detected. This corresponds to the size of
the bovine adrenal AT] receptor cloned by Sasaki et al. 1991).The PCR probe
is more sensitive, but the less sensitive Vogelstein probe also detects the AT]
mRNA species. A l.lkb species is also detected in the copy control lane, in
which 25pg 3T3 fibroblast RNA was spiked with a small amount of AT]
probe fragment. As little as 5pg AT] mRNA can be detected (copy 2). The
sizes of the DNA and RNA markers are indicated alongside.
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double-stranded probe as described in 2.2.3.17.1). The nucleotide
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composition also varied, a P-dCTP was used in excess, 50pCi/reaction, and
dA,T and GTP were used at 2.5mM. A small amount of unlabelled dCTP
was also included (0.25mM). The 'forward' primer concentration was 0.2pM,
and the 'reverse' 20pM. lOng AT! insert DNA was used as the template. All
other conditions were as described in 2.2.3.5. After the PCR reaction, the
product was checked for incorporation. If this was satisfactory, the probe
was used directly, with no further purification. Immediately before use, it
was denatured for 10 minutes at 100°C and chilled on ice.
Figure 2.4 shows an autoradiograph of a Northern blot of 25pg
samples of bovine adrenal zfr cell RNA probed with both a Vogelstein probe
and an asymmetric PCR probe to compare the sensitivity. Although the
asymmetric probe was more sensitive, the Vogelstein probe detected the ATX
mRNA at levels as low as 5pg (see copy controls), and therefore this simpler
method of probe preparation was chosen.
2.2.3.18 Analysis of Northern blotting data
For qualitative analysis, the blots were exposed to Kodak X-ray film
as described. For the quantitative analyses, however, the blots were laid
down to Bio-rad BI phosphorimager screens and volume analysis of the
resultant pixels in each band was performed, compensating for background
in each case. This was done for both the ATi and (3-actin - probed blots. The
AT: bands were then normalised to the corresponding p-actin bands and the
quantity of AT! receptor mRNA relative to that of the averaged basals was
obtained. Statistical analysis of any significance in the changes observed was
calculated using a paired t-test. Significance was inferred if a p-value of
<0.05 was obtained.
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Chapter 3 : Optimisation of a modified primary culture
— ——-»» ———/
of bovine adrenal zona glomerulosa cells
3.1 Introduction
Primary cell cultures of the zona glomerulosa from the adrenal cortex
have been used for many years as a model system to study the nature,
function and regulation of angiotensin II receptors (Hornsby & O'Hare, 1977;
Andoka et al. 1984; Douglas et al. 1984; Kojima et al. 1984), which mediate the
stimulation of aldosterone secretion from these cells (Catt et al. 1979).These
studies have focused on two model systems, each of which possesses specific
advantages : the rat, because of its flexibility for conducting in vivo
physiological and pharmacological investigations (Aguilera et al. 1980; Brilla
et al. 1993); and the ox, because of its closer steroidogenic similarity to man
(secreting Cortisol as the principal glucocorticoid) and the availability of
tissue (Neville & O'Hare, 1982).
Methods for isolation and culture of these cells have been widely
published (Saltman et al. 1976; Crivello et al. 1982; Elliott et al. 1985; Shepherd
et al. 1992). For bovine adrenal zona glomerulosa cultures, these largely rely
on slicing the adrenal gland, digesting the subcapsular cells, and separating
zg cells from other cell types by means of density gradient centrifugation.
More variation is found in the culture conditions. Most investigators claim
that to maintain the full steroidogenic capacity of the cells, certain
antioxidant compounds are necessary in the culture medium. This was first
proposed by Hornsby & Crivello (1983a), who suggested that the high
natural antioxidant content of the adrenal gland was necessary to maintain
steroid enzyme activity. The same group later demonstrated this to be the
case (Crivello et al. 1982; Crivello et al. 1983; Hornsby & Crivello, 1983b), by
showing that addition of metyrapone (a cytochrome P450 inhibitor) and
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other antioxidants to the culture medium slowed or stopped the normal
decline in steroid synthesising capacity of the cells.
The reason for the loss of steroid synthesising ability was believed to
be the accumulation of basally-secreted steroids acting as pseudosubstrates
for certain cytochrome P450s, especially ll^-hydroxylase. This was proposed
to lead to uncoupling of the enzymes and generation of harmful lipid
peroxides, which damage the cells (Crivello et al. 1983; Crivello et al. 1982;
Hornsby, 1989). Uncoupling of the enzymes would effectively reduce the
capacity of the cells to synthesise the appropriate steroids. The adrenal
cortex is particularly high in lipids, rendering it especially vulnerable to such
damage. To protect against this, it produces high levels of antioxidants such
as vitamin C (ascorbic acid), vitamin E (a-tocopherol), glutathione, selenium
and superoxide dismutase (SOD), a compound protectant against oxidative
damage. These are therefore commonly included in the culture media of
bovine adrenal zona glomerulosa cells (excepting SOD), with the addition of
transferrin and insulin.
In this chapter, data are presented describing a modified method of
bovine adrenal zona glomerulosa cell isolation, purification and primary
culture. The main modification was in the purification step, where a
Sephadex gel filtration system was used, and compared to, a more standard
Percoll density gradient to purify the zona glomerulosa cells. Full details of
both methods can be found in Chapter 2. The resulting cells, purified by
column filtration, maintain their capacity to secrete aldosterone for up to six
days in culture, without the use of antioxidants in the medium. Indeed, the
use of antioxidants in this system appeared to inhibit steroidogenesis.
Using this modified culture procedure, the day-by-day responses of
125the cells to angiotensin II, and changes in I-AH binding, were studied. This
provided an insight into the functioning of the AD receptor during short-
term culture. It also suggested that the observed decline in aldosterone
synthesis was due not to a lack of steroid synthesising capacity, but to a
decrease in All receptor number in the cells.
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3.2 Results
3.2.1 Purity of the culture
The purity of the slices used to isolate cells before Percoll or Sephadex
purification was assessed by examination of formalin-fixed slices typical of
those taken for the preparation. Slices were examined by light microscopy
for cells exhibiting zona glomerulosa (high nuclear:cytoplasmic ratio; low
numbers of lipid droplets) and zona fasciculata (lower nuclear:cytoplasmic
ratio; higher numbers of lipid droplets) characteristics. The slices taken for
the zg preparation were predominantly composed of cells with the
morphological features of the zona glomerulosa (shown in Table 3.1). A light
micrograph of a typical first slice from a bovine adrenal gland is shown in
Figure 3.1, where the majority of the adrenocortical cells are zg cells, with a
minority of zf cells on the inward face of the slice.
Purity of the cultures was also assessed by measuring the
cortisol:aldosterone ratio for cells prepared using either Percoll gradient or
Sephadex purification. If significant inner zone contamination were present,
stimulation with All or ACTH would be expected to produce larger amounts
of Cortisol compared to aldosterone secretion. All results for this and the
following sections are triplicate determinations (plus/minus standard error
of the mean) from representative experiments, which were performed at
least twice. Where statistical significance has been determined, Student7 s t-
test or one-way ANOVA has been used; significance was inferred when
p<0.05.
The ratio of Cortisol •: aldosterone production was calculated for zona
glomerulosa cells produced by both Percoll and column purification
methods, as shown in Figure 3.2. A method similar to this for assessing
culture purity was used by Braley et al. (1992), and also de Lean et al. (1984b).
The data for aldosterone and Cortisol secretion are also shown in Table 3.2.
Bovine zg cells were cultured for four days after isolation. Upon stimulation
with lOnM All or O.lnM ACTH, the Cortisol:aldosterone ratio decreased
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(when compared to basal), indicating a prevalence of aldosterone secretion
in these cells, and consistent with a purified zona glomerulosa cell
preparation with little or no inner zone cell contamination. There was no
significant difference between the cortisohaldosterone ratios for the two
purification methods. Measurement of the ratio in further experiments gave
a value of less than 10 in the basal state, suggestive of less than 35%
contamination with zfr cells (de Lean et al. 1984b).
3.2.2 Comparison of two purification methods used in the culture
The Percoll gradient purification involved many centrifugation steps
and forming the gradient was difficult. It was therefore felt that a
modification of the purification method used in our laboratory for bovine zfr
cells (Williams et al. 1989) might be an acceptable and more convenient
alternative. The modified method of zona glomerulosa cell preparation using
a Sephadex gel filtration protocol was then compared to the standard Percoll
density gradient method.
Figure 3.3 shows a comparison of aldosterone secretion following
stimulation with angiotensin II of zona glomerulosa cells prepared by either
the Percoll or column purification methods. Cells were cultured for four
12 7
days after isolation and stimulated with AH (10" - 10" M) for 3 hours.
Aldosterone was measured in the overlying media. It can be seen that there
is no significant difference between the two sets of cells. Figure 3.4 compares
responses of the two cell preparations to maximal concentrations of All,
ACTH and K+. Again, there is no significant difference between the two
preparations for stimulation with AH and ACTH, while the column method
gives better (p<0.01) results following stimulation with 12mM potassium.
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Table showing results of histopathological examination of outer slices
from three sample preparations. These slices consist mostly of zona
glomerulosa, with a minority of zona fasciculata cells and no zona




Haematoxylin/eosin-stained section of a typical outer slice from a
bovine adrenal gland. Slices 100pm thick were cut from fat-trimmed glands
and fixed in formalin. The slice shows the outer capsule, the entire zona











Basal 0.02 +/-0.003 0.03 +/-0.004 0.27+/-0.13 0.11 +/-0.0
An 10nM 0.22 +/-0.01 0.26 +/- 0.03 0.32 +/- 0.06 0.16 +/-0.02
ACTH O.lnM 0.21 +/-0.02 0.26 +/-0.004 0.14 +/-0.05 0.25 +/- 0.05
K+ 12mM 0.08 +/-0-01 0.22*+/" 0.03 0.35 +/-0.15 0.12 +/-0.05
Table 3.2
Steroid secretion rates (nM/mg protein) for bovine zg cells purified
using Percoll or Sephadex. There is no significant difference between the two
methods, with the exception of the potassium-stimulated aldosterone
secretion, where the Sephadex-purified cells gave a greater response than the
Percoll-purified cells (*p<0.01). This data is from a representative experiment
which was performed three times.
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Figure 3.2
Ratios of Cortisol : aldosterone secretion calculated for bovine zona
glomerulosa cells purified by Percoll (□) or Sephadex column (S). 20,000
cells/well were cultured for 4 days after isolation and stimulated for 3 hours
with either lOnM All, O.lnM ACTH or 12mM K+; data combined from three
experiments. Stimulation with all three agonists decreased the ratio,
indicating an increased production of aldosterone compared to Cortisol.
There was no significant difference in the cortisohaldosterone ratio between
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Figure 3.3
Dose-response curves to All for bovine zg cells purified by Percoll (A)
or Sephadex (■). Bovine zg cells were prepared and isolated by the two
methods, cultured for 4 days and stimulated with All for 3 hours. The two
sets of cells were taken from the same pool of glands. There was no
significant difference between maximal aldosterone production induced by
All in the two preparations. Data taken from one representative experiment
carried out on three separate occasions.
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3.2.3 Changes in aldosterone response to All stimulation during culture
The day-by-day aldosterone responses of cultured zona glomerulosa
cells to a maximal AD stimulus of lOnM (compared to basal responses) for
bovine zg cells from the day after isolation (day 1) to 5 days afterwards (day
6) is shown in Figure 3.5. These cells were prepared using the Sephadex
column purification method. The maximum response was reached on day 5
of culture, n-fold stimulation reaching 6.88 (see Table 3.3). After this the
response declines. Basal secretion, having remained fairly steady up until
day 5, decreased on day 6. The aldosterone secretion of freshly isolated cells
(day 0) was 0.348 +/- 0.03 nmol/mg protein basally, and 0.776 +/-
0.04nmol/mg protein following stimulation with lOnM AH
3.2.4 Effect of antioxidants on aldosterone response to All
As some of the antioxidants used in the culture medium were known
to be inhibitory to steroidogenesis (e.g. metyrapone), the effect of the
supplementary antioxidants in the medium on aldosterone secretion from
the cells was investigated. In Figure 3.6 the aldosterone response of the cells
to maximal concentrations of lOnM AD, O.lnM ACTH or 12mM potassium (3
hours incubation) over days 1 to 6 in culture, for cells cultured with (Figure
3.6a) and without (Figure 3.6b) the antioxidant supplements in the medium
are shown. Although basal responses were approximately equal for both
culture conditions, the cells cultured without antioxidants showed a greater
aldosterone response when compared to cells cultured with antioxidants.
Differences were significant on day 3 for all agonists, on day 5 for ACTH
and on day 4 for K+ (p<0.05). Figure 3.7 shows a dose-response curve to AH
for the two sets of cells carried out on day 5 of culture. The cells grown
without antioxidants are significantly more sensitive (p<0.05) than those
with reaching maximum response at 10"9M AH Cells cultured in the
presence of supplementary antioxidants reached maximum response to AH
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Figure 3.4
A comparison of aldosterone responses to maximal stimulatory
concentrations of All, ACTH and K+ in bovine zg cells purified by Percoll (0
) or Sephadex (□). Cells were isolated from the same pool of adrenal glands
and purified by either the Percoll density gradient or Sephadex column
method, cultured for 4 days and then stimulated with lOnM AH, O.lnM
ACTH or 12mM fC for 3 hours. Cells purified on Sephadex produced
slightly more aldosterone than the Percoll-purified cells after AH or ACTH
treatment, and significantly more (* : p<0.01) after K+ treatment. This data is
from a representative experiment, which was performed three times.
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Figure 3.5
Dav-by day aldosterone secretion of bovine zg cells purified using the
Sephadex column method. The bars correspond to basal secretion (□) and
secretion following stimulation with lOnM AH (S) for 3 hours. These cells
were cultured in the presence of antioxidants. Maximal response,
corresponding to an n-fold increase over basal of 6.88, is reached on day 5




Day-by-day aldosterone responses for 3 hour exposure to a maximal
stimulus of lOnM AH (0), O.lnM ACTH (0) and 12mM K+ (S). Basal
aldosterone secretion (□) is also shown. Both panels show bovine zg cells
isolated from the same pool of glands, purified by Sephadex gel filtration,
and cultured in the presence (Figure 3.6a : upper panel) or absence (Figure
3.6b : lower panel) of supplementary antioxidants. In the absence of
antioxidants, responses in all cases were higher, significantly so on days 3-4
(All and K+) and 3-5 (ACTF1); basal secretion was also greater on day 4
(p<0.05). The day of maximal response was later (day 5) in the presence of
antioxidants than in their absence (day 4). Data taken from one of two
representative experiments. (** p<0.01; * p<0.05 indicates responses









Dose response curve to All for bovine zg cells in the presence (■) or
absence (A) of antioxidants in the culture medium. Cells were cultured for 5
days after isolation in each case; both sets of cells were taken from the same
preparation. The cells without antioxidants appeared to be more sensitive to
All, reaching a maximum aldosterone response at 10" M All. In contrast,
those cultured with antioxidants appeared less sensitive, reaching a
maximum at 10"8M All. ** : p<0.005; * : p<0.05 for greater response in the
absence of antioxidants. Data from a representative of two similar
experiments.
/2"5
isolation for the two sets of cells to All : n-fold stimulation (over basal) for
cells without antioxidants was maximum on day 4 as compared to day 5 for
cells with antioxidants. This can be seen in Table 3.3.
A comparison of basal and All-stimulated aldosterone secretion in
bovine zg cells, prepared using Sephadex purification and cultured without
antioxidants, with that in bovine zg cells published by two other groups (de
Lean et al. 1984b; Shepherd et al. 1992) is given in Table 3.4. Although basal
secretion is less than in Shepherd et al. (1992), All-stimulated aldosterone
secretion was greater than in both published datasets.
3.2.5 Changes in All binding (receptor number) during culture
These studies were of a preliminary nature to examine the
relationship between maximal All binding and maximal aldosterone
responsiveness to All. Data from day-by-day radioligand binding studies
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(using I-A13) on zona glomerulosa cells in culture are shown in Figure 3.8.
125Maximal I-AII binding was reached on day 4 in culture (parallel to the
steroid secretion data) and fell to a plateau thereafter. These data were,
however, uncorrected for cell number and when this was done (by
correcting for protein samples taken on days 3 and 6) it appeared that until
day 4 the cells were growing and expressing functional receptors; after day 4
the cells continued to grow and appear healthy but were possibly unable to
express functional All receptors and therefore All binding decreased. The
actual receptor number and affinity (Bmax and Kd) were not calculated for
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each day, but were calculated for the day showing maximal I-AII binding.
The results were as follows : KD = 3.9 x 10~10M (range 2.0-6.8 x 10~10M); Bmax =
566.8fmol/106 cells (range 190-943.5 fmol/106 cells).
12if
Day after isolation Aldosterone (n-fold Aldosterone (n-fold
increase over basal) increase over basal)
with antioxidants without antioxidants
1 1.7+/-0.49 1 +/- 0.24
2 2.5 +/-0.5 2.3 +/-1.17
3 1.2 +/-0.04 9.3+/-0.5 *
4 3.1 +/-1.13 19.5 +/- 0.25 *
5 6.8 +/- 2.77 4.6+/-0.02
6 4.6 +/- 0.63 6.8 +/- 5.54
Table 3.3
This table shows the n-fold increases over basal aldosterone secretion
from bovine zona glomerulosa cells stimulated with lOnM AH for 3 hours,
on various days after isolation. Cells were cultured in the presence or
absence of supplementary antioxidants as described in Chapter 2. Note that
the cells are more sensitive, having a greater aldosterone response in the
absence of antioxidants which was statistically significant (* : p<0.005) on
days 3 and 4 after isolation. Data drawn from one of two representative
experiments.
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bovine zg cells Basal All-stimulated




(de Lean et al.
1984b)
1.11 +/- 0.24 6.58 +/-1.90
Table 3.4
Basal and All-stimulated aldosterone secretion rates (on d4 after
isolation), expressed as pmol/10 cells/3h (mean +/- s.e.m), for bovine zg
cells purified by Sephadex column filtration and cultured in the absence of
antioxidants. Similar rates for two published methods are given for
comparison. Basal secretion in our hands was significantly less (*p<0.001)
than that of Shepherd et dl. (1992); however, All-stimulated secretion was
significantly greater than in both published methods (**p<0.001). This
represents the combined data from four experiments.
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3.2.6 Characterisation of the All receptor subtypes in bovine adrenal zona
glomerulosa cells
125 TT
We wished to confirm whether the I-AD binding observed was, as
previously documented (Balla et al. 1991; Ambroz & Catt, 1992; Rainey et al.
1991), to the ATi receptor subtype. Bovine zg cells were cultured without
antioxidants for four days after isolation. They were then incubated for 2.5
hours with 125I-AII in the presence or absence of unlabelled All, DuP753 or
PD123177. Figure 3.9 shows that 125I-AII binding was almost completely
displaceable by the ATx-selective antagonist DuPont 753. A small (13%) but
significant (p<0.05) proportion of the binding was displaced by the AT2-
selective compound PD123177. This confirmed that the All receptor




Changes in the amount of I-AII bound by cultured bovine zona
glomerulosa cells on different days in culture. The binding increased sharply
up until day 4 after isolation, after which it was reduced to a plateau. This
gave an approximate measure of All receptor number, which appeared to
reach a maximum on day 4, similar to the aldosterone response. The
maximum receptor concentration, Bmax/ was calculated for day 4 and was
943.5fmol/106 cells. This graph also shows how the protein in each well
changed during culture : an approximation of cell number. The well protein
content increased throughout culture. (■ = total, A = non-specific, and ▼ =
125 ^
















Displacement of 12oI-AII from day 4 cultures of bovine zg cells by ■
unlabelled AD, ▲ DuPont 753, or ▼ PD123177. AD displaced 12;>I-A13 with an
ID50 of 6.8 x 10~10M, allowing a calculation of the receptor affinity (KD) to be
made at 6.3 x 10~10M. DuPont 753 displaced almost all the 12dI-AII, with an
ID5o of 3.3 x 10"7M, while PD123177 displaced a small but significant (p<0.05)




Previously published methods for culture of bovine zg cells
(Shepherd et al. 1992; Gyurko et al. 1992) were modified by using an
alternative method for purifying the cells after digestion. The Sephadex
column modification, adapted from that used to purify bovine zfr cells
(Williams et al. 1989) was thought to be quicker and less damaging to the
cells than the Percoll method, due to the decreased number of centrifugation
steps. To test this hypothesis, it was necessary to compare the purity and
responsiveness to steroidogenic stimuli (AH, ACTH, K+) of the two
preparations.
Both isolation and purification methods used in these studies
routinely produced viable cultures of zona glomerulosa cells, with low
contamination by zona fasciculata/reticularis cells. This was confirmed in
two ways.
Firstly, light microscopy analysis of formalin-fixed slices
representative of those used for preparation of zg cells indicated the majority
of the cells (60-80%) to be zg cells, as (Table 3.1). The photograph of a section
of a typical outer slice (Figure 3.1) also illustrates that only a small
proportion of the cells showed zf characteristics (lower nuclearrcytoplasmic
ratio and higher numbers of lipid droplets than zg cells). The accuracy of the
slicing technique used was therefore crucial to achieving a preparation
where zf contamination was kept to a minimum. Both Percoll density
gradient and Sephadex column purification methods removed red blood
cells and cellular debris.
Secondly, levels of zf contamination were assessed by calculating the
Cortisol: aldosterone ratio as (Figure 3.1). According to de Lean et al. (1984b),
a ratio of less than ten indicates zf contamination to be less than 35%. All
ratios obtained in this comparison, and continuing monitoring of the cells,
were consistently below this level. The cells purified on Percoll had a
slightly higher basal ratio than those purified on the column. However,
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stimulation with All and ACTH gave ratios which were almost identical.
♦
The reason for the higbsr basal production of cortlsoJ-. in Percoll-purified
cells (Table 3.2) is unknown; it is unlikely that the Percoll could have had
any lasting effect on the cells to lead to this result as great care was taken to
wash any Percoll residue away from the cells before plating. This
comparison indicates that the Sephadex method was as effective as Percoll at
purifying zg cells from red blood cells and debris, and that no preferential
loss of zg cells was being observed during the gel filtration process.
The Sephadex column gel filtration method yielded cells with
equivalent responses to steroidogenic stimuli to the Percoll-purified cells, as
seen in Figure 3.3. The Sephadex-purified cells had, however, a significantly
better response to potassium than cells purified on the Percoll density
gradient. The reason for this is unknown; it could be due to a difference in
purification but since the cells had been in culture 5 days before stimulation,
this is unlikely. In the absence of any significant difference between cells
produced by the two methods, the Sephadex purification was chosen for
further use due to its increased speed and simplicity.
When stimulated with angiotensin II, ACTH and K+, zona
glomerulosa cells purified by Sephadex filtration produced increased
amounts of aldosterone. Figure 3.5 shows stimulated aldosterone secretion
data expressed on a daily basis, from day 1 until day 6 of culture. For the
first three days after culture, there was no significant increase in aldosterone
production following stimulation with lOnM All, (the increase was
significant in freshly isolated cells). Aldosterone secretion appeared to rise
for the next two days reaching significance over basal on days 5 and 6. A
maximal response was observed on day 5 after isolation.
For some time our laboratory has been successfully culturing bovine
inner zone adrenocortical cells (Walker et al. 1988; Williams et al. 1989)
without the use of antioxidants to maintain steroidogenic response. The
postulated protective effect of such supplements (Crivello et al. 1982)
routinely used by many investigators (Andoka et al. 1984; Balla et al. 1991;
* ord lac£ of sfiMola+ior\ fay ar^) of +"v"e qgonishs cesd
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Ambroz & Catt, 1992; Shepherd et al. 1992; Shizuta et al. 1992) was therefore
investigated by culturing cells from the same preparation in medium with or
without the supplementary antioxidants and growth factors. The cells were
stimulated with maximal doses of All, ACTH and potassium, and
aldosterone responses in the two sets of media were compared. Without
antioxidant supplements the cells were able to secrete aldosterone both
basally and in response to steroidogenic agonists over the subsequent days.
By days 3-5 after culture, a significant level of stimulated aldosterone
secretion was observed (see Figure 3.6 and Table 3.3). This observation is in
direct contradiction with that of Hornsby7 s group (Crivello et al. 1982;
Crivello et al. 1983) who were unable to detect aldosterone synthesis upon
stimulation with AH after 4 days' culture in the absence of antioxidants. The
capacity of the zg cells in our hands to synthesise aldosterone from acute
stimuli seems to be actually diminished by the addition of antioxidant
supplements to the growth medium. On days 4 and 5 after isolation, the n-
fold increase over basal in aldosterone response to All is significantly less in
the presence of antioxidants than in their absence (Table 3.3)
Experiments to determine which of the supplements was responsible
for this were not undertaken. It is possible that metyrapone, which is a
known reversible inhibitor of cytochrome P450 (Crivello et al. 1982) exerted
some effect on the cells which was not reversed after the medium containing
the drug had been thoroughly washed away prior to stimulation. Other
investigators (Balla et al. 1991; Ambroz & Catt, 1992) incubated the cells in
antioxidant-free medium for one hour before commencing experiments. This
may have been a more effective method for removal of metyrapone. An
alternative explanation is that the serum substitute used in this laboratory
(CPSR-1) contained a different balance of antioxidants than the typicallv-
used FCS, and that this allowed the cells to regain aldosterone synthetic
capacity in their absence. If a different antioxidant balance was present in the
serum substitute, it is possible that a toxic excess may then have been
established by the addition of more antioxidants. Recently, Gallo-Payet et al.
132
(1993) showed a similar pattern to that reported here, but for cultures of rat
zona glomerulosa cells : no antioxidants were used for 5 days of culture,
with no significant loss of aldosterone synthesis (similar to the results in de
Lean et al. (1984b) in bovine adrenal subcapsular cells) and it was concluded
that the cells did not need antioxidants in such short-term cultures. This
group also demonstrated an increasing sensitivity of the cells to stimulation
with AD and ACTH, with falling basal levels of steroid production and
increased stimulated levels; our day-by-day results also showed this effect
(see Table 3.3).
Hornsby's group have previously published data showing that
accumulation of steroids in culture media can inhibit further steroid
production (Crivello et al. 1982; Crivello et al. 1983; Hornsby, 1989), and that
this can be reversed by inclusion of antioxidants and other protectant
compounds in the culture medium. The data from my studies indicated that,
in the bovine adrenal zona glomerulosa culture described, these effects are
not sufficiently pronounced to necessitate supplementing the medium.
Indeed, basal aldosterone secretion in our cultures using no antioxidants
showed significantly lower values than another group who used these
antioxidants ((Shepherd et al. 1992); see Table 3.4). However, stimulation
with AH led to a significantly greater aldosterone secretory response in
cultures grown in the absence of antioxidants. It may be that for some reason
the Sephadex purification method yields cells which are naturally more rich
in antioxidants such that they resist depletion under basal conditions for the
first few days in culture. This could account for our observations that cells
grown in unsupplemented medium regain their steroidogenic capacity and
also, perhaps, the inhibitory affect of these supplements : possibly
antioxidant "overdose" is occurring (e.g. metyrapone, when not acting as an
antioxidant, may inhibit conversion of deoxycorticosterone to
corticosterone).
Aldosterone secretion in zg cultures without antioxidants reached a
maximum (on stimulation with lOmM AH) after 4 days in culture,
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decreasing after this. Radioligand binding studies using 12oI-ATT gave
concordant results, with maximum binding seen on day 4 (see Figure 3.7).
However, protein data taken from sample wells after completion of binding
experiments indicated that the cells were still growing or increasing in
number after day 4. Thus the cells after 4-5 days in culture appear to lose
their AH receptors, which would explain the decrease in steroidogenic
response to All after day 5. Gallo-Payet et al. (1993) have also demonstrated a
loss of AD receptors during culture in rat zg cells. Thus although bovine
zona glomerulosa cells can be maintained in culture without supplementary
antioxidants for at least 6 days and remain healthy, during this time they
lose their receptors for AH. It is also possible that AD receptor affinity is
decreasing with time in culture. The results also suggest that the loss of
steroidogenic capacity after the first few days in culture is not related
directly to unavailability of the All receptor but to some intracellular
uncoupling of the receptor leading to an inability to produce steroids.
T» 125The radioligand binding data also showed that binding of I-AII in
bovine zg cells could be displaced by DuPont 753 and also, but to a much
smaller extent by PD123177 (Figure 3.8), confirming that the majority of the
receptors expressed in the cells on day 4 were of the ATj subtype. This
observation is in agreement with that of other investigators, including Ouali
et al. (1992), who found a small (15%) proportion of AT2 receptors in bovine
adrenocortical cells. It also agrees with the observation of Clyne et al. (1993)
for cultures of bovine adrenal zona fasciculata/ reticularis cells.
In conclusion, this chapter reports a modification to established
methods for bovine adrenal zona glomerulosa cell culture which allows
easier and faster cell isolation. The zg culture does not require antioxidants
to maintain steroidogenesis; indeed, antioxidants seem to depress
steroidogenesis. The changes that occur in zona glomerulosa cell responses
to stimuli during continued culture are also reported. Aldosterone secretion
(in response to All) remains low for 2-3 days then rises, with a parallel
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increase in apparent All receptor number. Subsequently, steroidogenic
response and All binding decreases after 4-6 days in culture, probably due
to loss of expression of the receptor. What leads to this loss of All receptor
binding is not clear. We have confirmed the findings of other researchers
(Balla et al. 1991; Ouali et al. 1992) that the majority of All receptors present
in the culture are of the ATi subtype.
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Chapter 4 : Pharmacological characterisation of ATi
receptors in bovine zona glomerulosa and rat
mesenteric vascular smooth muscle.
4.1 Introduction
The wide range of functions mediated by angiotensin II (discussed in
Chapter 1) are consistent with the known heterogeneity within AH receptors.
Following the advent of non-peptide All antagonists, AD receptors were
divided into types 1 and 2, with the known physiological effects being
(at;)
mediated by the type 1 receptor. In rodents, the receptors in the adrenal
A
cortex and vascular smooth muscle were known to be regulated m opposite, directions,
(rtgoilefo ses 1,0
in response to changes in dietary Na+. Before the subdivision of rodent ATXA*
receptors into types ATXa and ATXX), as a result of molecular cloning studies,
it was thought that some pharmacological difference between the two
receptor subtypes might underlie this difference in regulation.
This hypothesis was strengthened when Clyne et al. (1993), using
Schild analysis to obtain pA2 values, found that the ATX receptor present in
cultured bovine adrenal zona fasciculata/ reticularis cells appeared to be
pharmacologically distinct from that in rabbit aortic vascular smooth muscle
(Chiu et al. 1990) (see Table 4.1).
Measurement of antagonist pA2 values was first proposed as a
method of classifying antagonists by Schild (Schild, 1947; Simonian & Gill,
1979), and the model discussed by Arunlakshana and Schild (1959) is now
widely accepted as a means of receptor classification. The pA2 value, defined
as the negative logarithm of the concentration of an antagonist required to
shift the dose-response curve of an agonist twofold to the right, is unique for
a specific receptor. Thus, the pA2 value for a particular agonist-receptor-
antagonist combination should be constant wherever the location of the
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receptor (Arunlakshana & Schild, 1959; Mackay, 1978). Conversely, a
difference in pA2 values is highly indicative of the presence of different
receptor subtypes (Kenakin, 1987).
To clarify the discrepancy observed in pA2 values for DuP753 at ATX
receptors (Clyne et al. 1993), I report here the characterisation of the AT!
receptors in two types of tissues. The systems used for this comparison were
two cell culture preparations : bovine adrenal zona glomerulosa cells and rat
mesenteric artery smooth muscle cells. Although the pA2 value obtained by
Schild regression analysis for a given competitive antagonist binding to the
same receptor should not vary greatly between species (Kenakin, 1987), it
was intended initially to compare the two different tissue types within the
same species. The analysis in vascular tissue was thus firstly attempted in
cultured bovine pulmonary artery smooth muscle cells. Unfortunately, no
All receptors were expressed in these cells and so a model of rat vascular
smooth muscle cells, known to express functional ATi receptors (Lyall et al.
1992), was utilised instead. The responses to All used in the analyses were
aldosterone secretion from bovine zg cells, and phosphatidylinositol
turnover in rat mesenteric artery vsmc. The antagonist used was the ATX-
selective competitive non-peptide antagonist DuPont 753.
The aims of this chapter were to perform Schild regression analyses
using bovine zona glomerulosa and rat mesenteric artery smooth muscle
cells in culture and from these to obtain pA2 values for DuP753. These values
were then compared with each other and previously published pA2 values
(Chiu et al. 1990; Clyne et al. 1993) in order to determine whether the ATX
receptors analysed were pharmacologically distinct
4.1.1 Theory of Schild regression analysis
Schild regression analysis relies upon the premise that to obtain an
identical effect in the presence or absence of an antagonist, the same number
of receptors must be being activated. The dose-response curve to an agonist
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will therefore be shifted to the right in a parallel fashion when increasing
amounts of a competitive antagonist are added to the incubations.
If the antagonist used is truly competitive, and produces a parallel
rightwards shift in the agonist dose-response curves, Schild regression
analysis can be performed. The ratio of agonist concentration producing a
half-maximal response in the presence and absence of an antagonist
conforms to the following equation, known as the Schild equation :
log (dr - 1) = log [B] - log Kb
where dr is the dose ratio, [B] is the concentration of antagonist, and Kg is
the equilibrium dissociation constant for the antagonist.
The logarithm of the dose ratio minus 1 can be plotted against the
negative logarithm of the antagonist concentration to produce a regression
line. If the regression is linear and of slope not significantly different from
unity, the intercept of this line on log [B] yields the Kg. When the dose ratio
equals two, pKg = - log (dr - 1). Therefore, the pKg equals the pA2 when the
(erf y-O}
slope of the regression is equal to unity. The intercept on the abscissa thus




The results shown in this section were obtained from triplicate
determinations from representative experiments which were performed at
least three times. Data from cumulative cell preparations were used in the
Schild regression analyses. Dose-response curves are plotted as the mean +/-
s.e.m and fitted to a log dose-response curve by the curve-fit package of
FigP.
4.2.1 Dose-response curves in zg cells
Bovine zg cells were cultured as detailed in 2.2.1.1, and plated into 96-
well plates at 20,000 cells/well. Aldosterone secretory responses to a range
of concentrations of AH (All dose-response curves) were measured on day 4
after isolation, as in 2.2.2.1, in the absence and presence of DuP753 at 3.3 x
10"7, 1 x 10~6 and 3.3 x 10~6M. DuP753 was added to the cells 5min before All
in order to establish binding between the antagonist and the receptor. The
cells were stimulated with All for 3h after which aldosterone secretion into
the overlying medium was measured by RIA. These concentrations of
DuP753 were used after reference to both previous work on Schild analysis
of ATi receptors in bovine zfr cells (Clyne et al. 1993), and displacement of
12oI-AII from bovine zg cells by DuP753, which yielded an IC50 of 3.3 x 10~7
(Figure 4.1). Concentrations of DuP753 up to one log unit either side of the
IC50 were tested for their ability to displace AH dose-response curves; the
three concentrations giving consistent displacements were chosen (3.3 x 10" ,
1 x 10"6 and 3.3 x 10~6M DuP753). Figure 4.2 shows dose response curves to
All shifted to the right in a parallel fashion with increasing concentrations of
DuP753, without the maximal response being lowered.
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Determination of IC50 for DuP753 in bovine adrenal zg cells.
1.25
Increasing concentrations of DuP753 were used to displace I-All from AT}
receptors in cultured zg cells. Cells were cultured for 4 days after isolation
125and incubated with 100,000 cpm (0.05pmol) I-AE1 in the presence of
DuP753 at the concentrations shown for 2.5 hours. Displacement of binding
to 50% of maximum was observed at 3.3 x 10~7 M DuP753. Representative
data from one of two experiments.
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Figure 4.2
Displacement of dose-response curves to AH by increasing
concentrations of DuP753. Bovine zg cells were cultured for 4 days after
isolation and then stimulated with a range of concentrations of All for 3
hours. Aldosterone secretion was measured in the absence (■) or presence of
3.3 x 10"7 M DuP753 (A), 1 x 10"6 M DuP753 (T) or 3.3 x 10"6 M DuP753 (♦).
The curves shift to the right in a parallel fashion with no significant




Schild regression analysis for DuP753 acting on AT! receptors in
cultured bovine zg cells. Log (dr - 1) for the curves in Figure 4.2 and similar
data from 3 further dose-response analyses is plotted against - log [DuP753];
the intercept on the x axis yields the pA2 value for DuP753. The slope of the
regression is 0.94 (95% C.I. 0.41-1.47) and the pA2 (after constraint of the
slope to 1) was calculated to be 7.02 (95% C.I. 6.82-7.22).
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4.2.2 Schild regression analysis for zg cells
The Schild regression line for DuP753 in bovine zona glomerulosa
cells is shown in Figure 4.3. The slope of the regression was 0.94 (95% C.I.
0.41-1.47). As this was not significantly different from unity, the slope was
constrained to unity as the variation observed could be accounted for by
chance (Mackay, 1978). The pA2 obtained from this constrained plot was
calculated to be 7.02 (95% C.I. 6.82-7.22) (Table 4.1).
4.2.3 Dose-response curves in vsm cells
Inhibition of All-stimulated PI turnover in cultured rat mesenteric
artery cells was studied in order to determine concentrations of DuP753 to
use in Schild regression analysis. Figure 4.4 shows a representative
experiment. Cells were plated into 24-well plates at 50,000 cells/well and
allowed to grow to confluence. They were then labelled with H-inositol as
described in 2.2.2.6.1 for 72h prior to experiments carried out as in 2.2.2.6.2.
After the addition of LiCl and unlabelled inositol to the cells, DuP753 was
incubated with the cells for 5 minutes before addition of All, in order to
allow the antagonist to bind to the receptor. The cells were stimulated with
All for 20 minutes after which time the phosphatidylinositols were extracted
from the cells as in 2.2.2.6.3. Cells were used between passages four and
seven.
The IC50 for DuP753 was found to be 3.3 x 10"'M, identical to that in
the zg cells. Concentrations of DuP753 one log unit either side of the IC50
were tested for ability to' shift dose-response curves to An to the right.
Unusually, only concentrations lower than the IC°° were effective, with
higher concentrations producing no further shift. The concentrations of
-8
DuP753 used for the Schild regression analysis were therefore 3.3 x 10", 1 x
10"7 and 3.3 x 1(F7M DuP753.
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Figure 4.5 shows dose-response curves to All in the absence and
presence of DuP753. The curves again shift rightwards in a parallel fashion,
with no significant depression in the maximal response.
4.2.4 Schild regression analysis for vsm cells
The Schild regression line for DuP753 in cultured rat mesenteric
smooth muscle cells was then plotted (Figure 4.6) using combined data from
three similar experiments. The slope of the line was 1.61 (95% C.I. 0.99-2.22).
Although this was not significantly different from unity, unity was at the
extreme end of the confidence interval. For this reason, individual log KB
values were calculated from the log (dr - 1) values obtained for each
concentration of DuP753 using the Schild equation, assuming a slope of
unity. Nine such values were obtained, three for each DuP753 concentration.
The values were then analysed by ANOVA. The log KB values obtained for
Q
3.3 x 10" M DuP753 were significantly different (p<0.05) from those obtained
for the other two concentrations. This suggested that a Schild regression of
slope constrained to unity would be invalid (Mackay, 1978), and the pA2 was
therefore calculated from the regression line as plotted in Figure 4.6. The pA2





Determination of IC50 for DuP753 in cultured rat vsmc. Inhibition of
All-induced phosphatidylinositol turnover was measured (as total
3 3
accumulated H-phosphoinositols in the presence of a LiCl block) in H-
inositol labelled vsmc between passages 4 and 7. Cells were labelled for 72
hours before stimulation with lOnM All in the presence of increasing
concentrations of DuP753. The concentration of antagonist inhibiting
y
maximal response by 50% was calculated to be 3.3 x 10" M. Representative
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Figure 4.5
Dose-response curves to AD in cultured rat vsmc. Cells were labelled
with H-inositol for 72 hours and then stimulated for 20 minutes with
8
varying doses of AH in the absence (■) or presence of 3.3 x 10" M DuP753 (
A), 1 x 10_/ M DuP753 (▼) or 3.3 x 10"7 M DuP753 (♦). PI Turnover measured
as total accumulated H-phosphoinositols in the presence of a LiCl block.
Curves were shifted to the right in a parallel manner, with no significant
depression in the maximal response. Representative data from one of three
experiments.

















Schild regression line for DuP753 in cultured rat mesenteric artery
smooth muscle cells. Axes are as for Figure 4.3; the slope of the regression is
1.60 (95% C.I. 0.99-2.41). The pA2 for DuP753 was calculated from this
(from iorherccpt of -rtoe li>e o+ Oi










Bovine zfr 7.02 6.89-7.15
Rabbit vsm 8.48 8.43-8.53
Bovine zg 7.02 6.82-7.22
Rat vsmc 7.28 7.05-7.5*
Table 4.1
Comparison of experimental and published (Clyne et al. 1993; Chiu et
al. 1990) values for pA2 of DuP753 in adrenocortical cells and vascular
smooth muscle. The 95% confidence interval is also shown. No significant
difference was found between the experimental values measured in this
thesis for bovine zg and rat vsmc; either between these cell types or when
compared to the published values for bovine zfr cells. The pA2 value
published for vascular smooth muscle in the rabbit is, however, significantly
different from the others (p<0.001 by ANOVA).
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4.3 Discussion
Determination of pA2 values for the ATi receptor antagonist DuP753
by Schild analysis in bovine adrenal zg and rat mesenteric artery vsm
yielded values which were not significantly different from one another. This
raises a number of points both about All receptors and about their
classification. An early indication that the receptors in the bovine adrenal
zona glomerulosa and the rat mesenteric artery smooth muscle were not
pharmacologically different was suggested by the identical IC50 values
estimated for DuP753 in the two tissues. Pharmacologically distinct receptors
would be expected to vary in this respect. There was, however, differing
sensitivity in the two tissues, both in response to All and in the concentration
of DuP753 producing a rightwards shift. In the zona glomerulosa,
concentrations lower than the IC50 for DuP753 produced no significant shift,
whereas in the vascular smooth muscle, concentrations higher than the IC50
elicited no further shift. The EC50 for All was also one log unit less sensitive
8 9
in the rat mesenteric artery vsmc, being 3.3 x 10" M compared to 3.3 x 10" M
in the bovine zg.
A possible explanation for this is the different responses used to
quantitate the shifts. In the vsm cells, the second messenger response was
used as an index for receptor activation. Stimulation of PI turnover is only
part of the functional response to All in vsmc and, for example, a sustained
2+
influx of Ca may also be necessary to produce a full end-organ response.
Therefore, in these experiments it is possible that the full magnitude of the
end-organ response is not being reflected in the measurement made. This
may explain why the dose ratios obtained for the vsmc are lower than for the
zg cells, and would support the hypothesis that higher dose ratios are
possible over a wider range of antagonist concentrations when the true end-
organ response is used (as was the case when aldosterone secretion was
measured in bovine zg cells). These different approaches may also account
for the difference in EC50 to All observed in the two tissues. Because the true
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end-organ response is being measured for bovine zg cells, it is possible that a
lower concentration of All would be sufficient to elicit a half-maximal
response than for the measurement of PI turnover in rat mesenteric artery
vsmc. In this tissue, a higher concentration of AH would be required to elicit
the half-maximal response, as the measurement of response precedes the full
end-organ response of contraction.
There was a degree of scatter in the Schild regression plots for both
tissues, which may reflect use of data from multiple cell preparations, which
may have shown differing sensitivities to All and DuP753, and also differing
basal responses. The effect of any experimental error may also have been
multiplied. The most obvious consequence of this was the large confidence
intervals obtained for the slopes of the regression lines. For the zg Schild
regression, the slope was almost identical to unity (0.94), indicating a true
competitive antagonism of the DuP753 and that equilibrium had been
reached between receptor, agonist and antagonist during the analysis. As the
slope was not significantly different from unity, according to Mackay (1978),
the variation may be attributable to chance. Thus, a Schild regression line of
slope constrained to unity was plotted and the line extrapolated to the
abscissa to obtain the pA2. This was calculated to be 7.02 (Table 4.1).
This value was identical to that obtained for bovine adrenal zfr cells
in culture (Clyne et al. 1993), providing evidence that the AT; receptors in the
two zones are identical pharmacologically.
The slope for the vsmc Schild regression was 1.6. Though high, the
value was not significantly different from unity, although unity was at the
far extreme of the slope confidence interval. To determine whether the
regression plot could validly be constrained to 1, individual log KB values
were calculated using the Schild equation and were found to vary
significantly from 3.3 x 10"8M to 1 x 10_/M DuP753. On this basis, the Schild
regression line could not be constrained and the plot shown in Figure 4.6
was used to calculate the pA;?, which was found to be 7.28 (Table 4.1). There
are two possible explanations for the increased slope. One is that DuP753
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was riot acting competitively in this system. This is not likely since DuP753
has been shown to be a competitive antagonist in all other systems examined
(Wong et al. 1990; Iwai et al. 1991). A second possibility is a failure to achieve
equilibrium between the receptor, agonist and antagonist. The equilibrium is
both time- and dose-dependent and therefore will be established more
quickly for higher doses than lower ones. If true equilibrium has not been
reached, the effect of low doses of antagonist will be underestimated and
will therefore lead to a steepening of the Schild regression slope (Kenakin,
1987). It is also possible that, as DuP753 was added to the reaction before
All, AH might not have been able to equilibrate with the receptor to the same
extent as the DuP753; this could lead to a failure of AH to displace the
antagonist and thus a distortion of the results.
In the case of the zg, the duration of the experiment was 3 hours to
allow aldosterone to accumulate to measurable levels. In the case of the
vsmc, however, second messenger turnover was the measured variable. The
labelled phosphoinositols accumulate linearly over a restricted time-course,
dictating the selection of an early time-point - in this case, 20 minutes. It is
possible that this time was insufficient to ensure that full temporal
equilibrium was reached for DuP753 at the lowest dose.
Experimental pA2 values obtained in this thesis for both bovine
adrenal zg and rat vascular smooth muscle tissues were not significantly
different. This implies that the ATi receptors in these tissues are the same.
However, they were different from that published for vascular smooth
muscle.
Therefore, the data in this thesis is at odds with the previously
published pA2 value for DuP753 acting on rabbit aortic smooth muscle (Chiu
et al. 1990).
According to Arunlakshana and Schild (1959) and Mackay (1978), a
pA2 value should be constant for a particular receptor-antagonist coupling
and variations should not be great between laboratories. In rats, which have
been found to contain two ATX receptor subtypes, the subtypes have also
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been shown to be pharmacologically indistinguishable from each other and
the human ATx receptor (Balmforth et al. 1994) by a range of antagonists in
transfected COS cells. DuP753 is selective for the ATj receptor, which is the
only receptor type known to mediate the measured physiological responses
to All. Therefore, the differences in pA2 cannot be explained by a difference
in receptor population (e.g. the presence of AT2 receptors). It is therefore
necessary to consider the methods used for analysis of the AT: receptor
antagonism by DuP753 in the two instances. The previously reported pA2
value for rabbit aortic vsm was obtained using intact vessel segments in
organ bath studies, whereas the value reported here for rat mesenteric artery
was obtained from cultured cells. These two methods are quite different and
possibly not directly comparable; it is possible that this variation may have
contributed to the difference in pA2 values observed. For instance, the
culture conditions the cells were exposed to may in some way have changed
the affinity of the receptor for the antagonist. Such a change could affect a
measured pA2. Mackay (1978) also mentions the importance of using similar
systems when comparing pA2 values for receptor classification purposes.
It would seem, therefore, that although Schild analysis is a useful and
powerful tool in the classification of receptors by using selective antagonists,
variations in experimental procedures may affect the resulting values. It is
therefore important that the pA2 values obtained are truly comparable.
In this chapter, the AT: receptors present in cultured bovine adrenal
zona glomerulosa cells and cultured rat mesenteric artery smooth muscle
cells have been pharmacologically characterised by Schild analysis. This
analysis yielded pA2 values for the antagonist DuP753 acting at the ATi
receptor. The pA2 values obtained were found to be not significantly
different, indicating that the receptors are therefore pharmacologically
indistinguishable. The pA2 value for DuP753 acting at the ATi receptor in the
zg was also compared to the corresponding pA2 in the zfr. Both pA2 values
were again found to be not significantly different. These findings challenge
earlier evidence (Chiu et al. 1990; Clyne et al. 1993) that a difference exists
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between pA2 values in the adrenal cortex and vascular smooth muscle, and
highlights a possible pitfall in comparisons of pA2 values.
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Chapter 5 : Isolation and generation of a clone from the
bovine adrenocortical AT, receptor coding region by
PCR amplification
5.1 Introduction
One of the aims of this thesis was to study the regulation of the AT\
receptor. We wished to do this by analysing ATa receptor mRNA levels
using Northern blotting, the simplest method of examining steady-state
mRNA levels. To perform such an analysis, a probe recognising (i.e.
complementary in sequence) the ATi receptor mRNA must be generated.
The aim of this chapter, therefore, was to PCR-amplify the coding region of
the bovine adrenocortical ATx receptor (Sasaki et al. 1991), and from this
amplified sequence to generate a clone of the AT: receptor.
We chose this approach because of its simplicity and the knowledge
that the bovine ATi receptor contained no introns in its coding sequence (Dr.
T. Inagami, personal communication). PCR primers were designed against
the coding region of the published sequence for the bovine adrenal ATX
receptor, and used to amplify a l.lkb fragment from bovine genomic DNA.
This fragment was then inserted into a plasmid vector and subjected to
restriction mapping to confirm its identity with the AT} coding region
sequence. This cloning strategy can be seen in Figure 5.1. Further
confirmation having been. provided by full sequence analysis of the clone
and comparison with the published sequence, the clone was then
successfully used to generate a probe for use in Northern blot analysis of the
bovine adrenal AT} receptor.
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Figure 5.1
Cloning strategy for the bovine adrenal ATX receptor coding region
PCR fragment. The amplified PCR fragment (D is represented following
concatemerisation and restriction to produce EcoRI/BamHI compatible
'sticky ends', i.e. ready for insertion into the pSP72poly4 vector. Closed
circular pSP72polv4 (D is linearised by restriction digest to yield EcoRI and
BamHI compatible ends CD. The ATi receptor coding region PCR fragment is
then inserted into the cloning vector ®, followed by transformation into
E.coli DH5. ATj receptor transformants are then selected by growth on






5.2.1 PCR of the ATi receptor coding region sequence
In order to amplify the coding region of the ATi receptor, primers
were designed against the published sequence ((Sasaki et al. 1991), Figure
5.2). Since it had previously been established (Dr. T. Inagami, personal
communication) that the ATi receptor contained no introns in the coding
region, primers were designed to encompass the whole of this region, with 5
(5') and 13 (3') flanking bases on each side. The primers were 29 (5') and 32
(3') bases in length, with 23 bases homologous to the AT[ sequence. An
EcoRI site was included in the 5' primer, and a BamHI site in the 3' primer to
permit easier cloning by generation of non-compatible 'sticky ends'. Both
primers included a CG clamp (three or more C or G residues at the 5' end of
the primers) to anchor them more firmly to the DNA template by hydrogen
bonding. The locations of the primers and the additional bases incorporating
the restriction sites are shown in Figure 5.2.
After optimisation of the PCR (2.2.3.5), microgram quantities of the
1114bp A^ fragment were successfully amplified using the following
conditions : annealing temperature 65°C; initial DNA (purified from bovine
spleen) 0.02pg; Taq DNA polymerase; 32 cycles. The resultant DNA was
split into two pools which were purified by one of two methods (2.2.3.5).
5.2.2 Purification of the ATi PCR fragment for cloning
After purification, the two pools of ATi PCR fragment were
concatemerised (2.2.3.6) and restricted (2.2.3.7) to generate DNA with 'sticky
ends' for ligation into the cloning vector. Aliquots of the two pools of DNA
were taken following concatemerisation and restriction and run on
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Figure 5.2
Published sequence of the bovine adrenal ATj receptor (taken from
Sasaki et al. 1991). The coding region and its predicted amino acid sequence
are shown with the 5' and 3' flanking sequences of the cDNA clone.
Underlined in green are the sequences used for the PCR primers; added, also
in green, are the nucleotides comprising the added restriction sites (5' EcoRI;
3' BamHI), which are additionally highlighted. Underlined in red is the
sequence which was amplified, an amplimer of 1114bp.
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-409 CCAGGACACACTT -397
CAAAACA.ACCCCCGCCCCTCCAACCCTCCAAGAAGCAACCTCC-.CCCTA7AAA * - .GCACs..G.CTCAOACACOACCA « .COACCCCCAGTCACCCA -2 99
ACCCCC7CACCCTAC7CACCCCCCCCCCAGACGCCCCAC7AGCACC7CTCCC7ACCCCAGACCGCCA7CCACCAGCACCAACCCAACCCCACCCCACCA -19 9
ACAC- ... .A .CTCAC7AAC7CA. .CAAGCCATTCCAGAACCTC.OCATCCAGw .OvA« . .xvi<.A«ACtC .C wCAGACTCACTAACTCAACACATCAAA —".
-7qqmi"
yec lie leu Asr. Sec Ser 7>.r Giu Asp Gly lie Lys Acq lie Gin Asp Asp Cys Pro Lys Ala Cly Acq His Asr. 25
r^_J>y^AC^_GAA^^TOCr^Avr^AA. AGA A«C, CAA..GA, , -jo,. «S.» CCC.AAA CCT GCA AGGCAC AAT 7 5
I ^
Tyr He ?he lie Mec He Pro Thr Leu Tyr Ser lie lie Phe Val. Va_ Giy He Phe Gly Asr. 3er leu Val 7a 1 50
TAG ATA -T ATT ATG ATC CCT ACT TTA TAC ACT ATT ATC TTT CTC GTC GGG ATA TTT GCA AAT AG." ~G rTG CTC 153
He Val He Tyr Phe Tyr Her Lys Leu Lys Thr VaL Ala Ser VaL Phe leu Leu Asn Leu Ala Lou Ala Aso leu 75
ATT CTT ATT TAC TTT TAC ATG AAA CTG AAG ACT CTC GCG ACT GTT TTT CTT TTC AAT TTA GCT CTT GCT CAC TTA 225
rr
Cys leu leu Thr Leu Pro Leu Trp Ala Vai Tyr The Ala her Glu Tyr Arq Trp Pro Phe Gly Asr. Tyr leu *.00
TGC TTT TTA CTG ACT TTG CCA CTG TCC GCT CTC TAC ACT GCT ATG GAA TAC CGC TGG CCC TTC CCC AAT TAC CTA 300
Cys Ivs He Ala Ser Ala Ser Val Ser Phe Asr. Leu Tyr Ala Ser Val Pre Leu Leu Thr Cvs leu Ser He Aso 125
TGT AAG ATC GCT TCA CCC ACT CTC ACT TTC AAC CTC TAT CCC ACC CTG TTT CTA CTT ACA TGT CTA ACC ATT CAC 303
• •
Arq Tyr leu Ala lie Vai His Pro Mec Lys Ser Arq Leu Arq Arq Thr her Leu Vai Ala Lys 7a. Thr Cvs He 150
CCC TAC CTG GCT ATT GTT CAC CCA ATG AAG TCC CGC CTC CGG CGC ACA ATG CTT CTG GCC AAA CTC ACC TGC ATC 4=0
TV
lie He Tro Leu Leu Ala Gly leu Ala Ser Leu Pro Thr He lie His Arq Asn VaL Phe Phe He Glu A sr. Thr 175
ATT ATT TGG CTG CTG GCA GGT TTG GCC ACT TTG CCA ACT ATA ATC CAC CGC AAC CTA TTT TTC ATC GAG AAT ACC 525
▼ ▼
Asn He Thr Vai Cys Ala Phe His Tyr Glu Ser Gin Asn Ser Th r leu Pro Val Gly ueu sly leu Th r -ys Asr. 2 00
AAT ATC ACC GTT TGC GCT TTC CAT TAC GAA TCC CAA AAT TCT ACC CTC CCG CTA CGC CTC CCC TTT ACT .AAT 400
V
lie leu Giy Phe leu Phe Pro Phe leu He He Leu Thr Ser Tyr Thr leu He Trp Lvs Thr leu Ivs lys Ala 223
ATA TTC TTG TTT CCT TTT CTG ATC ATT CTT ACA AGC TAC A>— . .13 ATT tou AAG ACT TTT AAG AAC CCT 675
Tyr Glu He Gin Lys Asn lys Pro Arq Lys Aso Aso He Phe Lys He He leu Ala He Va 1 Phe Phe rhe 230
TAT GAA ATT CAC AAG AAC AAA CCA AGA AAA GAT GAT n. . TTC AAG ATA rt i . _ ' CCA AT— CTC TTT TTT TTT TTT 750
VI
Phe Ser Tro Vai Pro His Gin lie Phe Thr Phe hec Aso Val Leu He Gin leu Cly leu He Arq Aso Cys lys 27 =
TZ— —— — cc~ CAC CAC ATA TT ACT ATC GAT CTC TTA ATT CAC TTC C~C ATT TC~ GAC ~c~ AAA a. 2 3
VII
He Glu Aso He '/aL Aso Thr Ala Mec Pro He Thr He Cys leu Ala Tyr Phe Asn Asn Cvs leu Asn ? ro leu 3 00
ATT GAA GAT /AW. GTT GAC ACT GCC ATG CCC ATC ACT ATT TCC TTG GCT • A U ... AAC AAT TCC TTT . CTT TTT 900
ow — Tyr Cly Phe leu Civ lys lys Phe lys Lys —y - Phe leu Gin leu Leu Lys -•/- He Pro ? ro lys A . a Ivs 323
TTT TTT CTA CCA AAA AAA TTT AAA AAA TAT TTT CTA CAC CTT TTC AAA TAC ATT CCT TTA AAC GCT AAA 9T =
• • • •
Ser His Ser Asr. Leu Ser Thr Lys Mec Ser Thr Leu Ser Tyr Arq Pro Cer Glu Asn Gly Asn Ser Ser ..-.r lys 333
TCC CAC . OA AAC L.O TCC ACA AAA ATG AGC ACA C1C TCC TAC CGC CCC .CA CAA AAT uCA AAC .0- .w. ACC AAG .Or 3
Lys Pro Ala Pro Cys He Glu Val Glu .-A 359
AAC OCT CCC CCA TGC ATT GAG GTT GAG TAA CACA—TTCAAAC-TLTCTCTCAAC. CACCTTAAAGAACCACAACAAAAACATTCTT3TA 11 3 9
CAACACC7CAC7AC—AA/sTwAGw% . .w—»— . vw<\i . . .ACAA. .nAACwnCAnAA .AC/. . .A. J. ->W<-.C .C..n.. ........ .2.3
CAAAC TCTTCATTTCCAAAATT . . AC . OCCAAAA/.. CTC. - TT....ACT . . C— .CTT >J. . — . ^ . .n L . . — .awa . .<w.u . .A v. . . . ... . • : ->
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Figure 5.3
Purification of the amplified ATi fragment for cloning. The ethidium
bromide-stained 0.7% (w/v) agarose gel has been run bottom to top as
indicated by the arrow. Lane 1 contains X (HinDIII/EcoRI digest : 2.2.3.4.2)
DNA size markers; the appropriate sizes are indicated. Lanes 2-4 and 5-7 are
from ATx pools X and ® respectively. Lanes 2 and 5 : PCR fragment size ~
l.lkb; lanes 3 and 6 : AT: fragment after KKL procedure to generate
concatemers; lanes 4 and 7 : AT} fragment after restriction digest with EcoRI






Ethidium bromide-stained 0.7% (w/v) agarose gel showing the two
pools of ATi PCR fragment after gel purification and subsequent extraction.
Lane 1 shows % (HinDEH/EcoRI digest) DNA markers; the sizes of the
relevant bands are shown alongside. Lanes 2 and 3 are the pool CD and @"ATi
fragments, -l.lkb in length, in both cases.
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a 0.7% (w/v) agarose gel (Figure 5.3).
The figure is in two parts; the left three bands representing pool ®
and the right pool ©. The first band in each set (lanes 2 & 5) is the ATj
fragment, of the correct size (~l.lkb), after PCR. Clean, sharp bands are
present in each, indicating successful amplification of the desired product
and the absence of non-specific background. Some unamplified primers can
be seen at the top of each lane. The next set of bands (lanes 3 & 6) is the AT;
fragments after KKL concatemerisation. The concatemers are represented by
the band smearing down the gel, which indicates concatemers of increasing
length. The longer trailing band in pool ® suggests that the DNA fragments
in this pool have been more extensively concatemerised.
The third pair of bands (lanes 3 & 7) shows the l.lkb AT} fragment
regenerated after restriction digest of the concatemers with EcoRI and
BamHI, as in 2.2.3.7. The bands are again sharp and clear, denoting full
breakdown of the concatemers. At this stage, before gel purification of the
majority of the ATi receptor PCR fragments, small aliquots of the DNA were
taken for use in ligations (ATx (D and ® 'pre').
Figure 5.4 shows the appearance of the AT} fragments following
electrophoresis to remove excess PCR primers and recovery from an agarose
gel (2.2.3.8). As before, the fragments from the two pools are shown. The
bands are sharp and of the correct size. The band from pool ® is of greater
intensity than that from pool (D, indicating a greater degree of recovery in
the second pool. The primers have also been completely removed by the gel
purification. Aliquots of this gel-purified DNA were then used in ligations
(ATi (D and ® 'post7).
5.2.3 Choice and preparation of cloning vector
The vector chosen for the cloning of the AT^ receptor sequence was
pSP72polv4, a modified version of pSP72 (Promega) containing an altered
(S-'Moriay^ unpublished)
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Figure 5.5
pSP72poly4, the plasmid vector used for cloning the AT! receptor
sequence. This vector, derived from the Promega vector pSP72 contains a
modified polylinker (S.D. Morley, personal communication) : the nucleotide
sequence shown containing multiple restriction sites. Among these sites are
highlighted EcoRI and BamHI, which are compatible with sites designed
onto the AT} PCR fragment via the PCR primers. Red lines show the points
of cutting to generate 'sticky ends' for insertion of the ATj fragment. The
vector also contains a gene for ampicillin resistance, which was used to select
for bacteria transformed with the assembled cloning vector. Universal
sequencing primers are also indicated (pSP72XB and pSP72BX).
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EcoRI/BamHI insertion sites, compatible with the sites added to the ATa
sequence by the PCR primers, and the ampicillin selection facility, as well as
its small size and high copy number on transformation into DH5 E.coli cells.
Proven sequencing primers were also available flanking the insertion site.
The vector was prepared for use by digesting with EcoRI and BamHI,
followed by gel purification and extraction as detailed in 2.2.3.8. The use of
two restriction enzyme sites for cloning minimised the risk of vector re-
circularisation during ligation, as well as allowing unambiguous direction of
insertion of the ATi receptor sequence.
5.2.4 Cloning strategy and procedure
The cloning strategy employed is shown in Figure 5.1. AT} insert
(from the two pools at different stages) and pSP72poly4 vector were ligated
in varying proportions (5:1 and 20:1 insertvector on a molar basis, using
lOng vector), before transformation into the host bacteria (2.2.3.9, 2.2.3.11).
Transformants were selected by growth of colonies on L-agar plates
containing ampicillin. Table 2.1 (see Methods) shows the transformation
efficiencies for the different ligation reactions. Ligations from ATa <D 'posf
20:1, AT! © 'posf 5:1 and 20:1 yielded higher transformation efficiencies
than the other groups. 5 Sample colonies were taken from each plate to test
for incorporation of successfully ligated insert and vector.
5.2.5 Confirmation of positive colonies
Plasmid DNA was prepared from 50 sample colonies (2.2.3.12) and
digested with EcoRI and BamHI to detect the presence of an incorporated
insert (data not shown). Of these, 12 clones shown to contain a l.lkb insert
were re-analysed on a 0.7% (w/v) agarose gel, shown in Figure 5.6, and
retained for further analysis. Both the plasmid band (2.5kb) and insert band
(l.lkb) are clearly visible. Positive and negative controls are also shown. The
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frequency of successful ligation is shown in Table 2.1. It was highest in ATl
® 'posh 5 and 20:1, where all colonies picked were positive for the ATi
insert, showing the increased efficiency of this purification method. Of the
colonies sampled, twelve were found to be positive for a l.lkb insert.
5.2.6 Restriction mapping of positive ATt clones
Analysis of the published ATx receptor sequence (Sasaki et al. 1991)
indicated the presence of putative restriction sites for BSpMI, Dral, Muni,
Sail and SSpI within the coding sequence at positions 451, 926, 881, 989 and
933 respectively. Since all of these enzymes also restrict pSP72poly4 at
known sites, digestion of a pSP72poly4 recombinant plasmid containing the
EcoRI/BamHI ATi receptor PCR fragment should yield diagnostic
restriction fragments of predictable sizes. DNA from each of the twelve
clones in Figure 5.6 were therefore digested with these enzymes and the
resultant fragments resolved on a 0.7% (w/v) (Figure 5.7; a 2% (w/v) gel
was used for resolution of the lOObp Sail fragment).
Ten of the twelve clones analysed displayed the predicted pattern of
restriction sites and were thus tentatively identified as ATj receptor clones
(Table 5.1). The two other clones (pAT^.43 and 50) were unusual. Muni
digestion of pATi.43 yielded only one fragment, indicating the absence of
this site in the insert, while digestion with BSpMI, Dral and SSpI yielded the
predicted number of fragment. These, however, differed slightly in size from
what was expected, as did fragments resulting from digestion of pAT].50
with BSpMI, Dral, Muni and SSpI. The Sail site, however, was present in the
expected position in both clones.
Four of the clones were selected for further analysis : pAT].2C, and 44
were selected as representative of the putative ATX receptor PCR clones,





Confirmation that colonies after transformation contained AT} inserts.
Plasmid DNA was prepared from sample colonies picked from all
transformation plates (2.2.3.12) and digested with EcoRI and BamHI to
liberate any inserts from the vector. Those found to be positive (i.e. to
contain the l.lkb insert) are shown on this ethidium bromide-stained 0.7%
(w/v) agarose gel, with negative and positive controls. The top and bottom
portions of the gel contain the same markers and controls, with different test
clones. Top : lane 1 : X (HinDHI/EcoRI digest) DNA size markers, lane 2 ;
negative (vector only), lane 3 : positive (vector + 2.7kb control insert), lane 4 :
negative (vector only), lanes 5-10 : positives 2C, 26, 43, 44, 45, 46. Bottom :
lanes 1-4 as top, lanes 5-10 : positives 47, 48, 49, 50, 51, 52. AT^ receptor
insert bands are the expected (-l.lkb) size.
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Figure 5.7
Restriction mapping of the twelve pAT\ clones. After confirmation of
the expected insert size (l.lkb) by EcoRI/BamHI digestion, plasmid DNA
was digested with five restriction enzymes diagnostic for the AT} receptor
coding sequence : BSpMI (A); Muni (B); SSpI and Dral (C upper and lower);
and Sail (D). All of these enzymes also had restriction sites within
pSP72poly4. Consequently, if the l.lkb insert was indeed an ATI receptor
coding region, digestion with these enzymes would liberate a diagnostic
pattern of predictable fragment sizes as follows : BSpMI : 2.8kb and 735bp;
Muni : 2.7kb and 914bp; SSpI : 2.1kb and 1.4kb; Dral : 1.7kb, 1.2kb and
700bp; Sail : 3.5kb and lOObp. Arrows indicate the position of the smaller
Sail fragment on panel D. Two of the clones (pAT:.43 and 50) consistently
showed abnormalities in the restriction sites for the first four enzymes; these
are indicated with asterisks. Gels A and C were run as follows : X
(HinDIII/EcoRI digest) DNA size markers in the left-and righthandmost
lanes, Bluescript BSSK+ DNA markers (low size) in the right-hand
penultimate lane. The putative pATx clones were run in the order 2C, 26, 43-
52, flanked on either side by pSP72poly4 alone as a control. Panels B and D
are identical except that no negative controls were run, and D has an extra
lane of Bluescript markers in the left-hand penultimate lane.
Table 5.1
Restriction mapping of the twelve pATt clones. This table summarises
the information shown in the above figure. Restriction sites : Y=present;
N=absent, ?=abnormal.
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(pATi.n) Sail Muni BSpMI Dral SSpI pAT\.n ?
2C Y Y Y Y Y Y
26 Y Y Y Y Y Y
43 * Y X ? ? ? N
44 Y Y Y Y Y Y
45 Y Y Y Y Y Y
46 Y Y Y Y Y Y
47 Y Y Y Y Y Y
48 Y Y Y Y Y Y
49 Y Y Y Y Y Y
50 * Y ? ? ? ? N
51 Y Y Y Y Y Y
52 Y Y Y Y Y Y
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5.2.7 Sequencing of the pATi clones
DNA from large-scale preparations of pATi.2C, 44, 43 and 50 was
purified by CsCl gradient centrifugation (2.2.3.13), denatured and sequenced
by the dideoxynucleotide method (2.2.3.14). A typical sequencing gel
showing 5' sequence from each of the clones is shown in Figure 5.8. This gel
employed a sequencing primer designed to hybridise to the cloning vector
(pSP72XB); subsequently the rest of the length of the ATj insert was
sequenced by the technique of 'primer walking', where new sequencing
primers were designed against the far end of the sequence obtained from the
previous primer. The sequences of the primers used are shown in 2.2.3.14, in
order of use : the pSP72XB and BX are shown first for each direction,
followed by the PCR primers and then additional primers.
Comparison of the sequences for pAT^C, 44, 43 and 50 shown in
Figure 5.8, with each other and with the published sequence for the bovine
adrenal AT} receptor immediately suggested an explanation for the
anomalous restriction maps for clones pATx.43 and 50. The majority of
sequence for both clones was clearly derived from the bovine ATi receptor,
but pATx-43 contained two copies of the 5' EcoRI PCR primer separated by a
small amount of unidentifiable sequence. Meanwhile, pATx-50 contained a
small amount of inverted ATi sequence immediately after the 5' EcoRI PCR
primer, followed by an inverted copy of the 5' EcoRI PCR primer and
authentic AT} sequence. Approximately 50 and 80 extra bases were
incorporated into pAT}.43 and 50 respectively; these insertions would have
produced the observed anomalies in the restriction maps. Since these clones
obviously represented PCR amplification and cloning artefacts, they were
not subjected to any further analysis.
Analysis of the sequences for pATi.2C and 44 (Figure 5.8) from the
pSP72XB sequencing primer indicated that they represented authentic AT}
receptor clones. Accordingly, the inserts in these clones were sequenced
along their entire length on both strands, with the exception of two CG-rich
regions where the sequence was highly compressed. These were
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Figure 5.8
Sequencing gel from the analysis of pAT; clones; from left to right,
pAT;.2C, 44, 43 and 50. The base order, left - right, is TCGA. The primer
used is the 5' universal primer on pSP72poly4 (pSP72BX), yielding sequence
encompassing the 5' EcoRI cloning insertion site and the 5' start of the AT;
sequence. The start of the insertion site is clearly marked, as is the start of the
AT; coding sequence. Clones pAT;.2C and 44 contain no obvious differences;
however, clone pAT;.43 has an extra PCR primer incorporated into the
sequence, as marked. pAT;.50 contains an inverted PCR primer, some
inverted AT; coding sequence, and then a correctly inserted PCR primer
followed by the AT; coding sequence, further into the sequence. These are
indicated on the figure.
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\pA\2C 2pATh44 3 pATj.43 4 pAT/.50
ATj sequence (4)
Extra PCR primer (3)
Inverted PCR primer
ATi sequence (4)












818- CGCCTCCGG SKCCKR *
820- CCTCCGG TCCKS*




1475 A G G
Table 5.2
Sequence discrepancies from the published sequence for the bovine
adrenal ATa receptor (Sasaki et al. 1991). Base uncertainty codes are as
follows : Y : C/T; S : G/C; K : G/T; R :A/G. Discrepancies marked with an
asterisk indicate those from areas sequenced on one strand only due to
unresolveable C-G compressions. (Further sequencing of these areas to yield
uncompressed double-stranded sequence is anticipated).
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unresolveable using dITP as a dGTP analogue and therefore these sequences
were obtained for one strand only. Table 5.2 summarises the sequence
discrepancies in the clones pAT^C and 44 compared to the published
sequence. The overall homology was 98.4% for clone pATx-44, and 98.9% for
clone pATi.2C at the present state of analysis.
The sequence analysis indicated that the pATj clones generated were
in fact AT: receptors, and not of the AT2 subtype. It also showed that the
errors in the clones with abnormal restriction maps were due to
misincorporation of PCR primers at the 5' end. The degree of homology
compared with the published sequence indicates that the products are, with
the exception of the unresolved areas and single base misincorporations, true
copies of the bovine adrenal AT} receptor.
5.2.8 Use of the AT^ fragment to detect AT^ mRNA
As described in section 2.2.3.15 and 16, the ATi coding region DNA
generated by the cloning procedure was used as a probe in Northern blots to
detect ATx receptor mRNA in cultured bovine adrenocortical cells. An
example of an autoradiograph can be seen in Figure 2.4, where different
probe preparation methods were compared for their sensitivity. The
transcript size observed is the same as that published (Sasaki et al. 1991) :
3.3kb. The copy controls can also be clearly seen, indicating that in a 25pg




We wished to generate a probe for the bovine adrenal ATX receptor to
use in Northern blot analysis of AT} receptor mRNA steady-state levels. The
sequence of the receptor had previously been published (Sasaki et al. 1991);
the ATj receptor had also been shown to belong to a seven-transmembrane
region family of G-protein coupled receptors which contain no introns in the
coding regions of their genes (Dr. T. Inagami, personal communication). We
therefore decided to clone the entire receptor coding sequence by PCR
amplification. The amplification could be performed using bovine genomic
DNA as the coding region sequence contained no introns.
Primers were therefore designed to a high degree of specificity
against the ATi receptor coding sequence, encompassing the whole length of
the coding region, with a little 5' and 3' flanking sequence. A CG clamp was
designed onto the primer ends to facilitate efficient annealing; the primers
were also designed to contain 5' EcoRI and 3' BamHI restriction sites to
facilitate ligation into the cloning vector. On the first PCR amplification,
therefore, the primers would not exactly fit with the genomic sequence;
however, the noncomplementary 'tail' (see Figure 5.2) was short in
comparison with the rest of the primer, in order to minimise any problems
this might have caused.
After optimisation of the PCR conditions as in 2.2.3.5, a fragment of
the expected size (1114bp = -l.lkb) was successfully amplified, as shown in
Figure 5.3. Two purification methods for the PCR fragment were then used
to maximise the chances for successful ligation into the cloning vector. The
second of these methods yielded longer concatemers, as shown in Figure 5.3,
and DNA purified in this way also yielded more clones containing l.lkb
inserts (Table 2.1), leading to the conclusion that this purification method
was more effective than that used for pool (D, possibly due to improved
removal of enzymatic inhibitors.
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Twelve colonies out of a total of 50 transformants tested were found
to contain l.lkb inserts (Figure 5.6). The identity of those inserts was
confirmed by digestion of plasmid DNA isolated from these twelve colonies
with five restriction enzymes known to have cutting sites within the ATX
receptor sequence. Ten of these clones displayed restriction patterns
consistent with identification as an ATa clone, while the other two were
anomalous (Figure 5.7; Table 5.1).
These anomalies could have indicated one of two things : that several
errors had occurred during the amplification process, or alternatively that a
second ATi receptor subtype had been cloned. The existence of two
subclasses of AT; receptor in rodents is established (Yoshida et al. 1992), but
such a division in bovines has not been demonstrated.
Sequence analysis showed (Figure 5.8) that in fact these two
anomalous clones did contain AT^derived sequence and the observed
differences in restriction pattern arose from sequence artefacts generated
during PCR amplification. They were therefore not analysed any further.
The discrepancies observed in the 5' sequences of these two clones could
explain the differences observed in fragment size after restriction digests :
approximately 50 and 80 additional bases respectively were present in
pATx.43 and 50. The presence of these extra bases would have led to larger
bands being observed upon restriction mapping. This does not, however,
explain the absence of the Muni site in clone pAT^.43. This is probably due
to a PCR single base incorporation error, making the site unrecognisable to
the enzyme. The fact that this error occurred in only one clone makes this
explanation more probable.
Clones pAT^C and 44 were selected as examples of ATi receptor
clones for further sequence analysis. They were sequenced along their entire
length, and comparison of the full sequences for pATi.2C and 44 with the
published sequence revealed a number of discrepancies summarised in
Table 5.2. The single base substitutions found in clones pAT}.2C and 44
when compared to the published sequence are probably attributable to PCR
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copying errors. These errors have occurred at a rate comparable to those
reported for Taq polymerase (8.0 x Id6 mutations/bp/duplication; Cline et
al., 1996). As Taq polymerase has no proof-reading ability, they could have
been averted by the use of a proof-reading polymerase : proof-reading
capability can raise the fidelity of DNA replication up to 100-fold (Kunkel,
1992). However, the enzyme initially tested in PCR optimisation, ULTma,
proved unable to amplify the ATi receptor coding region under any of the
conditions tested, possibly due to its strong 3'-5' exonuclease activity and
consequent lack of processivity. It is also possible that the misincorporation
may have been a sequence-specific problem. Both pATx.2C and 44 contain a
single misincorporated base (81 bases into ATa sequence for 2C; 168 bases
into AT! sequence for 44) early into the amplimer length. If ULTma had
progressed to that point, found a misincorporated base and repaired it, and
then been unable to re-start polymerisation, successful amplification could
not have occurred. This might possibly explain, in part, the difficulty
experienced with this enzyme. Another possibility is that these single base
substitutions could also be due to the presence of allelic or strain variants in
AT! receptor sequences.
Table 5.2 shows two areas in each clone that have been incompletely
resolved. Both strands had been sequenced along the length of the clones,
and for the majority of the sequence had yielded only small compressions
resolvable by use of dlTP as a dGTP analogue. However, in these two areas,
even use of dlTP was not sufficient to resolve the compressions resulting
from the C-G-richness of the region. Due to constraints of time, no further
attention was given to this problem. Further sequence analysis, perhaps
using alternative primers or another dGTP analogue (such as 7-deaza-dGTP)
would, however, be the next step in obtaining full sequence for the clones
along both strands. However, the degree of homology obtained with the
published sequence, even with the unresolved areas, was 98.9% for pAT!.2C
and 98.4% for pATt.44. This was sufficient for a probe generated from these
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clones to successfully hybridise to ATx sequence under the chosen
hybridisation conditions as shown in Figure 2.4.
The sequence data obtained to date is sufficient to show that the
receptor sequenced is of the ATx class and not the AT2 subtype. This second
subtype shares only 36% homology with the type 1 receptor, making it
extremely unlikely that it could have been amplified using the primers
chosen. It can also be concluded that two subtypes of ATx receptors have not
been isolated in this cloning experiment; this possibility having been briefly
considered when examining the restriction mapping anomalies. To date, no
large mammals have been found to have ATx receptor subtypes.
The main aim of this chapter was to produce a clone of the bovine
adrenal ATx receptor. Successful amplification of the bovine adrenal ATx
receptor coding region and insertion of this sequence into a cloning vector
pSP72poly4 yielded 12 clones, 10 of which were found to contain ATx
sequence by restriction mapping. Two of these were fully sequenced and
showed over 98% homology with the published sequence. These clones were
then used to generate DNA for use as a probe for ATx mRNA in Northern
blots. When hybridised to Northern blots of bovine adrenocortical cell RNA,
a transcript of 3.3kb was detected (Figure 2.4), as shown by Sasaki et al.
(1991). (The probe generated by random priming gave a slightly less
sensitive signal than that generated by asymmetric PCR. However, the
increased simplicity of the 'Vogelstein' method, coupled with only a slight
loss of signal, led us to adopt this method for routine preparation of probes).
This furnishes further evidence that the clones generated and sequenced in
this chapter were in fact bovine adrenal ATx receptor clones.
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Chapter 6 : Regulation of bovine adrenocortical ATi
receptor mRNA expression in cultured bovine
adrenocortical cells
6.1 Introduction
Angiotensin II receptors represent an important point of control ofAll
action. An increase in number or affinity of the receptors could lead to an
increased response to the hormone and vice versa. Indeed, it has already
been observed that sodium restriction increases All receptors in the adrenal
cortex, and that this sensitises the response of this tissue to All (Aguilera et
al. 1980). It has further been discussed in section 1.5 that alterations in the
activity of the renin-angiotensin system can have important
pathophysiological implications; alterations in normal receptor regulation, as
one component of this system, could therefore also be important.
The adrenal cortex is one of the prime target organs for angiotensin II
and adrenocortical AH receptors have been extensively studied in many
species. We chose to examine the regulation of AD receptor mRNA in
primary cultures of bovine adrenal zona fasciculata cells. Both bovine zona
glomerulosa and zona fasciculata cells in culture respond to All stimulation
in the same manner as human adrenal cells (Naville et al. 1993). Although it
is accepted that the zona glomerulosa is the most important zone for All
action in the adrenal cortex, the receptors in the inner zone also induce a
steroidogenic response to All (Clyne et al. 1993; Ouali et al. 1993; Lebrethon et
al. 1994). Furthermore, they are pharmacologically identical to those in the
zona glomerulosa (see Chapter 4) and they utilise the same signal
transduction systems (Ouali et al. 1992; Clyne et al. 1993). Due to the large
numbers of cells required to carry out the planned experiments, use of zona
glomerulosa cells would have limited the studies as the yield of cells from
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these preparations was usually only a tenth of that from inner zone
preparations. Therefore the inner zone cells were selected as a model system
in these studies rather than outer zone cells.
The regulation of receptors can be studied at more than one level.
Most commonly, the levels of receptor protein (by radioligand binding or
Western blotting) or mRNA (by Northern blotting, RNAse protection or RT-
PCR) are analysed. We chose to analyse the steady-state levels of AT:
receptor mRNA by Northern blotting. Changes in mRNA levels would be
expected to occur sooner after treatment with an agonist than changes in
receptor protein levels, and this therefore allows a more immediate
determination of whether the levels are being increased or decreased.
Analysis of mRNA also precludes interference with measurement of receptor
protein levels (by radioligand binding) due to internalisation of the AH
receptor. Northern blot analysis is the simplest method of analysing steady-
state mRNA levels and was therefore the method of choice in this study.
As the receptor subtype mediating the physiological actions of All in
the zf and zg of the bovine adrenal cortex is known to be the ATX subtype
(Clyne et al. 1993), it was the regulation of AT} receptor mRNA levels which
were studied.
The regulation of ATi receptors has been widely studied. It has been
shown that AH can downregulate its own binding sites (i.e. receptor
number) in bovine adrenocortical cells (Penhoat et al. 1988), and that this can
be mimicked by stimulating the IP3/Ca2+ signal transduction system with a
combination of phorbol ester and calcium ionophore. ACTH and other
cAMP stimulators and analogues also decrease All receptor number in
cultured bovine adrenocortical cells (Penhoat et al. 1988). While this work
has revealed a similar regulatory pattern to the few studies in human
adrenal primary cell cultures (Naville et al. 1993), it has only encompassed
studies of AH binding, and not the expression of the AT} receptor mRNA.
Recently, Bird et al. have demonstrated that the ATx receptor in the human
adrenocortical cell line, H295R, is regulated in a similar pattern to previous
179
studies in both human and bovine adrenocortical cell primary cultures
(Penhoat et al. 1988; Naville et al. 1993), and have shown that changes in ATX
receptor mRNA levels precede the observed changes in AH binding sites
(Bird et al. 1995a). We therefore wished to study the regulation of the AT:
receptor at the mRNA level in primary cultures of bovine adrenocortical
cells, in order to determine whether the previously documented changes in
AH receptor number were correlated with any changes in AT! receptor
mRNA levels.
It was wished to examine effects on the AT: receptor mRNA level
induced by AD itself, and by direct stimulation of the signal transduction
pathway it stimulates, i.e. inositol phosphate/calcium. The effects on ATi
mRNA levels of activation of both the cyclic AMP and tyrosine kinase signal
transduction systems, which were both known to affect AD receptor number
in bovine zfr cells (Penhoat et al. 1988; Lebrethon et al. 1994), were also
examined in this study.
Agonists were chosen that could have effects on the receptor
physiologically, or that directly activated adrenocortical second messengers.
Therefore both AH and ACTH were studied, in addition to direct activators
2+
of the IP3/Ca (phorbol ester and calcium ionophore) and cAMP (8Br-
cAMP) signal transduction systems. IGF-1, known to activate tyrosine
kinase, has also been demonstrated to be active in the adrenal cortex (Weber
et al. 1994) and was studied for that reason. Potassium is important in the
control of the renin-angiotensin system, and stimulates steroidogenesis in
both zones of the human adrenal cortex in culture (Laird et al. 1991). Thus it
was also considered as a possible regulatory influence on ATx mRNA levels.
Finally, it was wished to consider the effects of adrenocortical steroids
themselves on ATi receptors. Two were studied : aldosterone and Cortisol.
Both are produced by the action of All on its receptor and are therefore
possible candidates for a product feedback type of regulation.
Physiologically, zona fasciculata cells are exposed to high concentrations of
Cortisol (Crivello et al. 1983) and might also be exposed to high
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concentrations of aldosterone before it reaches the adrenocortical capillary
network.
The aims of this chapter were, therefore, to examine the regulation of
bovine adrenocortical AT} receptor mRNA levels, and also the possibility
that the products of AT} receptor stimulation in the two zones of the adrenal
cortex participate in a feedback system. A consideration is also given to
whether the agents used to regulate the receptor raise basal steroid output in
these cells and whether this contributes to the observed regulation.
The experiments in this chapter were designed to examine the
regulation of steady-state levels of ATi receptor mRNA. Preliminary studies
to determine the time-course and dose-dependency of the effects of given
agonists were carried out twice. Three further experiments were then
performed to analyse quantitatively the effects of these agonists on AT}
receptor mRNA levels at times and concentrations shown previously to be
the most effective. Although the hybridisation procedure in Northern
blotting is semi-quantitative, the changes in levels could be quantitated by
comparing ATi receptor mRNA levels in treated cells to basal or control
samples (i.e. untreated cells) within an experiment. The quantitation of
signal from the hybridised blots on a phosphorimager was, however, fully
quantitative. To correct for loading variation on the blots, AT} mRNA levels
were normalised to levels of |3-actin mRNA before comparison with the basal
levels. The quantitated data is therefore presented as a percentage of basal
levels of the ratio ATi receptor mRNA : (5-actin mRNA. Statistical analysis




6.2.1 Levels of bovine adrenal ATi receptor mRNA in culture.
Before examining the regulation of ATi receptor mRNA levels, it was
wished to determine how these levels varied basally during the first few
days of culture. Bovine zona fasciculata/reticularis cells were isolated and
cultured as described in Chapter 2 (2.2.2.2). The cells were plated at a
6 2
density of 5 xlO cells per 25cm flask (as in 2.2.2.9); one flask of cells was
used per experimental point. After 24 hours in culture, RNA was isolated
from the cells in one flask. The medium was changed in the remaining
flasks. On the following morning, RNA was extracted from another flask
and the remaining cells were serum deprived. Six hours later, another flask
was removed and the RNA isolated. At 24 and 48 hours following the 6h
serum deprivation, RNA was isolated from a further flask. RNA from all
samples was then run on a Northern blot, which was probed for both ATi
and P-actin mRNA. Figure 6.1 shows the autoradiograph from this
experiment, and Table 6.1 shows the quantitation of the signal from this
autoradiograph.
For the first two days in culture the ATX receptor mRNA level
appeared to be undergoing a recovery period : its expression increased to a
constant level by the second day after isolation. Between days 2 and 4 in
culture, there was very little variation in expression of the receptor mRNA.
The increase observed in AT: mRNA levels during the first two days in
culture was also observed for P-actin; this possibly reflects a general
recovery after isolation. These results show that AT} receptor mRNA levels
do not change appreciably during the time period 48-96h after isolation. This
period was therefore chosen for experimentation, and any changes
appearing during experimentation can thus be attributed to the agonists
used.
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Figure 6.1 Basal levels of bovine adrenal Ah receptor mRNA expression in
culture
Bovine zfr cells were cultured as described in 2.2.2.2. 40 hours after isolation
the cells were serum deprived for 6h. Fresh serum-free medium was then
added and changed every day. Samples of RNA were taken throughout the
culture period. RNA was harvested after 1 day in culture (^2411, lane 1), 1
day plus overnight in culture (t=40h/ lane 2), two days in culture including 6
hours' serum deprivation (t=46h, lane 3), and 3 and 4 days in culture, serum
deprived (t=60h, lane 4; t=84h, lane 5). Both AT\ and (3-actin mRNAs are
shown on this Northern blot autoradiograph. Levels of both species of RNA
increased during the first two days in culture and remained constant
thereafter. (3-actin was more highly expressed in the bovine adrenal cell than
was ATa receptor mRNA.
-i on
Day after isolation ATi mRNA
(normalised to (3-actin)
1 (t=24h) 0.32
1 + overnight (t=40h) 0.47
2 (t=46h) * 0.75
3 (t=60h) * 0.75
4 (t=84h) * 0.72
Table 6.1: Levels ofATn mRNA expression during culture
Bovine zfr cells were cultured and sampled during the course of the
experiment described in 6.2.1 in order to assess the level of expression of the
ATi receptor mRNA. Data (expressed as arbitrary units) obtained from the
Northern blot shown in Figure 6.1. (* = serum-deprived).
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6.2.2 Effect ofAll on the expression of the ATi receptor
Zfr cells were treated with All in order to investigate the homologous
regulation of ATi receptor mRNA levels. The concentration previously
shown (Figure 3.3) to elicit a maximal steroidogenic response from zg cells,
lOnM All, was used to study the time course of regulation. Cultures of
bovine zfr cells were treated with lOnM All for periods of between 4 and 48
hours and Figure 6.2 shows a representative Northern blot autoradiograph
from such an experiment. There was a clear decrease of the receptor mRNA
by 8 hours, which recovered to basal levels by 24 to 48 hours.
The concentration-response of the effect of All was next studied. Zfr
cells were treated with doses of All ranging from O.lnM to lOOnM for 6
hours. A clear effect on the level of the AT} receptor mRNA was seen at InM,
with a lesser effect at O.lnM. 10 and lOOnM AH effectively abolished ATX
receptor mRNA expression (Figure 6.3).
A quantitative assessment of this effect was then obtained from
triplicate experiments. Bovine zfr cells were cultured as described and
treated with 1 and lOnM All for 6 hours, and lOnM AH for 48 hours. Figure
6.4 shows a bar chart combining the results from all three experiments, while
figure 6.5 shows an autoradiograph of a representative experiment. The most
significant effect resulted from a treatment of lOnM AD for 6 hours, which
decreased ATa receptor mRNA levels by 84% compared to control levels
(p<0.005). This effect was concentration-dependent, as InM AD produced a
smaller decrease of 64% (p<0.005). A chronic exposure to AH produced only
a slight, non-significant decrease of 21%, showing that the receptor levels
return to almost control levels on prolonged exposure to All.
2"F •
6.2.3 Effect of stimulants of the IPVCa signal transduction system
Cultures of bovine adrenal zfr cells were exposed to two compounds :
a phorbol ester, phorbol myristate-12-acetate (PMA), was used to directly
stimulate protein kinase C, and a calcium ionophore, A23187, was used to
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Effect ofAll on the levels ofAT7 mRNA
Figure 6.2
The time course of All's effect on AT} receptor mRNA levels was
investigated. Bovine zfr cells were cultured for two days, serum deprived for
6 hours and then treated with lOnM All for, as shown on the blot left to right,
8, 16, 24 and 48 hours (lanes 2,4,6,8). The corresponding control (basal)
samples are also shown (lanes 1,3,5,7). A decrease in ATa receptor mRNA
levels was apparent and maximal after 8 hours.
Figure 6.3
The concentration-dependency of the effect of All on its receptor
mRNA expression was also determined. Bovine adrenal zfr cells were
cultured as above and incubated for 6 hours with various concentrations of
AIL Left to right the lanes are : control, O.lnM, InM, and lOnM AIL A
decrease in ATa receptor mRNA levels was apparent at InM.
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Quantitative effect ofAH on ATn receptormRNA levels
Figure 6.4
The effect of All on AT: receptor mRNA was quantitated as described
in 6.1. Bovine zfr cells were cultured for 2 days and then serum deprived for
6h (as in 2.2.2.9) before being treated with 1 and lOnM AH for 6h and lOnM
All for 48h. The percentage of ATi receptor mRNA (normalised to (3-actin)
compared to basal levels is shown as the mean +/- s.e.m. of three
experiments. A significant decrease (p<0.005) in AT: mRNA was seen after
exposure to 1 or lOnM All for 6h, with recovery occurring after 48h
treatmentwith lOnM AH.
Figure 6.5
A representative Northern blot autoradiograph from the experiments


















stimulate calcium influx into the cells. The two compounds were used singly
and in combination at concentrations of lpM.
The result of a representative experiment to determine the time-course
for the effects of these two compounds is shown in Figure 6.6. PMA and
A23187 yielded very similar effects when applied separately, and more
pronounced effects when applied in combination. A dramatic decrease in
ATX receptor mRNA levels was apparent by 6h treatment, which recovered
to varying extents by 48h for the single treatments and not at all for the
combined treatment.
A dose-response experiment was also carried out (Figure 6.7). The
cells were treated for 48h with concentrations ranging from O.lnM to lpM of
PMA, A23187 or a combination of the two (A+P). The highest concentration
for the single treatments produced a decrease of the levels of ATi receptor
mRNA, but most of the lower concentrations were without effect. A23187
was effective at decreasing AT} receptor mRNA levels at lower
concentrations than was PMA; the combination was again most effective as a
decrease in AT} receptor mRNA levels was apparent at concentrations as low
as lOnM.
For quantitation of this effect, time-points of 6 and 48 hours and a
concentration of lpM PMA and A23187 were chosen, as these gave maximal
effects, and allowed a comparison to be made between acute and chronic
exposure. Three experiments were carried out and are summarised in Figure
6.8, whilst a representative autoradiograph from one of these experiments is
shown in Figure 6.9. Of the two agonists, PMA was the most effective,
causing a decrease in ATi mRNA levels by 87% (p<0.01) after a 6 hour, lpM
treatment. A23187 caused a decrease of 67% after the same time (p<0.01),
and the two treatments combined decreased the AT} mRNA levels by 91%
after 6 hours (p<0.005). As can be seen in Figure 6.6, (3-actin mRNA levels
were not affected by these treatments. Chronic exposure (48 hours) to lpM
PMA produced a decrease of 25% in AT; receptor mRNA levels, comparable
to that induced by lOnM AH. However, lpM A23187 appeared to produce an
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Effect of activation of the IP/Ca2+ signal transduction system on ATi
receptormRNA steady state levels
Figure 6.6
Levels of AT! receptor mRNA after treatment of cultured bovine zfr
cells with phorbol ester (PMA), calcium ionophore (A23187), and the two in
combination (A+P), all at lpM, to determine the time course of their effect on
A^ receptor mRNA levels. Bovine zfr cells were cultured as previously
described, serum deprived for 6h and exposed to these agents for 6, 18, 24
and 48h, as shown on this representative Northern blot autoradiograph.
Control (basal) samples are included for each time point. Lanes 1,5,9,13:
control; 2,6,10,14: lpM PMA; 3,7,11,15: lpM A23187; 4,8,12,16: lpM A+P.
Figure 6.7
Representative experiment to determine the dose-dependency of the
effects shown above. Bovine zfr cells were cultured as described previously,
incubated for 48 hours with InM, lOnM, lOOnM and lpM PMA, A23187 or
A+P. A control (basal) RNA sample is run in lane 1; from left to right in,
decreasing concentrations, are PMA (lanes 2-5), A23187 (lanes 6-9) and A+P
(lanes 10-13). (3-actin mRNA levels are also shown to illustrate that the
treatments used had no effect on its mRNA levels.
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Quantitative effects of stimulation of the IPVCa2+ signal transduction
system on ATl receptormRNA levels.
Figure 6.8
The percentage of basal levels of ATi receptor mRNA were
determined following treatment of bovine zfr cells with luM phorbol ester
(PMA) and calcium ionophore (A23187), either singly or in combination
(A+P) for 6 and 48h. The mean and standard error of ATi receptor mRNA
levels from three experiments are shown.
Figure 6.9
A Northern blot autoradiograph from a representative experiment of
those described above. The lanes 1-7 are aligned to the bars corresponding to

























increase, giving rise to ATj receptor mRNA levels 128% of control. The
combined treatment, as expected from the qualitative experiments, still
depressed the level of AT2 receptor mRNA after 48 hours, although a slight
recovery had taken place, to 21% of control (p<0.01 vs. basal).
6.2.4 Effect of stimulants of the cyclic AMP signal transduction system
To examine the effects of stimulating the cyclic AMP/protein kinase
A signal transduction system, cultured bovine zfr cells were treated with
ACTH, a physiological activator of the system, and also 8-Br-cAMP, a cAMP
analogue.
A representative time course for the effect of InM ACTH and O.lmM
8-Br-cAMP on the levels of ATi receptor mRNA in bovine zfr cells is shown
in figures 6.10a and 6.10b. Both compounds produced a decrease in AT}
receptor mRNA levels; this effect first became apparent at 8 hours for 8-Br-
cAMP (Figure 6.10a), but at 48h for ACTH (Figure 6.10b), AT} receptor
mRNA levels reaching a minimum level by 48 hours of treatment in both
cases.
To determine the dose-dependency of this decrease, bovine zfr cells
were treated over a range of concentrations with one or other of the agonists
for 48 hours (Figure 6.11). A concentration as low as lpM 8-Br-cAMP
produced a noticeable effect on AT: receptor mRNA levels, with a maximal
effect at O.lmM. ACTH produced a decrease even at O.OlnM, with a maximal
effect at InM.
To quantitate the observed effects on AT} receptor mRNA levels,
bovine zfr cells were exposed to O.lmM 8-Br-cAMP and InM ACTH for 6
and 48 hours, to reveal any difference between acute and chronic exposure.
These experiments are shown in Figures 6.12 and 6.13, the former showing
the combined results from three experiments plotted as a bar chart, and the
latter a representative autoradiograph. Both agonists produced a greater
decrease in AT} receptor mRNA levels after 48 hours : to 16% of control
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Effect of activation of the cuclic AMP signal transduction system on AT,
receytormRNA levels
Figure 6.10
This representative experiment assessed the time course of the effects
of stimulation of the cyclic AMP second messenger pathway on levels of ATi
receptor mRNA. Bovine zfr cells were cultured for two days, serum deprived
for 6h and then incubated with either O.lmM 8-Br-cAMP for 8, 24 and 48h
(Figure 6.10a) or InM ACTH (Figure 6.10b) for 6, 18, 24 or 48 hours (lanes
2,4,6,(8) in increasing time). Control samples are also shown (lanes 1,3,5,(7)).
Figure 6.11
The dose-dependency of the response of ATi receptor mRNA levels to
activation of the cAMP signal transduction system was then determined.
Bovine zfr cells were incubated with O-l, i^OjiOO^ 8-Br-cAMP and o ot,o-j,
I nM ACTH for 48 hours. A control sample is shown in lane 1 and then left to
right are ACTH in decreasing concentrations (i.e. InM to 0.01 nM), and 8-Br-
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Quantitative effect of stimulation of the cyclic AMP signal transduction
system on ATn receytormKNA levels.
Figure 6.12
Changes in ATX receptor mRNA levels determined quantitatively
following stimulation of the cyclic AMP second messenger system by either
the physiological ligand, ACTH, or the cAMP analogue, 8-Br-cAMP. Bovine
zfr cells were cultured as described previously and treated with O.lmM 8Br-
cAMP or InM ACTH for 6 or 48h. The mean and standard error of AT;
receptor mRNA levels from three experiments are shown.
Figure 6.13
A Northern blot autoradiograph from a representative experiment of
the three described above. The lanes 1-5 are aligned left to right with the
corresponding treatments detailed in Figure 6.12.
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levels for 8-Br-cAMP (p<0.005) as opposed to 72% after 6 hours, while
receptor n (?Nh lex/efe to
treatment with InM ACTK -tended -todecrease fTi; 55% and 47% after 6 and
A
48h respectively. Only the chronic (48h) treatment with 8Br-cAMP yielded a
statistically significant decrease in AT: receptor mRNA levels.
6.2.5 : Effects of stimulants of other signal transduction systems on ATi
receptor mRNA steady state levels in bovine zfr cells
A representative time-course for the effects of the tyrosine kinase
agonist IGF-1 and potassium on the levels of ATi receptor mRNA is shown
in figure 6.14. Bovine zfr cells were cultured for 2 days, serum deprived for
6h and then treated with 10ng/mL IGF-1 and 12mM potassium for 8, 16, 24,
and 48h. IGF-1 at 10ng/mL initially induced a decrease in AT} receptor
mRNA levels, as seen after 8 hours incubation. Plowever, after longer
treatment, this was reversed and a distinct increase became apparent.
Potassium (12mM) also increased ATx receptor mRNA levels, and this effect
was apparent after 16 hours incubation, reaching a maximum by 48 hours
treatment (figure 6.14).
The dose-dependency of these effects was then studied. Cells were
treated with a range of concentrations of the two agonists for 48 hours and a
representative autoradiograph can be seen in Figure 6.15. lOng/mL IGF-1
induced the highest increase in AT} receptor mRNA levels, with 5ng/mL
having little effect and the lowest concentration none at all on ATi receptor
mRNA levels. Potassium, however, showed an unusual dose-response. 8mM
potassium had no effect on the levels of AT; receptor mRNA, 12mM, as
previously seen, increased the mRNA levels, and 16mM appeared to cause a
decrease in ATi receptor mRNA levels.
The effect of lOng/mL IGF-1 and 12mM potassium were further
investigated by quantitative analysis of three further Northern blot
experiments. Bovine zfr cells were cultured as previously described and
treated with 10ng/mL IGF-1, 12 or 16mM K+, for 6 and 48h. The mean (+/-
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Effect of activating other signal transduction systems on AT1 receptor
mRNA levels
Figure 6.14
Effects of IGF-1 - mediated activation of tyrosine kinases and
potassium on levels of AT! receptor mRNA in cultured bovine zfr cells. Cells
were cultured for 2 days and serum deprived for 6h, then treated with
lOng/mL IGF-1 or 12mM potassium for 8, 16, 24 and 48 hours; control
samples were also taken at each time point. Across this Northern blot
autoradiograph left to right run the time points in increasing duration for
control (lanes 1,4,7,10), IGF-1 (lanes 2,5,8,11) and potassium (lanes 3,6,9,12).
Figure 6.15
The dose-dependency of the above affects was then determined.
Bovine zfr cells were cultured for two days, serum deprived and incubated
for 48 hours with 1, 5 and lOng/mL IGF-1, and 8, 12, 16, and 20mM
potassium. A control sample was also run; this appears in lane 1, the IGF-1
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Quantitative effects ofIGF-1 and K+ on ATi receptormRNA levels
Figure 6.17
The effects of IGF-1 and K+ on expression of AT: mRNA were then
quantitated. Bovine adrenocortical cells were cultured as previously
described and treated with 10ng/mL IGF-1 or 12mM K+ for 6 or 48 hours;
the bars show the mean +/- s.e.m of ATi receptor mRNA levels for three
separate experiments.
Figure 6.18
A representative autoradiograph from a Northern blot of one of the
above experiments. The numbers on the lanes left to right correspond to the






























































(% basal) mean +/- sem
12 6 138 +/-10
12 48 114 +/- 24
16 48 83 +/" 12
Table 6.2 : Quantitative effects of potassium on expression of AT7_ receptor
mRNA levels
Mean +/- sem (from three combined experiments) of AT^ receptor
mRNA levels in bovine zfr cells after treatmentwith potassium for the stated
concentrations and times.
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s.e.m) percentage of basal AT} receptor mRNA levels following these
treatments can be seen in Figure 6.16, while a representative autoradiograph
is shown in Figure 6.17. No significant increases in AT; receptor mRNA
levels were observed due to the degree of variation between experiments,
but a trend towards increasing levels by both agonists can be seen. A
decrease of AT; mRNA levels by IGF-1 after 6 hours exposure was also
clearly evident
Table 6.2 shows the mean levels of AT; mRNA in bovine zfr cells
treated with 12 and 16mM potassium, to illustrate the contrasting effects
obtained with these two concentrations. Acute stimulation (6h) with 12mM
potassium induced an increase AT; receptor mRNA levels, which decreased
after chronic (48h) treatment. Use of the higher concentration of potassium
(16mM) tended to decrease the levels of AT; receptor mRNA.
6.2.6 : Effect of adrenal steroids on levels of AT; receptormRNA in bovine
zfr cells
Bovine zfr cells were cultured as described in 2.2.1.1 and after 6h
serum deprivation they were exposed to a range of concentrations of two
adrenal steroids, Cortisol and aldosterone, for 48 hours. The concentrations of
steroids used were representative of their physiological levels in the adrenal
cortex (Crivello et al. 1983). The result of these experiments is shown in a
representative Northern blot autoradiograph in Figure 6.18. It can be seen
that even at the highest concentration used (lOOnM), aldosterone had no
visible effect on the levels of AT; receptor mRNA, and was therefore not
studied further. lOpM Cortisol, however, induced a clear decrease of the AT;
receptor mRNA levels, which was also noticeable at lpM.
The time course of the effect of Cortisol on AT; receptor mRNA levels
was next investigated. Bovine zfr cells were cultured as described previously
and incubated for 6, 18, 24 and 48h with lOuM Cortisol. A decrease in AT;
receptor mRNA levels was first apparent as early as 6 hours and indeed was
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Effect ofadrenal steroids on AT7 receptormRNA levels
Figure 6.18
Bovine zfr cells were cultured for two days, serum deprived and
incubated for 48 hours with a range of concentrations of aldosterone and
Cortisol. This Northern blot autoradiograph shows a control sample run in
lane 1; lanes 2-5 are Cortisol samples (10pM, lpM, lOOnM and lOnM); lanes 6-
9 are aldosterone samples (lOOnM, 10nM, InM and O.lnM).
Figure 6.19
Bovine zfr cells were incubated with 10pM Cortisol for 6, 24 and 48
hours toinvstigate the time course of Cortisol's effect on ATi receptor mRNA
levels. Control samples are shown in lanes 1, 3, and 5, and the treated
samples in lanes 2, 4, and 6 in increasing duration of incubation.
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Quantitative effect ofCortisol on levels ofAT1 receptormRNA.
Figure 6.20
Levels of ATi receptor mRNA relative to basal expression after
exposure of bovine zfr cells to lOpM Cortisol for 6 and 48h. These data,
expressed as the mean (+/- sem), are combined from three experiments.
Figure 6.21
A Northern blot autoradiograph taken from one of the three
experiments combined above. The lanes are aligned left to right with the


















maximal at this point. After 48h, ATj receptor mRNA levels had recovered to
some extent but had not reached control levels.
The extent of the decrease induced by lOuM Cortisol was then
assessed quantitatively. Bovine zfr cells were treated with 10pM Cortisol for 6
and 48h (Figures 6.20 and 6.21). Figure 6.20 represents a combination of the
data from three experiments expressed as mean +/- s.e.m of ATa receptor
mRNA levels as a percentage of basal, while Figure 6.21 shows a
representative Northern blot autoradiograph from one of these experiments.
The decrease induced by 10pM Cortisol was significant (p<0.005) after 6
hours treatment, causing a fall in ATi receptor mRNA levels to 59% of
control. Again a recovery in AT} receptor mRNA levels was observed for
chronic treatment, with the level returning to 70% of control after 48 hours
treatment.
6.2.7 ; Effect of serum on the homologous regulation of ATt_ receptor
mRNA levels
Normally, experiments which examine regulation of mRNA levels are
carried out on serum-depleted cells. This makes the cells quiescent and
allows gene regulation to be studied with no masking of the effects by the
activated state of the cells. As the ATa receptor is involved in growth,
however, it was decided to carry out experiments in serum-containing
medium to determine what, if any, effect serum would have on the
regulation ofA^ receptor mRNA levels.
Bovine zfr cells were cultured as previously described but, instead of
serum depriving all the flasks, some were maintained in serum during the
course of the experiment. Certain flasks were treated with lOnM AH for four
or eight hours. It can be clearly seen that serum increased the level of AT2
receptor mRNA expression (Figure 6.22); however, this appeared to be a
non-specific effect since the levels of (3-actin mRNA were also increased.
Also noticeable was the fact that in the absence of serum, lOnM AD induced
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Figure 6.22
Effect of serum on levels of AT! receptor mRNA. Bovine zfr cells were
cultured as described for two days. Half were then serum deprived and
certain flasks were incubated with lOnM All for 4 or 8 hours. Lanes 1, 3 and
5 are control samples, lanes 2,4 and 6 were incubated with lOnM All for 4
hours (2) and 8 hours (4, 6) respectively. Lanes 1-4 were incubated in the
absence of serum, whereas lanes 5 and 6 had serum present throughout the
experiment
Treatment Cortisol n-fold increase over basal
All (lOnM, 6h) 30.6
All (lOnM, 48h) 19
All (InM, 6h) 10.6
PMA (IpM, 6h) 16.3
PMA (lpM, 48h) 3.7
A23187 (lpM, 6h) 5
A23187 (lpM, 48h) 2.3
A+P (lgM, 6h) 3
A+P (lpM, 48h) 1.7
8Br-cAMP (O.lmM, 6h) 37
8Br-cAMP (O.lmM, 48h) 89.7
ACTH (InM, 6h) 58.3
ACTH (InM, 48h) 59.7
IGF-1 (10ng/mL, 6h) 6.3
IGF-1 (lOng/mL, 48h) 5.3
K+ (12mM, 6h) 7.3
K+ (12mM, 48h) 8.7
Table 6.3
Shown are changes in basal Cortisol secretion observed in bovine zfr
cells treated with the above agonists at the concentrations and times listed.
Cortisol content was assayed in media removed from cells during the three
quantitative experiments to study changes in AT! mRNA levels. All
treatments increased Cortisol secretion in the cells, even when the direction of
regulation was different. Secretion was normalised to length of exposure for
one flask of cells. For untreated flasks, basal Cortisol secretion was 15 +/-
2pmol Cortisol/5 x 106 cells/h.
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a pronounced decrease in the mRNA levels of the AT] receptor, whereas in
the presence of serum this decrease was not observed.
6.2.8 Steroidogenic response of the treated bovine zfr cells
Since an effect of Cortisol on levels of AT] receptor mRNA had been
seen in the previous experiments, it was wished to analyse the amount of
Cortisol present in the overlying media from the cells in the quantitative
experiments. Media were collected at 24 and 48 hours of chronic incubations,
and at the end of the 6 hour incubations, and assayed for Cortisol content.
The results from these assays are displayed in Figure 6.23; the combined
data from three experiments are shown for the maximally effective
concentration and time for each agonist used (except for Cortisol).
Two points can be drawn from this data. Firstly, that, as expected in a
zona fasciculata preparation, ACTH and 8-Br-cAMP were more effective at
stimulating basal Cortisol production than was AH The IP3/Ca2" system
agonists were also not as effective as All itself. All these agents had elicited a
decrease in AT] receptor mRNA levels; however, IGF-1 and K+, which




In this chapter, it was wished to examine the regulation of steady-
state levels of ATi receptor mRNA in primary cultures of bovine
adrenocortical cells. The results of these studies demonstrate that not only
can angiotensin II regulate the levels of ATi receptor mRNA, but that
activation of adrenocortical second messenger systems, and high
concentrations of Cortisol, can also modulate AT] receptor mRNA expression.
The decrease in ATx receptor mRNA induced by AH was first
noticeable within 4 hours and thus precedes the decline in protein levels
previously observed in bovine adrenocortical cells (Penhoat et al. 1988).
125Those studies, using I-AII binding, showed a decrease in the number of
binding sites with no loss of affinity after 24h treatment. Recent studies in
H295R cells (Bird et al. 1995a) also found that All caused a decrease in both
ATi receptor mRNA and receptor protein (shown by radioligand binding);
the changes in receptor mRNA levels preceded those in receptor protein by
around 6h. Levels of both mRNA and protein recovered after chronic
stimulation, in agreement with our results (Figure 6.2). In the light of these
findings, we would expect AH receptor protein to have followed this pattern
in our experiments.
All, however, does not downregulate its own receptors in all tissues.
High levels of AH upregulate adrenal ATXb receptor mRNA in rats and also
AT} receptor number and mRNA levels in cultured rat kidney tubule cells
(Cheng et al. 1995). These, however, are probably species dependent
differences. The AT! receptor genes have different regulatory regions in the
two subtypes found in rats and mice, in contrast to the one class in humans
and bovines. Regulation of ATi receptors in these latter two species can not,
therefore, be accomplished through different regulatory sequences in two
ATi subtype genes, but may be through the action of tissue-specific
transcription factors.
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We have further shown that regulation of the ATi receptor by its
2+
ligand, All, can be mimicked by activating the IP3/Ca second messenger
system. Stimulation of bovine zfr cells with either phorbol ester or calcium
ionophore induced a decrease and recovery in ATa mRNA similar in
magnitude and duration to that induced by AH This indicates that both PKC
(activated by phorbol ester) and calcium influx (stimulated by calcium
ionophore) are involved in the decrease induced by AH. There is contrasting
evidence as to whether the PKC or the calcium arm of the signal
transduction system plays the major part in this effect. From our data, it
would seem to be the PKC which predominates, as the decrease induced by
PMA was more significant and mirrored the AD effect more closely than did
the A23187. A similar effect was also demonstrated in H295R cells (Bird et al.
1995a). This group reported that PMA and calcium ionophore in
combination could fully duplicate the decrease in AT2 receptor mRNA levels
induced by All, but that phorbol ester alone could not. This observation is
intriguing when considered with the fact that PKC has been reported to be
less important in All-stimulated actions than calcium (Ganguly & Waldron,
1994; Kapas et al. 1994). The data presented by Penhoat, examining AH
receptor regulation by radioligand binding in bovine adrenocortical cells
(Penhoat et al. 1988), showed on the other hand a greater effect of calcium
ionophore in decreasing All binding sites. However, both components (i.e.
PMA and A23187) were necessary to fully duplicate the magnitude of the
acute response of AH binding sites to All. When considering the chronic
response to All observed in our studies, full activity of both arms of the
2+
IP3/Ca signal transduction system would not seem to be involved in the
observed recovery in levels of ATi receptor mRNA : the PMA/A23187
combination prevented the recovery in ATa receptor mRNA levels observed
during chronic AH treatment.
Calcium influx and PKC stimulation do not always exactly mimic
All's effects on its receptors, however. Following cloning of an AT] receptor
(Makita et al. 1992), it was shown that inhibition of PKC did not affect the
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All-induced decrease of endogenous AT} receptor mRNA in cultured rat
glomerular mesangial cells. A23187 did not mimic All in this respect either,
suggesting that the PKC/Ca2+ pathway was not involved in the regulation of
ATi receptors by AD in these cells. This also suggests that although in
adrenocortical cells regulation of AH receptors by AH may be mediated by
activity of the IP3/Ca2+ system, it is not the only mechanism by which it
occurs.
Our findings indicate that activation of the cyclic AMP signal
transduction system can also decrease levels of AT} receptor mRNA
expression, but that this regulation does notmimic that induced by All itself.
In bovine adrenocortical cells, the cAMP system does not act so rapidly on
ATa receptor mRNA levels as in the human, where an effect on XT\ receptor
mRNA levels was maximal within 3 hours of stimulation with dibutyryl
cAMP (Bird et al. 1995a). In our studies the effect was not maximal until 48
hours after stimulation, but the degree of decrease was greater : 17% of
control levels of AT} receptor mRNA after 48 hours incubation with 8-Br-
cAMP, as opposed to 30% after 3h dibutyryl cAMP treatment in H295R cells.
The different cAMP analogues appear to have acted at different speeds to
decrease ATi receptor mRNA; it is possible that structural variation between
the two analogues contributed to this discrepancy.
Whereas we observed a decrease to 17% of control levels of ATi
receptor mRNA after 48h 8Br-cAMP treatment, Penhoat et al, who also used
8-Br-cAMP, observed a decrease to only 60% of control levels of All receptor
numbers in bovine adrenocortical (zfr) cells after 24 hours treatment
(Penhoat et al. 1988). In our hands, ACTH was less effective than the cAMP
analogue at decreasing AT: receptor mRNA levels, whereas Penhoaf s group
found the opposite (Penhoat et al. 1988). The reason for the greater efficacy of
the second messenger analogue compared to the physiological ligand of the
cAMP system, ACTH, is not clear. It may, however, be due to the more
direct effect of 8-Br-cAMP mimicking greater levels of cAMP than the ACTH
was able to transduce. It may also reflect differing effects of the two
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compounds on ATj receptor mRNA levels and receptor protein. However, a
greater efficacy of the cAMP analogue in decreasing ATi binding sites and
receptor mRNA levels was also observed in H295R cells (Bird et al. 1995a).
The effect of the cAMP signal transduction system on All receptors
has been investigated in other tissues. Chen et al. (1994) demonstrated a
transitory decrease in ATX mRNA expression in cultured rat kidney
glomerular cells after treatment with forskolin, a direct activator of PKA,
after which AT: mRNA levels increased to a level twice that of the control
cells. Thus PKA would appear to induce a bi-directional regulation of the
All receptor. The mechanism for this effect is not clear.
Angiotensin II is known to exert its effects in some tissues through
tyrosine kinase activation and opening of calcium channels (Cohen et al.
1988; Ganguly et al. 1995; Marrero et al. 1995). Might these signals also affect
ATi mRNA levels? Our studies have shown that chronic exposure (48h) of
zfr cells to IGF-1 caused an increase in AT} receptor mRNA levels,
confirming the finding of Langlois et al, who demonstrated increases in AT:
receptor mRNA expression in cultured bovine adrenocortical cells in
response to a number of growth factors, including IGF-1 (Langlois et al.
1994). We additionally demonstrated an acute effect of this locally produced
growth factor, which caused a decrease in levels of ATX receptor mRNA
following 6h exposure. This acute response to IGF-1 treatment parallels the
effect of AH, indicating that tyrosine kinases could be possibly be involved
in All-induced ATX receptor mRNA decreases in the adrenal cortex.
However, the chronic responses differ, leading to the conclusion that long-
term AH effects on its own'receptor mRNA levels are probably not mediated
through tyrosine kinases.
It is known that potassium can open voltage-dependent calcium
channels in the human adrenal cortex (Laird et al. 1991). Our results from zfr
cells treated with 12mM potassium, despite high variability, indicated a
moderate but statistically insignificant increase in ATx mRNA levels. The
increase was highest (124%) after 6 hours, then decreased to 114% after 48
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hours, indicating that protracted high potassium has the reverse effect to
protracted high AIL However, a higher concentration of potassium (16mM)
tended to downregulate the receptor mRNA (84% after 48 hours), and a
recent study in H295R cells also demonstrated that 14mM potassium
significantly increased AT: mRNA levels and AT} receptor protein (Bird et
al. 1995c).
From these data, two hypotheses can be advanced. The first is that
potassium has a threshold effect on AT} receptor mRNA levels in
adrenocortical cells. Up to a certain level, an increase will be observed, but
beyond that the regulation is reversed. This hypothesis would go some way
to explaining the high variation in our experiments with potassium : some
preparations of zfr cells might be more sensitive to potassium than others.
These cells would exhibit a decrease in ATi receptor mRNA levels in
response to potassium at a lower concentration than would less sensitive
cells. An increase in levels of ATi receptor mRNA would be observed in
response to 12mM potassium in these less sensitive cells, but at the higher
concentration a decrease of ATi receptor mRNA levels would be seen.
The alternative hypothesis relates to the mode of action of potassium
in regulating ATi receptors. Potassium has been shown to open voltage-
gated calcium channels in the adrenal cortex zona fasciculata (Laird et al.
1991; Bird et al. 1995c) and thus presumably modulates steroidogenesis, and
All receptors, through the actions of calcium-calmodulin protein kinases,
2"b
similar to the calcium component of the IP3/Ca system in aldosterone
synthesis. These kinases may well exhibit species differences, and this would
account for the different regulatory responses to the same agonist observed
in the two different species (LM.Bird, personal communication). It could also
account for the increase observed following high dietary potassium of ATi
mRNA in rat adrenals (Lehoux et al. 1994) compared to the response to high
potassium observed in human adrenal cells (Bird et al. 1995c). However, as it
has previously been demonstrated that dietary potassium loading increases
All receptors in the rat adrenal but decreases them in rat vascular smooth
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muscle (Douglas, 1979), this particular species difference may again reflect
the subdivision of the ATj receptor class in rats and its unity in bovines and
humans.
In vivo, plasma potassium concentrations of the magnitude used in
these experiments would be incompatible with life, and the concentration
needed to produce an increase in steroid secretion in freshly isolated cells is
much lower (less than 8mM : Kojima et al. 1985). However, in these
experiments, potassium was not detrimental to the cells and the
concentrations used were those that had elicited maximal steroidogenic
responses. It is therefore a distinct possibility that cell culture alters the cell's
sensitivity to high potassium levels.
In the past, steroids have been discounted as regulators of angiotensin
II receptors. Campanile and Goodfriend (1981) published a study in which
many different steroids were tested for their ability to inhibit binding of All
to its receptor in the adrenal cortex and act as feedback modulators. None
had any effect at physiological concentrations and steroids were discounted
as being able to regulate adrenal All receptors.
The finding in our study that Cortisol increased ATt receptor mRNA
levels in cultured bovine zfr cells is interesting in more than one way. Firstly,
it suggests that a steroid short-loop feedback system is in operation in these
cells, as Campanile & Goodfriend (1981) tried to show. Such a system could
provide a mechanism for limiting Cortisol production in response to raised
AD concentrations. The adrenal cell could limit this by decreasing the
amount of All receptors capable of coupling to steroid production and
therefore the amount of Cortisol produced.
Another interesting facet of these results is the inability of aldosterone
to regulate ATi receptor mRNA expression. This leads to postulation of the
existence of zone-specific regulation by steroids. Thus, in the zona
glomerulosa, aldosterone might downregulate AT} receptor mRNA
expression, as Cortisol does in the zona fasciculata. Cortisol would be
220
without effect in the zona glomerulosa, as these cells would not be exposed
to high Cortisol concentrations.
Other recent studies have indicated that in tissues other than the
adrenal cortex, both mineralocorticoids and glucocorticoids can also act as
regulators of All receptors, particularly the ATX subtype. Most of this work
has been done in vascular tissues to examine whether steroidal modulation
of ATj receptors could be a potential mechanism for glucocorticoid-induced
hypertension. Dexamethasone has indeed been found to upregulate ATi
receptors (at both protein and mRNA levels) in cultured vascular smooth
muscle cells (Gruenfeld & Eloy, 1987; Sato et al. 1994), as has aldosterone
(Ullian et al. 1992). Therefore steroids are capable of modulating the All
receptor, and can do this bidirectionally, as there have been reports of
glucocorticoids downregulating ATj receptor mRNA levels in hepatocytes
(Wintersgill et al. 1995) as well as foetal ovine liver and kidney (Segar et al.
1995). This latter group also found that Cortisol increased ATa receptor
mRNA levels in heart and vascular smooth muscle, a further example of
reciprocal regulation ofAll receptors in different tissues.
Following the finding that Cortisol, the product of All and ACTH
stimulation in bovine zfr cells, could downregulate ATj receptor mRNA
expression, it was necessary to determine whether this was responsible for
the effects seen in treatment with these agonists and their analogues. Finding
such an indirect effect of Cortisol (rather than a direct effect of the agonists
used) would have diminished our previous results. The Cortisol secreted into
the overlying medium during experiments was therefore measured. The
findings were quite conclusive. The amount of Cortisol secreted into the
medium bore no absolute relation to the degree or direction of the regulation
of ATi receptor mRNA levels observed. PMA/A23187 in combination, for
instance, decreased the levels of AT; receptor mRNA to the same extent as
All for 6 hours but produced 6 times less Cortisol. ACTH and 8-Br-cAMP did
not downregulate the AT} receptor mRNA levels to the same extent as All,
but the cells treated with these compounds secreted 2 and 3 times more
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Cortisol. K+ and IGF-1, which both increased ATj receptor mRNA levels,
increased basal secretion of Cortisol to the same level as the PMA/A23187
combination, which almost completely depleted the cells of AT: receptor
mRNA. Therefore, although high levels of Cortisol do downregulate AT2
receptor mRNA levels in bovine zfr cells, this is not the only mechanism by
which the decrease is effected.
The last variable to be examined in this series of experiments was the
effect of serum on the expression and regulation of ATi receptor mRNA.
Serum increases many genes, as it promotes the cell to an actively growing
state. This is particularly pertinent to the expression of angiotensin receptors,
as All is itself a growth factor. It is not surprising, then that the presence of
serum increased AT} receptor mRNA, but it is more surprising that this
increase was persistent. lOnM All in normal experimental conditions
decreases AT: receptor mRNA expression to 16% of control within 6h.
However, when the same experiment was conducted in the presence of
serum, this regulation was not observed. An explanation for this could be
drawn from the results obtained with IGF-1, and with bFGF (Langlois et al.
,1994). The growth factors present in serum could be upregulating the
receptor to such an extent that this masks the decrease induced by All, and
thus no apparent change is seen.
The findings from the experiments presented in this chapter are
subject to certain limitations. Firstly, a degree of variability has been
observed in the results from some of these experiments, particularly with
regard to incubations of bovine zfr cells with IGF-1 and potassium. In large
part, this is due to the experimental model system i.e. primary cell cultures.
Because these are by their nature obtained from different sources for each
preparation, there will be variations in the responsiveness and other
characteristics of each preparation. Therefore, although the trend observed
may be the same, the magnitude of the effect may vary. This can lead to
variation when results are combined from different experiments. Slight
differences in experimental technique between experiments will also play a
222
part, as may inter-preparation variations in agonist sensitivity. Minimising
such variation is one of the advantages of using a tumour-derived cell line,
such as the human adrenocortical cell line H295R. This cell line, derived
from an invasive primary adrenocortical carcinoma, has become available as
a mixed adrenocortical cell line producing over 20 steroids and is much used
as a model for human adrenal cells (Gazdar et al. 1990).
There are many advantages to these cells. The main among them is
that this is a human cell line and thus the problem of species difference can
be minimised. Also the problem of variance in primary cultures discussed
above is also minimised. Longer term experiments can also be attempted as
the cells do not lose their enzymes and die as in primary cultures (see also
Chapter 3 discussion); the H295R cells divide and are stable indefinitely.
However, there are also disadvantages. Zone-specific studies can not
be attempted in these cells as they are a multipotent cell line, that is they
produce steroids from all three zones of the cortex. They can be influenced to
one pathway, e.g. mineralocorticoid, but not exclusively. The H295R cells
also have different proportions of steroidogenic enzymes than in primary
cultures of human adrenocortical cells : the level of aldosterone synthase is
much lower and consequently much less aldosterone is synthesised; they
also have much lower levels of ACTH receptors than primary cultures. This
can obviously influence the results of experiments involving these variables.
Lastly, as H295R cells are derived from an adrenal tumour, they are by
definition less differentiated than an early primary culture; this may also
influence experimental results.
Secondly/ in this study, experiments were carried out to examine
changes in mRNA steady-state levels only. We can therefore only speculate
as to how the decrease in ATa receptor mRNA level is achieved. The early
time points at which decreases in AT} receptor mRNA levels were observed
would seem to indicate that mRNA synthesis is being switched off in some
way, or possibly that it is being destabilised. The former possibility could be
assessed by performing RNA run-on/run-off assays, which would yield
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information about the transcription of the ATi receptor mRNA. The
consequent recovery in mRNA following long-term treatment with All is
harder to explain; it is possible that the loss of synthesis or destabilisation is
only short-lived, or that in response to this, the ATi receptor DNA is
transcribed at a higher rate; this may then lead to the observed increase.
Another possible limitation of these experiments was that Cortisol,
which can act as a mineralocorticoid in some situations, was used instead of
a 'pure' glucocorticoid like dexamethasone. Criticism of this can be
answered by the fact that aldosterone, a mineralocorticoid, was absolutely
without effect on ATX mRNA levels in these experiments. It is therefore
extremely unlikely that Cortisol was acting as a mineralocorticoid in this
context.
The results presented in this chapter have broadened our knowledge
of the regulation of ATj receptors in this important model tissue. Levels of
ATi receptor mRNA can be regulated both homologously and
heterologously, with activation of multiple signal transduction systems
known to operate in the adrenal cortex affecting basal levels. Cross-talk
between signal transduction systems could therefore have complex effects on
both All receptors and All action. The changes in levels of AT} receptor
mRNA appear to precede observed changes in All receptor protein,
suggesting that the major level of All receptor regulation is its transcription.
Evidence has also been presented for the existence of a steroid short-loop
feedback system in the adrenal cortex, indicating that the ATi receptor can
be modulated by ^as well as its agonist
hne steroid produoad as a <esoH- of ;fs sf.AuloH=>n
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Chapter 7 : General Discussion
The aims of this thesis were to study the nature and regulation of
angiotensin II receptors in the bovine adrenal cortex. To this end, existing
protocols for the culture of bovine adrenocortical zona glomerulosa cells
were modified. A simpler method for purification of the cells following
collagenase dispersion was introduced, and it was demonstrated that the
addition of antioxidants was not necessary for maintenance of steroid
secretion. These antioxidants, recommended by many investigators (Crivello
et al. 1982; Braley et al. 1992; Shepherd et al. 1992), were in fact found to have
an inhibitory effect on steroid secretion for the first two days in culture.
Experiments to elucidate the particular antioxidant responsible for this
effect, or what in our culture medium was responsible for maintaining
responsiveness to All, ACTH and potassium, would be a fascinating
extension to these studies. A fuller characterisation of the purified culture
(e.g. cytospin analysis of cell types following purification, analysis of
changes in All receptor number and affinity during culture) would also
complement the results presented here.
To resolve an interesting observation that ATX receptors in cultured
bovine zfr cells might be pharmacologically distinct from those in rabbit
vascular smooth muscle (Clyne et al. 1993), Schild analysis was performed in
two cell culture systems : bovine adrenal zg cells and rat mesenteric artery
vascular smooth muscle cells. This, while revealing that the AT} receptors in
the two zones of the adrenal cortex were pharmacologically identical and not
significantly different from those in rat vascular smooth muscle cells,
pointed at another interesting observation. The pA2 values generated for
cultured rat vascular smooth muscle cells were significantly different from
those obtained from organ bath studies on rabbit aortic smooth muscle
strips. The possibility is therefore raised that Schild analysis to determine
pA2 values may not be as widely comparable a technique as was thought.
One way to resolve the observed discrepancy would be to perform a similar
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Schild analysis to that performed in this thesis on rat mesenteric artery
vascular smooth muscle, but using the isolated perfused mesenteric artery.
This would then be a more comparable method to that which generated the
pA2 value for losartan in the rabbit aorta (Chiu et al. 1990). If a difference in
pA2 values were then obtained, this would raise a very important
consideration that pA2 values might not be as comparable between species as
was originally thought (Mackay, 1978).
Having demonstrated that the ATi receptors in the inner and outer
zones of the bovine adrenal cortex were pharmacologically
indistinguishable, it was possible to focus on the bovine zfr culture as a
model for regulation of the All receptor. The coding sequence of the ATj
receptor generated from PCR of bovine genomic DNA was shown through
sequence analysis to be at least 98% identical with the published sequence
for this receptor (Sasaki et al. 1991). However, certain discrepancies remained
after the sequence analysis had been performed. Two areas of each clone
analysed (pAT}.2C and 44) could not be adequately sequenced along both
strands due to CG-rich regions inducing compressions of the sequence data.
The present data, however, does not preclude that the PCR-generated
sequences are identical to the published sequence. To complete this analysis,
therefore, more analysis using either primers designed against different
bases of the coding region to those used previously, or other available dGTP
analogues, should be performed; the latter may prove to be the better
starting point.
The last part of the work in this thesis has examined the regulation of
ATi receptor mRNA steady-state levels in cultures of bovine adrenocortical
inner zone cells. The data produced has shown that this regulation is
multifactorial: AT} receptor mRNA levels can be affected by not just AH but
also second messengers active in the adrenal cortex. This raises interesting
questions about the mechanisms by which the regulation is brought about,
which is the controlling influence, and what the physiological significance of
the changes observed might be.
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Simultaneous activation of the signal transduction systems studied in
this thesis may have contrasting or synergistic effects on the levels of ATX
receptor mRNA, and as all the systems studied are active in the adrenal
gland, dissection of which are the major influences may be difficult. Cross¬
talk between second messenger systems clearly has important implications
for the expression of ATX receptors. As a second messenger rarely works
alone during cell stimulation, correlation of ATX receptor mRNA regulation
to a single intracellular signal in an adrenocortical cell culture system is not
feasible.
From the results in presented in this thesis, it would seem that the
regulation by All of its receptor mRNA levels is principally mediated by the
2"b
IP3/Ca signal transduction system. However, as both arms of the system
appear to mimic the effects of All, it may be difficult to determine the exact
mechanism by which the effect is mediated.
Regulation of AD receptors in bovine adrenocortical cells by All and
ACTH has been demonstrated to be similar in both zfr and zg cells, in that
both secretagogues decrease the number of binding sites without affecting
affinity (Penhoat et al. 1988). All and ACTH have also been shown to
decrease ATX receptor mRNA levels in cultured human adrenocortical cells
(Naville et al. 1993). Both AD and ACTH are stimuli for aldosterone
secretion, so it is not surprising that they should both regulate zg All
receptors in the same direction as zfr All receptors. Indeed, a discrepancy
could affect the maintenance of normal aldosterone secretion. The
significance of ACTH regulating All receptors in the zfr is less clear. It may
perhaps reflect the fact that although AD will cause the zfr to secrete Cortisol,
it will not do this in the presence of fluctuating ACTH levels. This was
suggested by the findings of Mason et al. (1979) who demonstrated secretion
of Cortisol from human adrenals in vivo, in response to All, only in the
presence of an ACTH clamp. All-stimulated Cortisol secretion is therefore
secondary to ACTH-stimulated Cortisol secretion : maybe the decrease of AH
receptors by ACTH ensures that this has to be so.
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The mechanisms behind the regulation of ATi receptor mRNA levels
by ACTH and cAMP are not fully understood. According to Makita et al.
(1992), there are no cAMP-responsive elements in the ATX receptor gene
promoter region, therefore they postulated that the effects were post-
transcriptional in nature, involving changes in mRNA stability. The same
group reported that cAMP-induced decrease of rat ATa receptor mRNA was
(Mqfcitc* eh a|, 1992")
not dependent on protein synthesis, whereas All-induced decrease was, thus
providing further evidence for the differing mechanisms of regulation by the
two systems, as suggested by the different timescales observed in bovine zfr
cells.
The mechanism of the decrease in AT} receptor mRNA levels induced
by Cortisol is also not certain. The ATi receptor in rodents is known to have a
glucocorticoid response element (Guo et al. 1995); given the similarities in
genomic organisation and receptor regulation in different species, it is likely
that a similar element is also present in bovines and that this is immediately
responsible for the regulation observed.
It is interesting to speculate on how the regulatory agents investigated
in these studies might affect the expression of ATX receptor mRNA in vivo.
The adrenal gland is exposed to AH at both a local and a systemic level.
Plasma AD may be more likely to modulate acute effects of AH on its own
receptor, while the local renin-angiotensin system could be involved in long-
term regulation in the adrenal cortex. Raised concentrations of IGF-1 and K+
are probably locally generated. An intriguing picture emerges that
influences which act to downregulate the ATj receptor mRNA levels are
systemically generated, while those acting to raise the levels are locally
generated (here the action of All in raising its receptor mRNA levels on
chronic exposure can be included).
The physiological implications of the observed masking of regulation
of ATi receptor mRNA by serum are less clear. The significance would
depend partly on whether this masking of regulation was present for all the
downregulators examined, or solely for AH, and partly on whether this
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'growth factor' was present in normal serum or plasma. If it were purely a
serum and not a plasma factor, there should not be much effect on AT}
receptor regulation in vivo. However, if the factor were present in plasma, it
could well reach the ATi receptors in adrenocortical cells and influence their
regulation to an unknown degree. If, for some reason, the amount of
postulated 'growth factor' were to be abnormally high, this could have
significant effects on ATX receptor expression and steroidogenic responses to
angiotensin II.
The results presented in this chapter have broadened our knowledge
of the regulation of AT} receptors in this important model tissue. However,
further work is needed to expand this knowledge to yield a fuller picture of
the nature, significance and mechanisms of All receptor regulation. First to
be addressed would be the performance of ligand binding experiments to
examine how closely the receptor protein follows the mRNA in response to
the agonists studied. Use of transcription inhibitors, protein synthesis
inhibitors and run-on/ run-off assays would also be needed to assess at what
level the observed regulation is taking place and whether it varies between
agonists. The experiments should also be extended to the zona glomerulosa,
if the low cell yield can be overcome (use of RT-PCR to assess ATx receptor
mRNA levels is a possibility) as the possible existence of zone-specific
regulation should not be ignored. This could add another dimension to the
theories of adrenocortical zonation.
Co-ordinate regulation of AT! and AT2 receptors has been proposed,
shown in some tissues (Kijima et al. 1995), and refuted in others (De Gasparo
et al. 1994). It would therefore be most interesting to examine the changes in
AT2 receptor mRNA levels following incubation of both zg and zfr cells with
the agonists used previously. Under normal conditions virtually no AT2
receptors are present, and therefore any increase would be very exciting.
The challenge of dissecting out which signal transduction systems
plays the major part in regulating the ATi receptor could be initiated by
expressing the AT: receptor in non-steroidogenic cells (e.g. CHO cells) in
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which only one system is known to be active. Other systems could then be
mimicked and alterations in regulation of the expressed receptor
determined. Another attractive possibility would be to study some of the
agonists used in a bovine vascular smooth muscle cell culture system.
Examination of how steroids might affect this non-steroidogenic tissue
should prove interesting.
Lastly, once the mechanism by which the receptor is regulated has
been determined, isolation of any putative tissue-specific transcription
factors responsible for inducing this regulation would be fascinating and
also may provide a way to manipulate ATi receptor regulation should this
be possible or necessary.
In concluding this chapter, I would like to consider the potential
pathophysiological significance of the results obtained. The renin-
angiotensin system is highly important in regulating blood pressure and
volume. The AT} receptor is a significant part of this system, and if its
regulation were disturbed, so then might be the responses to All in its target
organs. This can be envisaged by considering the effect of ACTH on AT}
receptor regulation. Chronically raised ACTH, as well as increasing Cortisol,
may downregulate AT} receptors, and thus decrease adrenal sensitivity to
AIL This could in turn lead to disturbances in aldosterone secretion and
electrolyte balance. To fully understand the implications of disturbance of
All receptor regulation, it is essential to understand both the nature of All
receptors and how their regulation is effected. The results presented in this
thesis show that both are highly complex; the regulation especially appears
to involve the interplay of many intracellular systems, which may act at a
local or a systemic level.
230
Appendix 1: Publications
The following publications have arisen from the work presented in
this thesis :
GC Dell, SD Morley, JJ Mullins, BCWilliams and SWWalker (1996):
Regulation of Angiotensin II (ATj) receptor expression in bovine
adrenocortical cells. Journal ofEndocrinology 148 : OC8
GC Dell, SD Morley, J] Mullins, BCWilliams and SWWalker :
Multiple signal transduction systems regulate type 1 Angiotensin II receptor
mRNA expression in bovine adrenocortical cells. Endocrine Research 22 : 363-
368
GC Dell, SD Morley, JJ Mullins, SWWalker and BCWilliams :
Regulation of type 1 angiotensin II receptor (ATi) mRNA expression in
bovine adrenocortical cells by multiple signal transduction systems and
adrenocortical steroids. Endocrinology, in preparation.
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MULTIPLE SIGNAL TRANSDUCTION SYSTEMS REGULATE
ANGIOTENSIN II TYPE 1 (AT]) RECEPTOR mRNA EXPRESSION IN
BOVINE ADRENOCORTICAL CELLS
G.C. Dell1, S.D. Morley1'2, J.J.Mullins2, B.C. Williams3 and S.W. Walker1
Departments ofClinical Biochemistry1, Centre for Genome Research2 and
Medicine3, University ofEdinburgh, Edinburgh, U.K.
ABSTRACT
Regulation of ATt receptor mRNA expression is an important determinant of
angiotensin Il-induced steroidogenesis. We have PCR-amplified the bovine
adrenal ATj receptor coding region using primers designed from the published
bovine ATj receptor sequence. This has been used as a probe on Northern blots to
detect changes in the levels of ATj receptor mRNA in primary cultures of bovine
zona fasciculata cells in response to activation of several different signal
transduction mechanisms in additon to two major adrenal steroid products,
Cortisol and aldosterone. ATX receptor mRNA decreased in response to 6hr All
(10 nM) treatment, but returned to basal levels following 48h All treatment. This
effect was mimicked by the phorbol ester PMA (1 pM) and the calcium ionophore
A23187 (1 |iM), both singly and in combination. Activation of the cAMP pathway
by ACTH (1 nM) and 8-bromo-cAMP (0.1 pM) also decreased ATt receptor
mRNA levels. In contrast, both IGF-1 (10 ng/ml) and potassium ions (12 mM)
increased the levels of ATj receptor mRNA. Finally, Cortisol (10 pM) but not
aldosterone (lOOnM) decreased ATj receptor mRNA. We conclude that the
regulation of AT, receptor mRNA in bovine zona fasciculata cells could involve
several different signal transduction systems in addition to adrenocortical steroids
themselves.
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INTRODUCTION
Angiotensin II (All) acts through specific ATX receptors to regulate
aldosterone secretion from the zona glomerulosa of the adrenal cortex in most
mammalian species including the human. In the human and bovine species All also
stimulates Cortisol secretion from the zona fasciculata (zf) (1, 2). Bovine
adrenocortical cells provide a useful model for the human since they exhibit
similar steroidogenic responsiveness (3). All receptor activation in bovine zf cells
is coupled to the inositol trisphosphate/calcium (IiyCa2+) second messenger
system (4). Previous studies in bovine zf cells demonstrated that prolonged
exposure to All or to effectors of both cyclic AMP (cAMP) dependent kinases and
protein kinase C decreased the binding of 125I-AII, consistent with a loss of All
receptors (5). A similar pattern of down-regulation ofATi receptors was inferred
by analysis of ATi receptor mRNA levels in the H295R human adrenocortical
tumour cell line (6).
In this study, we report on the regulation of ATX receptor mRNA in primary
cultures of bovine zf cells. It has now become clear that the control of Cortisol
secretion in zf cells is multifactorial and since multiple signal transduction
mechanisms are present in adrenocortical cells, we chose to study the effects of
All itself, the phorbol ester PMA, the calcium ionophore A23187, ACTH,
(which acts through cAMP), 8-bromo-cAMP, insulin-like growth factor-1 (IGF-
1, a stimulator of tyrosine kinase) and potassium, which activates voltage-gated
Ca2+ channels (7,8). In addition we tested whether the two principal steroid
products of the adrenal cortex, namely Cortisol and aldosterone, had the potential
to directly regulate ATi receptor mRNA.
METHODS
The bovine adrenal ATj receptor coding region was amplified by PCR with
primers designed from the published ATL receptor sequence (9), using genomic
DNA as the template, and inserted into a modification of pSP72 (Promega).
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Bovine zf cells were isolated and cultured as described previously (10). On the
second day after isolation, the cells were serum deprived for 6 h before being
exposed to agonists for the stated times and concentrations. Medium containing
agonists was changed daily. At the end of the treatment period, total RNA was
isolated from the cells using RNAzol reagent (11). 25 pg RNA was analyzed by
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Northern blotting (12) and hybridized to a P-labelled probe for the AT, receptor,
prepared by random priming (13) of the cloned AT, receptor coding region.
Experiments were performed in duplicate.
RESULTS
Exposure of bovine zf cells to 10 nM All resulted in a rapid and dramatic
decrease in AT, receptor mRNA, which was detectable after 4 h and maintained
until 24 h, but returned to basal levels after 48 h. A similar time-course of
decrease, followed by recovery of AT, receptor mRNA was observed after
exposure of the cells to either 1 pM-phorbol ester (PMA) or calcium ionophore
(A23187). However, when these two agonists were applied in combination, AT,
receptor mRNA showed the same rapid decrease, but remained depressed after 48
h (Table I). Treatment of the cells with either 1 nM ACTH, or with 0.1 mM-8-
bromo cAMP, also caused a decrease in AT, receptor mRNA (Table I). This
decrease was first apparent after 8 h, and reached its maximum after 48 h. Acute
exposure (8 h) of cells to 10 ng/mL IGF-1 produced a decrease in AT, receptor
mRNA, which recovered and indeed was increased above basal levels after 48 h
exposure (Table I). Potassium (12 mM) also increased AT, receptor mRNA,
reaching a maximal effect after 48 h treatment (Table I). Aldosterone (100 nM)
had no effect on ATi receptor mRNA. In contrast, Cortisol (10 pJM) induced a
pronounced decrease in ATi receptor mRNA in these cells (Table I).
DISCUSSION
These results, although qualitative in nature, indicate the complexity of AT,
receptor mRNA regulation in bovine zf cells. All induced a rapid decrease in
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TABLE I
Effect of acute and chronic treatment with various agonists on AT, receptor
mRNA in bovine zf cells (4 decrease; T increase; <-» unchanged).
Agonist AT, receptor mRNA level AT, receptor mRNA level
(acute) (chronic)
All (10 nM) 44 <r-»
PMA (1 pM) 44
A23187(1 pM) 4
PMA+ A23187 (1 pM) 44 44
ACTH (1 nM) 4 44
8-Bromo-cAMP (0.1mM) 4 44
IGF-1 (10 ng/mL) 4 tt
Potassium (12 mM) n T
Cortisol (10 pM) 44 4
Aldosterone (100 nM) <r->
ATi receptor mRNA. This down-regulation could be mimicked by exposure to
PMA or A23187 singly or in combination. However, after chronic incubation with
the PMA/A23187 combination, levels of ATj receptor mRNA did not recover as
they did after All treatment. These results compare with published data on All
receptor binding in bovine zf cells (5) except that the decrease in AT, receptor
mRNA in our study occurred more acutely after exposure to these agonists than
did the decrease in AT, receptor binding previously reported (5). In H295R cells,
Bird et al. also observed that changes in AII receptor binding lagged behind
changes in AT, receptor mRNA by some 6 h in response to AII and PMA/A23187
(6). Although both ATj receptor mRNA and AII receptor binding levels appear
to respond similarly to cAMP activators and analogs in both bovine and human
species, these changes nevertheless occur on different time scales. In the human
H295R cells, maximal decrease in AT, mRNA occurred after 6 h stimulation (6),
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whereas in bovine zf cells we observed a greater decrease after 48h both with
ACTH and 8-bromo-cAMP. In contrast to the effects of cAMP, the tyrosine
kinase agonist, IGF-1, caused an acute decrease followed by a more chronic and
pronounced increase in ATj receptor mRNA. This finding is in keeping with the
results of other workers (14). Potassium is the only agonist which led to both an
acute and chronic increase in ATi receptor mRNA in bovine zf cells and this
contrasts with recent results from H295R cells, which showed that 14 mM
potassium produced a significant decrease in ATj receptor mRNA (6). The reason
for this discrepancy is not clear and requires further investigation. Adrenal
steroids have not previously been considered to be important in the physiological
regulation of All receptors (15). However, we observed that Cortisol, but not
aldosterone, produced both an acute and chronic decrease in ATt receptor mRNA.
These findings suggest that Cortisol can directly regulate ATX receptor expression
at the level of transcription. Clearly further experiments are required in order to
elucidate this novel finding.
In conclusion we have demonstrated that AT! receptor mRNA can be
differentially regulated by several separate signal transduction mechanisms and
potentially by adrenocortical steroids themselves.
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